Clinical Approach to Urticaria
<!DOCTYPE html>
<html lang=”en”>
<head>
<meta charset=”UTF-8″>
<meta name=”viewport” content=”width=device-width, initial-scale=1.0″>
<title>Clinical Approach to Hives (Urticaria) – Pediatric</title>
<link rel=”stylesheet” href=”https://cdnjs.cloudflare.com/ajax/libs/font-awesome/4.7.0/css/font-awesome.min.css”>
<link rel=”stylesheet” href=”styles.css”>
</head>
<body>
<div class=”page-wrapper”>
<div class=”tasks-container”>
<!– Hidden radio buttons for task switching –>
<input type=”radio” name=”tasks” id=”task1″ class=”task-control” checked>
<input type=”radio” name=”tasks” id=”task2″ class=”task-control”>
<input type=”radio” name=”tasks” id=”task3″ class=”task-control”>
<input type=”radio” name=”tasks” id=”task4″ class=”task-control”>
<input type=”radio” name=”tasks” id=”task5″ class=”task-control”>
<input type=”radio” name=”tasks” id=”task6″ class=”task-control”>
<input type=”radio” name=”tasks” id=”task7″ class=”task-control”>
<input type=”radio” name=”tasks” id=”task8″ class=”task-control”>
<!– LEFT NAVIGATION PANEL –>
<div class=”tasks-panel”>
<div class=”panel-header”>
<h2 class=”panel-title”>Clinical Approach to Hives (Urticaria)</h2>
<span class=”panel-subtitle”>Pediatric Comprehensive Framework</span>
</div>
<ul class=”tasks-list”>
<li class=”task-item” data-task-id=”task1″><label class=”task-label” for=”task1″><div class=”task-number”>1</div><div class=”task-text”>Symptom Overview</div><span class=”task-meta-tag tag-overview”>Overview</span></label></li>
<li class=”task-item” data-task-id=”task2″><label class=”task-label” for=”task2″><div class=”task-number”>2</div><div class=”task-text”>Pathophysiology</div><span class=”task-meta-tag tag-pathophys”>Mechanism</span></label></li>
<li class=”task-item” data-task-id=”task3″><label class=”task-label” for=”task3″><div class=”task-number”>3</div><div class=”task-text”>History Taking</div><span class=”task-meta-tag tag-history”>History</span></label></li>
<li class=”task-item” data-task-id=”task4″><label class=”task-label” for=”task4″><div class=”task-number”>4</div><div class=”task-text”>Physical Examination</div><span class=”task-meta-tag tag-examination”>Examination</span></label></li>
<li class=”task-item” data-task-id=”task5″><label class=”task-label” for=”task5″><div class=”task-number”>5</div><div class=”task-text”>Differential Diagnosis</div><span class=”task-meta-tag tag-differential”>Differential</span></label></li>
<li class=”task-item” data-task-id=”task6″><label class=”task-label” for=”task6″><div class=”task-number”>6</div><div class=”task-text”>Investigations</div><span class=”task-meta-tag tag-investigations”>Workup</span></label></li>
<li class=”task-item” data-task-id=”task7″><label class=”task-label” for=”task7″><div class=”task-number”>7</div><div class=”task-text”>Clinical Decision-Making</div><span class=”task-meta-tag tag-decision”>Algorithm</span></label></li>
<li class=”task-item” data-task-id=”task8″><label class=”task-label” for=”task8″><div class=”task-number”>8</div><div class=”task-text”>Pearls and Pitfalls</div><span class=”task-meta-tag tag-pearls”>Summary</span></label></li>
</ul>
</div>
<!– RIGHT CONTENT PANEL –>
<div class=”content-panel”>
<!– ==================== TASK 1: SYMPTOM OVERVIEW ==================== –>
<div class=”task-content” id=”task1-content”>
<div class=”task-header”>
<h1 class=”task-title”>1. Symptom Overview</h1>
<p class=”task-subtitle”>Understanding the clinical significance and classification of urticaria in children</p>
</div>
<div class=”task-body”>
<p>Urticaria, commonly known as hives, is one of the most frequent dermatologic conditions encountered in pediatric practice. Approximately 15-25% of children will experience at least one episode of acute urticaria during childhood, making it a common reason for emergency department visits and urgent care consultations. The condition affects children of all ages, from infants to adolescents, with a slight female predominance in chronic cases. While acute urticaria is typically benign and self-limiting, it can cause significant distress to both children and their caregivers, and in rare cases may herald a more serious systemic allergic reaction.</p>
<div class=”callout-box info-box”>
<div class=”callout-icon”><i class=”fa fa-info-circle”></i></div>
<div class=”callout-content”>
<h4>Definition</h4>
<p>Urticaria is characterized by the sudden appearance of wheals (raised, erythematous, pruritic lesions with central pallor) that result from localized dermal edema due to transient plasma extravasation. Individual wheals typically last less than 24 hours and resolve without leaving residual marks. When deeper subcutaneous and submucosal tissues are involved, the condition is termed angioedema, which commonly affects the lips, eyelids, hands, feet, and genitalia.</p>
</div>
</div>
<div class=”callout-box info-box”>
<div class=”callout-icon”><i class=”fa fa-info-circle”></i></div>
<div class=”callout-content”>
<h4>Key Epidemiology in Children</h4>
<div class=”grid-2″>
<div>
<ul>
<li><strong>Lifetime prevalence:</strong> 15-25% of children</li>
<li><strong>Acute urticaria:</strong> Accounts for >80% of pediatric cases</li>
<li><strong>Chronic urticaria:</strong> Affects 0.1-0.3% of children</li>
</ul>
</div>
<div>
<ul>
<li><strong>Peak age for acute:</strong> Preschool and school-age children</li>
<li><strong>Infection-related:</strong> 40-80% of acute pediatric cases</li>
<li><strong>Identifiable trigger:</strong> Found in only 20-30% of chronic cases</li>
</ul>
</div>
</div>
</div>
</div>
<h2>Classification by Duration</h2>
<p>Duration is the primary method of classifying urticaria and has significant implications for etiology, workup, and management.</p>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Category</th>
<th>Duration</th>
<th>Common Causes in Children</th>
<th>Clinical Significance</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Acute Urticaria</strong></td>
<td>Less than 6 weeks</td>
<td>Viral infections (most common), food allergies, medication reactions, insect stings</td>
<td>Usually self-limiting; identify and avoid triggers if possible; reassure family</td>
</tr>
<tr>
<td><strong>Acute Recurrent Urticaria</strong></td>
<td>Repeated episodes, each lasting less than 6 weeks with symptom-free intervals</td>
<td>Recurrent viral infections, intermittent allergen exposure, physical triggers</td>
<td>Consider pattern recognition for triggers; may warrant allergy evaluation</td>
</tr>
<tr>
<td><strong>Chronic Urticaria</strong></td>
<td>Greater than 6 weeks (wheals occurring most days)</td>
<td>Chronic spontaneous urticaria (most common), chronic inducible urticaria, autoimmune conditions</td>
<td>Often idiopathic; may require specialist referral; significant impact on quality of life</td>
</tr>
</tbody>
</table>
</div>
<h2>Classification by Character and Morphology</h2>
<div class=”grid-2″>
<div class=”grid-item”>
<h3>Wheals (Hives)</h3>
<p><strong>Appearance:</strong> Raised, erythematous papules or plaques with surrounding erythema and often central pallor</p>
<p><strong>Size:</strong> Variable, from a few millimeters to several centimeters; may coalesce into larger plaques</p>
<p><strong>Duration:</strong> Individual lesions typically resolve within 30 minutes to 24 hours</p>
<p><strong>Key feature:</strong> Migratory nature — old lesions fade while new ones appear in different locations</p>
</div>
<div class=”grid-item”>
<h3>Angioedema</h3>
<p><strong>Appearance:</strong> Deeper, less well-defined swelling of subcutaneous or submucosal tissue</p>
<p><strong>Common sites:</strong> Lips, eyelids, tongue, hands, feet, genitalia</p>
<p><strong>Duration:</strong> Typically lasts 24-72 hours</p>
<p><strong>Key feature:</strong> Often described as painful or burning rather than pruritic; occurs with wheals in approximately 40% of cases</p>
</div>
</div>
<h2>Classification by Pattern and Timing</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Pattern</th>
<th>Description</th>
<th>Suggests</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Immediate onset (minutes to 2 hours)</strong></td>
<td>Rapid appearance after exposure to trigger</td>
<td>IgE-mediated food allergy, medication allergy, insect sting hypersensitivity</td>
</tr>
<tr>
<td><strong>Delayed onset (hours to days)</strong></td>
<td>Gradual development without clear temporal relationship to exposure</td>
<td>Viral infection (most common), serum sickness-like reaction, drug reaction</td>
</tr>
<tr>
<td><strong>Physical trigger-related</strong></td>
<td>Reproducible appearance with specific physical stimulus</td>
<td>Cold urticaria, cholinergic urticaria (heat/exercise), dermatographism, pressure urticaria</td>
</tr>
<tr>
<td><strong>Nocturnal predominance</strong></td>
<td>Wheals appear or worsen at night</td>
<td>Chronic spontaneous urticaria, dust mite sensitivity, delayed pressure urticaria</td>
</tr>
<tr>
<td><strong>Exercise-induced</strong></td>
<td>Appears during or shortly after physical activity</td>
<td>Cholinergic urticaria, exercise-induced anaphylaxis (with or without food co-factor)</td>
</tr>
<tr>
<td><strong>Contact pattern</strong></td>
<td>Wheals localized to area of contact with substance</td>
<td>Contact urticaria (foods, latex, plants, animals)</td>
</tr>
</tbody>
</table>
</div>
<h2>Classification by Etiology</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Category</th>
<th>Subtypes</th>
<th>Pediatric Considerations</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Chronic Spontaneous Urticaria</strong></td>
<td>Autoimmune (with anti-IgE or anti-FcεRI antibodies) or idiopathic</td>
<td>Less common in children than adults; female predominance in adolescents; may be associated with thyroid autoimmunity</td>
</tr>
<tr>
<td><strong>Chronic Inducible Urticaria</strong></td>
<td>Cold, heat, solar, dermatographic, cholinergic, aquagenic, vibratory, delayed pressure</td>
<td>Cold urticaria is most common physical urticaria in children; cholinergic urticaria peaks in adolescence</td>
</tr>
<tr>
<td><strong>Allergic (IgE-mediated)</strong></td>
<td>Food, medication, insect venom, latex, aeroallergen</td>
<td>More common trigger in children than adults; cow’s milk, egg, peanut, tree nuts most common food triggers</td>
</tr>
<tr>
<td><strong>Infection-associated</strong></td>
<td>Viral (most common), bacterial, parasitic</td>
<td>Accounts for majority of acute pediatric urticaria; upper respiratory infections, gastroenteritis, urinary tract infections</td>
</tr>
</tbody>
</table>
</div>
<h2>Associated Features and Severity Assessment</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Severity</th>
<th>Features</th>
<th>Management Implications</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Mild</strong></td>
<td>Localized wheals, minimal pruritus, no angioedema, no systemic symptoms</td>
<td>Outpatient management; oral antihistamines as needed</td>
</tr>
<tr>
<td><strong>Moderate</strong></td>
<td>Widespread wheals, significant pruritus affecting sleep or daily activities, peripheral angioedema (lips, eyes, extremities)</td>
<td>Regular antihistamines; short-term follow-up; consider allergen testing if recurrent</td>
</tr>
<tr>
<td><strong>Severe / Anaphylaxis</strong></td>
<td>Urticaria with respiratory symptoms (stridor, wheeze, dyspnea), cardiovascular instability, gastrointestinal symptoms, tongue or throat swelling</td>
<td>Emergency management; epinephrine; hospitalization may be required; mandatory allergy referral</td>
</tr>
</tbody>
</table>
</div>
<div class=”highlight-box”>
<p><strong>Key Concept: The Pediatric Urticaria Triad</strong></p>
<p>In children with acute urticaria, three causes account for the vast majority of cases:</p>
<ul>
<li><strong>Viral infections</strong> — The most common trigger (40-80%), often with concurrent or recent upper respiratory or gastrointestinal symptoms</li>
<li><strong>Food allergies</strong> — Particularly in infants and young children; typically presents within 2 hours of ingestion</li>
<li><strong>Idiopathic</strong> — No identifiable trigger found despite thorough history; still usually self-limiting</li>
</ul>
<p>Unlike adults, medications and autoimmune causes are less common triggers in the pediatric population.</p>
</div>
<div class=”callout-box tip-box”>
<div class=”callout-icon”><i class=”fa fa-lightbulb-o”></i></div>
<div class=”callout-content”>
<h4>Clinical Pearl: Wheals vs. Other Rashes</h4>
<p>A key distinguishing feature of urticaria is the transient nature of individual wheals — they should resolve completely within 24 hours without leaving any residual marking. If individual lesions persist beyond 24 hours, leave bruising or pigmentation, or are painful rather than pruritic, consider urticarial vasculitis and other mimics that require different evaluation and management.</p>
</div>
</div>
<div class=”content-footer”>
<div class=”copyright”>© Medaptly. All rights reserved.</div>
<div class=”logo”><img src=”https://medaptlytemplates.doo.ee/Medaptly_Logo-removebg-preview.png” alt=”Medaptly Logo”></div>
</div>
</div>
</div>
<!– ==================== TASK 2: PATHOPHYSIOLOGY ==================== –>
<div class=”task-content” id=”task2-content”>
<div class=”task-header”>
<h1 class=”task-title”>2. Pathophysiology and Mechanisms</h1>
<p class=”task-subtitle”>Understanding the underlying mechanisms of urticaria in children</p>
</div>
<div class=”task-body”>
<p>Urticaria results from the activation and degranulation of mast cells in the skin, leading to the release of histamine and other vasoactive mediators. This causes localized vasodilation, increased vascular permeability, and sensory nerve stimulation — resulting in the characteristic triad of erythema, edema (wheal), and pruritus. Understanding these mechanisms is essential for rational therapeutic approaches and for explaining the condition to families.</p>
<h2>The Urticaria Pathway</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Component</th>
<th>Structure</th>
<th>Function in Urticaria</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Trigger</strong></td>
<td>Allergen, infection, physical stimulus, autoantibody, or unknown</td>
<td>Initiates the cascade by activating mast cells through various mechanisms</td>
</tr>
<tr>
<td><strong>Mast Cells</strong></td>
<td>Tissue-resident immune cells in dermis, particularly around blood vessels and nerves</td>
<td>Central effector cell; degranulation releases preformed and newly synthesized mediators</td>
</tr>
<tr>
<td><strong>Primary Mediators</strong></td>
<td>Histamine (preformed), tryptase, heparin, prostaglandins, leukotrienes (newly synthesized)</td>
<td>Cause vasodilation, increased permeability, smooth muscle contraction, nerve stimulation</td>
</tr>
<tr>
<td><strong>Blood Vessels</strong></td>
<td>Dermal capillaries and postcapillary venules</td>
<td>Dilate and become permeable, allowing plasma extravasation and wheal formation</td>
</tr>
<tr>
<td><strong>Sensory Nerves</strong></td>
<td>Cutaneous C-fibers and Aδ fibers</td>
<td>Stimulation causes pruritus; axon reflex causes surrounding erythema (flare)</td>
</tr>
</tbody>
</table>
</div>
<h2>Mast Cell Activation Pathways</h2>
<p>Mast cells can be activated through multiple distinct pathways, which has important implications for identifying triggers and selecting treatments.</p>
<div class=”grid-3″>
<div class=”grid-item”>
<h3>IgE-Mediated (Type I Hypersensitivity)</h3>
<p><strong>Mechanism:</strong> Allergen cross-links IgE antibodies bound to high-affinity IgE receptors (FcεRI) on mast cell surface</p>
<p><strong>Triggers:</strong> Foods, medications, insect venoms, latex, aeroallergens</p>
<p><strong>Timing:</strong> Rapid onset (minutes to 2 hours after exposure)</p>
<p><strong>Clinical relevance:</strong> Most important mechanism in pediatric food allergy; amenable to allergen avoidance and immunotherapy</p>
</div>
<div class=”grid-item”>
<h3>Autoimmune (Type IIb Hypersensitivity)</h3>
<p><strong>Mechanism:</strong> Autoantibodies (anti-IgE or anti-FcεRI) directly activate mast cells without allergen</p>
<p><strong>Triggers:</strong> No external trigger; intrinsic autoimmune process</p>
<p><strong>Timing:</strong> Chronic, spontaneous episodes</p>
<p><strong>Clinical relevance:</strong> Present in 30-50% of chronic spontaneous urticaria; may respond to omalizumab; associated with other autoimmune conditions</p>
</div>
<div class=”grid-item”>
<h3>Non-Immunologic (Direct Mast Cell Activation)</h3>
<p><strong>Mechanism:</strong> Direct stimulation of mast cells without IgE involvement via MRGPRX2 receptor or physical stimuli</p>
<p><strong>Triggers:</strong> Opioids, radiocontrast, NSAIDs, physical stimuli (cold, heat, pressure), complement activation</p>
<p><strong>Timing:</strong> Variable; often predictable with known triggers</p>
<p><strong>Clinical relevance:</strong> NSAID hypersensitivity common in children; physical urticarias are reproducible</p>
</div>
</div>
<h2>Key Mediators and Their Effects</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Mediator</th>
<th>Source</th>
<th>Effects</th>
<th>Therapeutic Target</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Histamine</strong></td>
<td>Preformed in mast cell granules</td>
<td>Vasodilation, increased permeability, pruritus (via H1 receptors), gastric acid secretion (H2)</td>
<td>H1-antihistamines (first-line therapy); H2-antihistamines (adjunctive)</td>
</tr>
<tr>
<td><strong>Tryptase</strong></td>
<td>Preformed in mast cell granules</td>
<td>Activates complement, degrades neuropeptides, proinflammatory</td>
<td>Serum tryptase used as biomarker for mast cell activation</td>
</tr>
<tr>
<td><strong>Prostaglandin D2</strong></td>
<td>Newly synthesized via cyclooxygenase</td>
<td>Vasodilation, bronchoconstriction, recruitment of inflammatory cells</td>
<td>COX inhibitors may worsen urticaria in susceptible patients</td>
</tr>
<tr>
<td><strong>Leukotrienes (LTC4, LTD4, LTE4)</strong></td>
<td>Newly synthesized via lipoxygenase</td>
<td>Increased vascular permeability, bronchoconstriction, mucus secretion</td>
<td>Leukotriene receptor antagonists (montelukast) as adjunctive therapy</td>
</tr>
<tr>
<td><strong>Platelet-Activating Factor</strong></td>
<td>Newly synthesized</td>
<td>Hypotension, bronchoconstriction, increased permeability; key mediator in anaphylaxis</td>
<td>No specific clinically available antagonist</td>
</tr>
<tr>
<td><strong>Cytokines (TNF-α, IL-4, IL-5, IL-13)</strong></td>
<td>Newly synthesized and secreted</td>
<td>Late-phase inflammation, eosinophil recruitment, prolonged symptoms</td>
<td>Corticosteroids; biologics targeting specific cytokines</td>
</tr>
</tbody>
</table>
</div>
<h2>How Conditions Cause Urticaria</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Condition</th>
<th>Mechanism</th>
<th>Treatment Implication</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Viral Infection</strong></td>
<td>Immune complex formation, direct viral activation of mast cells, cross-reactivity between viral antigens and self-antigens</td>
<td>Self-limiting; symptomatic treatment with antihistamines; no antivirals needed for urticaria</td>
</tr>
<tr>
<td><strong>IgE-Mediated Food Allergy</strong></td>
<td>Food protein cross-links specific IgE on mast cells, causing rapid degranulation</td>
<td>Strict allergen avoidance; epinephrine auto-injector for patients at risk of anaphylaxis; consider oral immunotherapy</td>
</tr>
<tr>
<td><strong>Cold Urticaria</strong></td>
<td>Cold exposure triggers mast cell degranulation, possibly through cold-sensitive ion channels or cryoproteins</td>
<td>Cold avoidance; premedication with antihistamines before cold exposure; warn about swimming risks</td>
</tr>
<tr>
<td><strong>Cholinergic Urticaria</strong></td>
<td>Elevated core body temperature activates mast cells via acetylcholine release from sympathetic nerves</td>
<td>May respond to antihistamines; anticholinergics sometimes helpful; gradual heat tolerance may develop</td>
</tr>
<tr>
<td><strong>Dermatographism</strong></td>
<td>Mechanical shear stress on skin triggers mast cell degranulation at the site of pressure</td>
<td>Avoid triggers (tight clothing, scratching); regular antihistamines; reassurance that it is benign</td>
</tr>
<tr>
<td><strong>Chronic Spontaneous Urticaria (Autoimmune)</strong></td>
<td>Autoantibodies against IgE or FcεRI receptors cause persistent mast cell activation without external trigger</td>
<td>Higher antihistamine doses often required; omalizumab effective by reducing free IgE; may remit over years</td>
</tr>
<tr>
<td><strong>NSAID-Induced Urticaria</strong></td>
<td>COX-1 inhibition shifts arachidonic acid metabolism toward leukotriene pathway, sensitizing mast cells</td>
<td>Avoid NSAIDs; acetaminophen usually safe; selective COX-2 inhibitors may be tolerated</td>
</tr>
<tr>
<td><strong>Serum Sickness-Like Reaction</strong></td>
<td>Immune complex deposition following drug exposure (commonly antibiotics) activates complement and mast cells</td>
<td>Stop offending drug; symptoms self-limited; antihistamines and corticosteroids for symptom relief</td>
</tr>
</tbody>
</table>
</div>
<h2>Pediatric-Specific Pathophysiological Considerations</h2>
<div class=”grid-2″>
<div class=”grid-item”>
<h3>Immune System Development</h3>
<ul>
<li>Immature immune regulation in infants may lead to more robust mast cell responses</li>
<li>Higher frequency of viral infections in young children contributes to infection-associated urticaria</li>
<li>Food allergies are more common in early childhood due to immature gut barrier and immune tolerance</li>
<li>Autoimmune chronic urticaria is less common in children than adults</li>
</ul>
</div>
<div class=”grid-item”>
<h3>Skin Characteristics</h3>
<ul>
<li>Pediatric skin has higher mast cell density in some studies</li>
<li>Thinner epidermis may lead to more visible and dramatic-appearing wheals</li>
<li>Higher surface area to body weight ratio means greater systemic absorption of topical medications</li>
<li>Dermatographism is common and often incidental finding in children</li>
</ul>
</div>
</div>
<h2>The Wheal and Flare Response</h2>
<div class=”highlight-box”>
<p><strong>Understanding the Triple Response of Lewis:</strong></p>
<ol>
<li><strong>Initial erythema (red line):</strong> Local vasodilation due to direct histamine effect on blood vessels — appears within seconds</li>
<li><strong>Wheal (raised, pale center):</strong> Plasma extravasation from increased vascular permeability — develops over 1-3 minutes</li>
<li><strong>Flare (surrounding erythema):</strong> Axon reflex causing vasodilation in surrounding skin — mediated by neuropeptides (substance P, CGRP)</li>
</ol>
<p>This classic response demonstrates the interplay between mast cell mediators, blood vessels, and sensory nerves that produces the clinical appearance of urticaria.</p>
</div>
<h2>Why Angioedema Occurs</h2>
<p>Angioedema represents the same pathophysiological process occurring in deeper tissues (subcutaneous and submucosal) rather than the superficial dermis. The loose connective tissue in certain areas — particularly the face (periorbital, lips), tongue, genitalia, and extremities — allows for more dramatic fluid accumulation. Two distinct mechanisms can cause angioedema:</p>
<div class=”grid-2″>
<div class=”grid-item”>
<h3>Histamine-Mediated Angioedema</h3>
<p><strong>Mechanism:</strong> Same mast cell activation pathway as wheals</p>
<p><strong>Characteristics:</strong> Usually accompanies urticaria; pruritic; responds to antihistamines; onset over minutes to hours</p>
<p><strong>Pediatric relevance:</strong> This is the typical form seen with allergic reactions and chronic urticaria in children</p>
</div>
<div class=”grid-item”>
<h3>Bradykinin-Mediated Angioedema</h3>
<p><strong>Mechanism:</strong> Excess bradykinin due to hereditary angioedema (C1-inhibitor deficiency) or ACE inhibitors</p>
<p><strong>Characteristics:</strong> No urticaria; not pruritic (often painful); does NOT respond to antihistamines; may involve airway</p>
<p><strong>Pediatric relevance:</strong> Hereditary angioedema typically presents in childhood or adolescence; ACE inhibitor use rare in children</p>
</div>
</div>
<div class=”callout-box warning-box”>
<div class=”callout-icon”><i class=”fa fa-exclamation-triangle”></i></div>
<div class=”callout-content”>
<h4>Critical Distinction: Hereditary Angioedema</h4>
<p>If a child presents with recurrent angioedema WITHOUT urticaria, particularly if there is a family history of similar episodes or unexplained laryngeal edema, consider hereditary angioedema (HAE). This bradykinin-mediated condition requires specific treatment (C1-inhibitor concentrate, icatibant, or ecallantide) and does NOT respond to antihistamines, corticosteroids, or epinephrine. Early recognition is critical as laryngeal attacks can be fatal.</p>
</div>
</div>
<div class=”callout-box tip-box”>
<div class=”callout-icon”><i class=”fa fa-lightbulb-o”></i></div>
<div class=”callout-content”>
<h4>Often Overlooked Mechanism: Pseudoallergic Reactions</h4>
<p>Many substances can cause urticaria through direct (non-IgE) mast cell activation, termed “pseudoallergic” reactions. In children, this commonly occurs with foods containing natural histamine or histamine-releasing compounds (strawberries, tomatoes, citrus, chocolate) or food additives. These reactions are dose-dependent, variable, and do not represent true allergy — meaning skin testing will be negative and small amounts may be tolerated. Families often incorrectly label these as “food allergies,” leading to unnecessary dietary restrictions.</p>
</div>
</div>
<div class=”section-divider”>
<div class=”section-divider-icon”><i class=”fa fa-flask”></i></div>
</div>
<h2>Complications of Urticaria Itself</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Complication</th>
<th>Mechanism</th>
<th>Clinical Significance</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Secondary Skin Infection</strong></td>
<td>Excoriation from scratching introduces bacteria</td>
<td>Monitor for signs of infection; keep nails short; optimize pruritus control</td>
</tr>
<tr>
<td><strong>Sleep Disturbance</strong></td>
<td>Pruritus often worsens at night; antihistamines may cause next-day sedation</td>
<td>Significant quality of life impact; use non-sedating antihistamines</td>
</tr>
<tr>
<td><strong>Anxiety and Psychological Impact</strong></td>
<td>Unpredictable nature, visible rash, fear of anaphylaxis</td>
<td>Address fears; provide clear action plan; consider psychology referral for chronic cases</td>
</tr>
<tr>
<td><strong>Anaphylaxis</strong></td>
<td>Massive systemic mast cell degranulation (urticaria is often the first sign)</td>
<td>Recognize early signs; treat promptly with epinephrine; educate families on recognition</td>
</tr>
</tbody>
</table>
</div>
<div class=”content-footer”>
<div class=”copyright”>© Medaptly. All rights reserved.</div>
<div class=”logo”><img src=”https://medaptlytemplates.doo.ee/Medaptly_Logo-removebg-preview.png” alt=”Medaptly Logo”></div>
</div>
</div>
</div>
<html lang=”en”>
<head>
<meta charset=”UTF-8″>
<meta name=”viewport” content=”width=device-width, initial-scale=1.0″>
<title>Clinical Approach to Hives (Urticaria) – Pediatric</title>
<link rel=”stylesheet” href=”https://cdnjs.cloudflare.com/ajax/libs/font-awesome/4.7.0/css/font-awesome.min.css”>
<link rel=”stylesheet” href=”styles.css”>
</head>
<body>
<div class=”page-wrapper”>
<div class=”tasks-container”>
<!– Hidden radio buttons for task switching –>
<input type=”radio” name=”tasks” id=”task1″ class=”task-control” checked>
<input type=”radio” name=”tasks” id=”task2″ class=”task-control”>
<input type=”radio” name=”tasks” id=”task3″ class=”task-control”>
<input type=”radio” name=”tasks” id=”task4″ class=”task-control”>
<input type=”radio” name=”tasks” id=”task5″ class=”task-control”>
<input type=”radio” name=”tasks” id=”task6″ class=”task-control”>
<input type=”radio” name=”tasks” id=”task7″ class=”task-control”>
<input type=”radio” name=”tasks” id=”task8″ class=”task-control”>
<!– LEFT NAVIGATION PANEL –>
<div class=”tasks-panel”>
<div class=”panel-header”>
<h2 class=”panel-title”>Clinical Approach to Hives (Urticaria)</h2>
<span class=”panel-subtitle”>Pediatric Comprehensive Framework</span>
</div>
<ul class=”tasks-list”>
<li class=”task-item” data-task-id=”task1″><label class=”task-label” for=”task1″><div class=”task-number”>1</div><div class=”task-text”>Symptom Overview</div><span class=”task-meta-tag tag-overview”>Overview</span></label></li>
<li class=”task-item” data-task-id=”task2″><label class=”task-label” for=”task2″><div class=”task-number”>2</div><div class=”task-text”>Pathophysiology</div><span class=”task-meta-tag tag-pathophys”>Mechanism</span></label></li>
<li class=”task-item” data-task-id=”task3″><label class=”task-label” for=”task3″><div class=”task-number”>3</div><div class=”task-text”>History Taking</div><span class=”task-meta-tag tag-history”>History</span></label></li>
<li class=”task-item” data-task-id=”task4″><label class=”task-label” for=”task4″><div class=”task-number”>4</div><div class=”task-text”>Physical Examination</div><span class=”task-meta-tag tag-examination”>Examination</span></label></li>
<li class=”task-item” data-task-id=”task5″><label class=”task-label” for=”task5″><div class=”task-number”>5</div><div class=”task-text”>Differential Diagnosis</div><span class=”task-meta-tag tag-differential”>Differential</span></label></li>
<li class=”task-item” data-task-id=”task6″><label class=”task-label” for=”task6″><div class=”task-number”>6</div><div class=”task-text”>Investigations</div><span class=”task-meta-tag tag-investigations”>Workup</span></label></li>
<li class=”task-item” data-task-id=”task7″><label class=”task-label” for=”task7″><div class=”task-number”>7</div><div class=”task-text”>Clinical Decision-Making</div><span class=”task-meta-tag tag-decision”>Algorithm</span></label></li>
<li class=”task-item” data-task-id=”task8″><label class=”task-label” for=”task8″><div class=”task-number”>8</div><div class=”task-text”>Pearls and Pitfalls</div><span class=”task-meta-tag tag-pearls”>Summary</span></label></li>
</ul>
</div>
<!– RIGHT CONTENT PANEL –>
<div class=”content-panel”>
<!– ==================== TASK 1: SYMPTOM OVERVIEW ==================== –>
<div class=”task-content” id=”task1-content”>
<div class=”task-header”>
<h1 class=”task-title”>1. Symptom Overview</h1>
<p class=”task-subtitle”>Understanding the clinical significance and classification of urticaria in children</p>
</div>
<div class=”task-body”>
<p>Urticaria, commonly known as hives, is one of the most frequent dermatologic conditions encountered in pediatric practice. Approximately 15-25% of children will experience at least one episode of acute urticaria during childhood, making it a common reason for emergency department visits and urgent care consultations. The condition affects children of all ages, from infants to adolescents, with a slight female predominance in chronic cases. While acute urticaria is typically benign and self-limiting, it can cause significant distress to both children and their caregivers, and in rare cases may herald a more serious systemic allergic reaction.</p>
<div class=”callout-box info-box”>
<div class=”callout-icon”><i class=”fa fa-info-circle”></i></div>
<div class=”callout-content”>
<h4>Definition</h4>
<p>Urticaria is characterized by the sudden appearance of wheals (raised, erythematous, pruritic lesions with central pallor) that result from localized dermal edema due to transient plasma extravasation. Individual wheals typically last less than 24 hours and resolve without leaving residual marks. When deeper subcutaneous and submucosal tissues are involved, the condition is termed angioedema, which commonly affects the lips, eyelids, hands, feet, and genitalia.</p>
</div>
</div>
<div class=”callout-box info-box”>
<div class=”callout-icon”><i class=”fa fa-info-circle”></i></div>
<div class=”callout-content”>
<h4>Key Epidemiology in Children</h4>
<div class=”grid-2″>
<div>
<ul>
<li><strong>Lifetime prevalence:</strong> 15-25% of children</li>
<li><strong>Acute urticaria:</strong> Accounts for >80% of pediatric cases</li>
<li><strong>Chronic urticaria:</strong> Affects 0.1-0.3% of children</li>
</ul>
</div>
<div>
<ul>
<li><strong>Peak age for acute:</strong> Preschool and school-age children</li>
<li><strong>Infection-related:</strong> 40-80% of acute pediatric cases</li>
<li><strong>Identifiable trigger:</strong> Found in only 20-30% of chronic cases</li>
</ul>
</div>
</div>
</div>
</div>
<h2>Classification by Duration</h2>
<p>Duration is the primary method of classifying urticaria and has significant implications for etiology, workup, and management.</p>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Category</th>
<th>Duration</th>
<th>Common Causes in Children</th>
<th>Clinical Significance</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Acute Urticaria</strong></td>
<td>Less than 6 weeks</td>
<td>Viral infections (most common), food allergies, medication reactions, insect stings</td>
<td>Usually self-limiting; identify and avoid triggers if possible; reassure family</td>
</tr>
<tr>
<td><strong>Acute Recurrent Urticaria</strong></td>
<td>Repeated episodes, each lasting less than 6 weeks with symptom-free intervals</td>
<td>Recurrent viral infections, intermittent allergen exposure, physical triggers</td>
<td>Consider pattern recognition for triggers; may warrant allergy evaluation</td>
</tr>
<tr>
<td><strong>Chronic Urticaria</strong></td>
<td>Greater than 6 weeks (wheals occurring most days)</td>
<td>Chronic spontaneous urticaria (most common), chronic inducible urticaria, autoimmune conditions</td>
<td>Often idiopathic; may require specialist referral; significant impact on quality of life</td>
</tr>
</tbody>
</table>
</div>
<h2>Classification by Character and Morphology</h2>
<div class=”grid-2″>
<div class=”grid-item”>
<h3>Wheals (Hives)</h3>
<p><strong>Appearance:</strong> Raised, erythematous papules or plaques with surrounding erythema and often central pallor</p>
<p><strong>Size:</strong> Variable, from a few millimeters to several centimeters; may coalesce into larger plaques</p>
<p><strong>Duration:</strong> Individual lesions typically resolve within 30 minutes to 24 hours</p>
<p><strong>Key feature:</strong> Migratory nature — old lesions fade while new ones appear in different locations</p>
</div>
<div class=”grid-item”>
<h3>Angioedema</h3>
<p><strong>Appearance:</strong> Deeper, less well-defined swelling of subcutaneous or submucosal tissue</p>
<p><strong>Common sites:</strong> Lips, eyelids, tongue, hands, feet, genitalia</p>
<p><strong>Duration:</strong> Typically lasts 24-72 hours</p>
<p><strong>Key feature:</strong> Often described as painful or burning rather than pruritic; occurs with wheals in approximately 40% of cases</p>
</div>
</div>
<h2>Classification by Pattern and Timing</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Pattern</th>
<th>Description</th>
<th>Suggests</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Immediate onset (minutes to 2 hours)</strong></td>
<td>Rapid appearance after exposure to trigger</td>
<td>IgE-mediated food allergy, medication allergy, insect sting hypersensitivity</td>
</tr>
<tr>
<td><strong>Delayed onset (hours to days)</strong></td>
<td>Gradual development without clear temporal relationship to exposure</td>
<td>Viral infection (most common), serum sickness-like reaction, drug reaction</td>
</tr>
<tr>
<td><strong>Physical trigger-related</strong></td>
<td>Reproducible appearance with specific physical stimulus</td>
<td>Cold urticaria, cholinergic urticaria (heat/exercise), dermatographism, pressure urticaria</td>
</tr>
<tr>
<td><strong>Nocturnal predominance</strong></td>
<td>Wheals appear or worsen at night</td>
<td>Chronic spontaneous urticaria, dust mite sensitivity, delayed pressure urticaria</td>
</tr>
<tr>
<td><strong>Exercise-induced</strong></td>
<td>Appears during or shortly after physical activity</td>
<td>Cholinergic urticaria, exercise-induced anaphylaxis (with or without food co-factor)</td>
</tr>
<tr>
<td><strong>Contact pattern</strong></td>
<td>Wheals localized to area of contact with substance</td>
<td>Contact urticaria (foods, latex, plants, animals)</td>
</tr>
</tbody>
</table>
</div>
<h2>Classification by Etiology</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Category</th>
<th>Subtypes</th>
<th>Pediatric Considerations</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Chronic Spontaneous Urticaria</strong></td>
<td>Autoimmune (with anti-IgE or anti-FcεRI antibodies) or idiopathic</td>
<td>Less common in children than adults; female predominance in adolescents; may be associated with thyroid autoimmunity</td>
</tr>
<tr>
<td><strong>Chronic Inducible Urticaria</strong></td>
<td>Cold, heat, solar, dermatographic, cholinergic, aquagenic, vibratory, delayed pressure</td>
<td>Cold urticaria is most common physical urticaria in children; cholinergic urticaria peaks in adolescence</td>
</tr>
<tr>
<td><strong>Allergic (IgE-mediated)</strong></td>
<td>Food, medication, insect venom, latex, aeroallergen</td>
<td>More common trigger in children than adults; cow’s milk, egg, peanut, tree nuts most common food triggers</td>
</tr>
<tr>
<td><strong>Infection-associated</strong></td>
<td>Viral (most common), bacterial, parasitic</td>
<td>Accounts for majority of acute pediatric urticaria; upper respiratory infections, gastroenteritis, urinary tract infections</td>
</tr>
</tbody>
</table>
</div>
<h2>Associated Features and Severity Assessment</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Severity</th>
<th>Features</th>
<th>Management Implications</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Mild</strong></td>
<td>Localized wheals, minimal pruritus, no angioedema, no systemic symptoms</td>
<td>Outpatient management; oral antihistamines as needed</td>
</tr>
<tr>
<td><strong>Moderate</strong></td>
<td>Widespread wheals, significant pruritus affecting sleep or daily activities, peripheral angioedema (lips, eyes, extremities)</td>
<td>Regular antihistamines; short-term follow-up; consider allergen testing if recurrent</td>
</tr>
<tr>
<td><strong>Severe / Anaphylaxis</strong></td>
<td>Urticaria with respiratory symptoms (stridor, wheeze, dyspnea), cardiovascular instability, gastrointestinal symptoms, tongue or throat swelling</td>
<td>Emergency management; epinephrine; hospitalization may be required; mandatory allergy referral</td>
</tr>
</tbody>
</table>
</div>
<div class=”highlight-box”>
<p><strong>Key Concept: The Pediatric Urticaria Triad</strong></p>
<p>In children with acute urticaria, three causes account for the vast majority of cases:</p>
<ul>
<li><strong>Viral infections</strong> — The most common trigger (40-80%), often with concurrent or recent upper respiratory or gastrointestinal symptoms</li>
<li><strong>Food allergies</strong> — Particularly in infants and young children; typically presents within 2 hours of ingestion</li>
<li><strong>Idiopathic</strong> — No identifiable trigger found despite thorough history; still usually self-limiting</li>
</ul>
<p>Unlike adults, medications and autoimmune causes are less common triggers in the pediatric population.</p>
</div>
<div class=”callout-box tip-box”>
<div class=”callout-icon”><i class=”fa fa-lightbulb-o”></i></div>
<div class=”callout-content”>
<h4>Clinical Pearl: Wheals vs. Other Rashes</h4>
<p>A key distinguishing feature of urticaria is the transient nature of individual wheals — they should resolve completely within 24 hours without leaving any residual marking. If individual lesions persist beyond 24 hours, leave bruising or pigmentation, or are painful rather than pruritic, consider urticarial vasculitis and other mimics that require different evaluation and management.</p>
</div>
</div>
<div class=”content-footer”>
<div class=”copyright”>© Medaptly. All rights reserved.</div>
<div class=”logo”><img src=”https://medaptlytemplates.doo.ee/Medaptly_Logo-removebg-preview.png” alt=”Medaptly Logo”></div>
</div>
</div>
</div>
<!– ==================== TASK 2: PATHOPHYSIOLOGY ==================== –>
<div class=”task-content” id=”task2-content”>
<div class=”task-header”>
<h1 class=”task-title”>2. Pathophysiology and Mechanisms</h1>
<p class=”task-subtitle”>Understanding the underlying mechanisms of urticaria in children</p>
</div>
<div class=”task-body”>
<p>Urticaria results from the activation and degranulation of mast cells in the skin, leading to the release of histamine and other vasoactive mediators. This causes localized vasodilation, increased vascular permeability, and sensory nerve stimulation — resulting in the characteristic triad of erythema, edema (wheal), and pruritus. Understanding these mechanisms is essential for rational therapeutic approaches and for explaining the condition to families.</p>
<h2>The Urticaria Pathway</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Component</th>
<th>Structure</th>
<th>Function in Urticaria</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Trigger</strong></td>
<td>Allergen, infection, physical stimulus, autoantibody, or unknown</td>
<td>Initiates the cascade by activating mast cells through various mechanisms</td>
</tr>
<tr>
<td><strong>Mast Cells</strong></td>
<td>Tissue-resident immune cells in dermis, particularly around blood vessels and nerves</td>
<td>Central effector cell; degranulation releases preformed and newly synthesized mediators</td>
</tr>
<tr>
<td><strong>Primary Mediators</strong></td>
<td>Histamine (preformed), tryptase, heparin, prostaglandins, leukotrienes (newly synthesized)</td>
<td>Cause vasodilation, increased permeability, smooth muscle contraction, nerve stimulation</td>
</tr>
<tr>
<td><strong>Blood Vessels</strong></td>
<td>Dermal capillaries and postcapillary venules</td>
<td>Dilate and become permeable, allowing plasma extravasation and wheal formation</td>
</tr>
<tr>
<td><strong>Sensory Nerves</strong></td>
<td>Cutaneous C-fibers and Aδ fibers</td>
<td>Stimulation causes pruritus; axon reflex causes surrounding erythema (flare)</td>
</tr>
</tbody>
</table>
</div>
<h2>Mast Cell Activation Pathways</h2>
<p>Mast cells can be activated through multiple distinct pathways, which has important implications for identifying triggers and selecting treatments.</p>
<div class=”grid-3″>
<div class=”grid-item”>
<h3>IgE-Mediated (Type I Hypersensitivity)</h3>
<p><strong>Mechanism:</strong> Allergen cross-links IgE antibodies bound to high-affinity IgE receptors (FcεRI) on mast cell surface</p>
<p><strong>Triggers:</strong> Foods, medications, insect venoms, latex, aeroallergens</p>
<p><strong>Timing:</strong> Rapid onset (minutes to 2 hours after exposure)</p>
<p><strong>Clinical relevance:</strong> Most important mechanism in pediatric food allergy; amenable to allergen avoidance and immunotherapy</p>
</div>
<div class=”grid-item”>
<h3>Autoimmune (Type IIb Hypersensitivity)</h3>
<p><strong>Mechanism:</strong> Autoantibodies (anti-IgE or anti-FcεRI) directly activate mast cells without allergen</p>
<p><strong>Triggers:</strong> No external trigger; intrinsic autoimmune process</p>
<p><strong>Timing:</strong> Chronic, spontaneous episodes</p>
<p><strong>Clinical relevance:</strong> Present in 30-50% of chronic spontaneous urticaria; may respond to omalizumab; associated with other autoimmune conditions</p>
</div>
<div class=”grid-item”>
<h3>Non-Immunologic (Direct Mast Cell Activation)</h3>
<p><strong>Mechanism:</strong> Direct stimulation of mast cells without IgE involvement via MRGPRX2 receptor or physical stimuli</p>
<p><strong>Triggers:</strong> Opioids, radiocontrast, NSAIDs, physical stimuli (cold, heat, pressure), complement activation</p>
<p><strong>Timing:</strong> Variable; often predictable with known triggers</p>
<p><strong>Clinical relevance:</strong> NSAID hypersensitivity common in children; physical urticarias are reproducible</p>
</div>
</div>
<h2>Key Mediators and Their Effects</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Mediator</th>
<th>Source</th>
<th>Effects</th>
<th>Therapeutic Target</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Histamine</strong></td>
<td>Preformed in mast cell granules</td>
<td>Vasodilation, increased permeability, pruritus (via H1 receptors), gastric acid secretion (H2)</td>
<td>H1-antihistamines (first-line therapy); H2-antihistamines (adjunctive)</td>
</tr>
<tr>
<td><strong>Tryptase</strong></td>
<td>Preformed in mast cell granules</td>
<td>Activates complement, degrades neuropeptides, proinflammatory</td>
<td>Serum tryptase used as biomarker for mast cell activation</td>
</tr>
<tr>
<td><strong>Prostaglandin D2</strong></td>
<td>Newly synthesized via cyclooxygenase</td>
<td>Vasodilation, bronchoconstriction, recruitment of inflammatory cells</td>
<td>COX inhibitors may worsen urticaria in susceptible patients</td>
</tr>
<tr>
<td><strong>Leukotrienes (LTC4, LTD4, LTE4)</strong></td>
<td>Newly synthesized via lipoxygenase</td>
<td>Increased vascular permeability, bronchoconstriction, mucus secretion</td>
<td>Leukotriene receptor antagonists (montelukast) as adjunctive therapy</td>
</tr>
<tr>
<td><strong>Platelet-Activating Factor</strong></td>
<td>Newly synthesized</td>
<td>Hypotension, bronchoconstriction, increased permeability; key mediator in anaphylaxis</td>
<td>No specific clinically available antagonist</td>
</tr>
<tr>
<td><strong>Cytokines (TNF-α, IL-4, IL-5, IL-13)</strong></td>
<td>Newly synthesized and secreted</td>
<td>Late-phase inflammation, eosinophil recruitment, prolonged symptoms</td>
<td>Corticosteroids; biologics targeting specific cytokines</td>
</tr>
</tbody>
</table>
</div>
<h2>How Conditions Cause Urticaria</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Condition</th>
<th>Mechanism</th>
<th>Treatment Implication</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Viral Infection</strong></td>
<td>Immune complex formation, direct viral activation of mast cells, cross-reactivity between viral antigens and self-antigens</td>
<td>Self-limiting; symptomatic treatment with antihistamines; no antivirals needed for urticaria</td>
</tr>
<tr>
<td><strong>IgE-Mediated Food Allergy</strong></td>
<td>Food protein cross-links specific IgE on mast cells, causing rapid degranulation</td>
<td>Strict allergen avoidance; epinephrine auto-injector for patients at risk of anaphylaxis; consider oral immunotherapy</td>
</tr>
<tr>
<td><strong>Cold Urticaria</strong></td>
<td>Cold exposure triggers mast cell degranulation, possibly through cold-sensitive ion channels or cryoproteins</td>
<td>Cold avoidance; premedication with antihistamines before cold exposure; warn about swimming risks</td>
</tr>
<tr>
<td><strong>Cholinergic Urticaria</strong></td>
<td>Elevated core body temperature activates mast cells via acetylcholine release from sympathetic nerves</td>
<td>May respond to antihistamines; anticholinergics sometimes helpful; gradual heat tolerance may develop</td>
</tr>
<tr>
<td><strong>Dermatographism</strong></td>
<td>Mechanical shear stress on skin triggers mast cell degranulation at the site of pressure</td>
<td>Avoid triggers (tight clothing, scratching); regular antihistamines; reassurance that it is benign</td>
</tr>
<tr>
<td><strong>Chronic Spontaneous Urticaria (Autoimmune)</strong></td>
<td>Autoantibodies against IgE or FcεRI receptors cause persistent mast cell activation without external trigger</td>
<td>Higher antihistamine doses often required; omalizumab effective by reducing free IgE; may remit over years</td>
</tr>
<tr>
<td><strong>NSAID-Induced Urticaria</strong></td>
<td>COX-1 inhibition shifts arachidonic acid metabolism toward leukotriene pathway, sensitizing mast cells</td>
<td>Avoid NSAIDs; acetaminophen usually safe; selective COX-2 inhibitors may be tolerated</td>
</tr>
<tr>
<td><strong>Serum Sickness-Like Reaction</strong></td>
<td>Immune complex deposition following drug exposure (commonly antibiotics) activates complement and mast cells</td>
<td>Stop offending drug; symptoms self-limited; antihistamines and corticosteroids for symptom relief</td>
</tr>
</tbody>
</table>
</div>
<h2>Pediatric-Specific Pathophysiological Considerations</h2>
<div class=”grid-2″>
<div class=”grid-item”>
<h3>Immune System Development</h3>
<ul>
<li>Immature immune regulation in infants may lead to more robust mast cell responses</li>
<li>Higher frequency of viral infections in young children contributes to infection-associated urticaria</li>
<li>Food allergies are more common in early childhood due to immature gut barrier and immune tolerance</li>
<li>Autoimmune chronic urticaria is less common in children than adults</li>
</ul>
</div>
<div class=”grid-item”>
<h3>Skin Characteristics</h3>
<ul>
<li>Pediatric skin has higher mast cell density in some studies</li>
<li>Thinner epidermis may lead to more visible and dramatic-appearing wheals</li>
<li>Higher surface area to body weight ratio means greater systemic absorption of topical medications</li>
<li>Dermatographism is common and often incidental finding in children</li>
</ul>
</div>
</div>
<h2>The Wheal and Flare Response</h2>
<div class=”highlight-box”>
<p><strong>Understanding the Triple Response of Lewis:</strong></p>
<ol>
<li><strong>Initial erythema (red line):</strong> Local vasodilation due to direct histamine effect on blood vessels — appears within seconds</li>
<li><strong>Wheal (raised, pale center):</strong> Plasma extravasation from increased vascular permeability — develops over 1-3 minutes</li>
<li><strong>Flare (surrounding erythema):</strong> Axon reflex causing vasodilation in surrounding skin — mediated by neuropeptides (substance P, CGRP)</li>
</ol>
<p>This classic response demonstrates the interplay between mast cell mediators, blood vessels, and sensory nerves that produces the clinical appearance of urticaria.</p>
</div>
<h2>Why Angioedema Occurs</h2>
<p>Angioedema represents the same pathophysiological process occurring in deeper tissues (subcutaneous and submucosal) rather than the superficial dermis. The loose connective tissue in certain areas — particularly the face (periorbital, lips), tongue, genitalia, and extremities — allows for more dramatic fluid accumulation. Two distinct mechanisms can cause angioedema:</p>
<div class=”grid-2″>
<div class=”grid-item”>
<h3>Histamine-Mediated Angioedema</h3>
<p><strong>Mechanism:</strong> Same mast cell activation pathway as wheals</p>
<p><strong>Characteristics:</strong> Usually accompanies urticaria; pruritic; responds to antihistamines; onset over minutes to hours</p>
<p><strong>Pediatric relevance:</strong> This is the typical form seen with allergic reactions and chronic urticaria in children</p>
</div>
<div class=”grid-item”>
<h3>Bradykinin-Mediated Angioedema</h3>
<p><strong>Mechanism:</strong> Excess bradykinin due to hereditary angioedema (C1-inhibitor deficiency) or ACE inhibitors</p>
<p><strong>Characteristics:</strong> No urticaria; not pruritic (often painful); does NOT respond to antihistamines; may involve airway</p>
<p><strong>Pediatric relevance:</strong> Hereditary angioedema typically presents in childhood or adolescence; ACE inhibitor use rare in children</p>
</div>
</div>
<div class=”callout-box warning-box”>
<div class=”callout-icon”><i class=”fa fa-exclamation-triangle”></i></div>
<div class=”callout-content”>
<h4>Critical Distinction: Hereditary Angioedema</h4>
<p>If a child presents with recurrent angioedema WITHOUT urticaria, particularly if there is a family history of similar episodes or unexplained laryngeal edema, consider hereditary angioedema (HAE). This bradykinin-mediated condition requires specific treatment (C1-inhibitor concentrate, icatibant, or ecallantide) and does NOT respond to antihistamines, corticosteroids, or epinephrine. Early recognition is critical as laryngeal attacks can be fatal.</p>
</div>
</div>
<div class=”callout-box tip-box”>
<div class=”callout-icon”><i class=”fa fa-lightbulb-o”></i></div>
<div class=”callout-content”>
<h4>Often Overlooked Mechanism: Pseudoallergic Reactions</h4>
<p>Many substances can cause urticaria through direct (non-IgE) mast cell activation, termed “pseudoallergic” reactions. In children, this commonly occurs with foods containing natural histamine or histamine-releasing compounds (strawberries, tomatoes, citrus, chocolate) or food additives. These reactions are dose-dependent, variable, and do not represent true allergy — meaning skin testing will be negative and small amounts may be tolerated. Families often incorrectly label these as “food allergies,” leading to unnecessary dietary restrictions.</p>
</div>
</div>
<div class=”section-divider”>
<div class=”section-divider-icon”><i class=”fa fa-flask”></i></div>
</div>
<h2>Complications of Urticaria Itself</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Complication</th>
<th>Mechanism</th>
<th>Clinical Significance</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Secondary Skin Infection</strong></td>
<td>Excoriation from scratching introduces bacteria</td>
<td>Monitor for signs of infection; keep nails short; optimize pruritus control</td>
</tr>
<tr>
<td><strong>Sleep Disturbance</strong></td>
<td>Pruritus often worsens at night; antihistamines may cause next-day sedation</td>
<td>Significant quality of life impact; use non-sedating antihistamines</td>
</tr>
<tr>
<td><strong>Anxiety and Psychological Impact</strong></td>
<td>Unpredictable nature, visible rash, fear of anaphylaxis</td>
<td>Address fears; provide clear action plan; consider psychology referral for chronic cases</td>
</tr>
<tr>
<td><strong>Anaphylaxis</strong></td>
<td>Massive systemic mast cell degranulation (urticaria is often the first sign)</td>
<td>Recognize early signs; treat promptly with epinephrine; educate families on recognition</td>
</tr>
</tbody>
</table>
</div>
<div class=”content-footer”>
<div class=”copyright”>© Medaptly. All rights reserved.</div>
<div class=”logo”><img src=”https://medaptlytemplates.doo.ee/Medaptly_Logo-removebg-preview.png” alt=”Medaptly Logo”></div>
</div>
</div>
</div>
<!– ==================== TASK 3: HISTORY TAKING ==================== –>
<div class=”task-content” id=”task3-content”>
<div class=”task-header”>
<h1 class=”task-title”>3. History Taking</h1>
<p class=”task-subtitle”>A comprehensive approach to eliciting the urticaria history in children</p>
</div>
<div class=”task-body”>
<!– RED FLAGS – MUST BE FIRST –>
<div class=”callout-box warning-box”>
<div class=”callout-icon”><i class=”fa fa-exclamation-triangle”></i></div>
<div class=”callout-content”>
<h4>Red Flags — Require Urgent Evaluation</h4>
<div class=”grid-2″>
<div>
<ul>
<li><strong>Respiratory distress</strong> — stridor, wheeze, dyspnea, hoarse voice (airway angioedema, anaphylaxis)</li>
<li><strong>Tongue or throat swelling</strong> — impending airway compromise</li>
<li><strong>Hypotension or tachycardia</strong> — anaphylactic shock</li>
<li><strong>Altered consciousness</strong> — severe anaphylaxis or sepsis</li>
<li><strong>Drooling or difficulty swallowing</strong> — oropharyngeal angioedema</li>
</ul>
</div>
<div>
<ul>
<li><strong>Angioedema without urticaria</strong> — consider hereditary angioedema</li>
<li><strong>Family history of laryngeal edema deaths</strong> — hereditary angioedema</li>
<li><strong>Individual lesions lasting greater than 24 hours</strong> — urticarial vasculitis</li>
<li><strong>Lesions that bruise or leave pigmentation</strong> — vasculitis, mastocytosis</li>
<li><strong>Fever with ill appearance</strong> — systemic infection, serum sickness</li>
<li><strong>Joint pain and swelling</strong> — serum sickness-like reaction, vasculitis</li>
</ul>
</div>
</div>
</div>
</div>
<!– MNEMONIC –>
<h2>Systematic History: The “WHEALS” Approach</h2>
<div class=”highlight-box”>
<p>Use the mnemonic <strong>”WHEALS”</strong> to ensure comprehensive history taking in pediatric urticaria:</p>
<ul>
<li><strong>W</strong> — <strong>What do they look like and When did they start?</strong> Describe the lesions; onset timing; duration of individual wheals; pattern of recurrence</li>
<li><strong>H</strong> — <strong>How is the child affected?</strong> Pruritus severity; sleep disturbance; school absence; associated symptoms (respiratory, gastrointestinal, systemic)</li>
<li><strong>E</strong> — <strong>Exposures and Events preceding onset:</strong> Foods eaten; medications; infections; insect stings; new products; travel; physical triggers</li>
<li><strong>A</strong> — <strong>Allergies and Atopic history:</strong> Known allergies; eczema; asthma; allergic rhinitis; previous similar episodes; family atopic history</li>
<li><strong>L</strong> — <strong>Lasting features and Lesion characteristics:</strong> Do individual lesions resolve within 24 hours? Any bruising, pain, or residual marks? Angioedema present?</li>
<li><strong>S</strong> — <strong>Systemic symptoms and Social history:</strong> Fever; joint pain; breathing difficulty; family history of angioedema; daycare; recent travel; stress</li>
</ul>
</div>
<h2>Characterizing the Urticaria</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Question Category</th>
<th>Specific Questions to Ask</th>
<th>Clinical Relevance</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Onset and Duration</strong></td>
<td>”When did the rash first appear?” “How long has this episode been going on?” “Has this happened before?”</td>
<td>Distinguishes acute (less than 6 weeks) from chronic (greater than 6 weeks); recurrent episodes suggest identifiable trigger</td>
</tr>
<tr>
<td><strong>Individual Lesion Duration</strong></td>
<td>”How long does each bump last before it fades?” “Do they leave any marks when they go away?”</td>
<td>Wheals lasting greater than 24 hours or leaving bruising suggest urticarial vasculitis — requires different workup</td>
</tr>
<tr>
<td><strong>Distribution and Migration</strong></td>
<td>”Where on the body did it start?” “Does it move around?” “Is it always in the same place?”</td>
<td>Migratory pattern typical of urticaria; fixed lesions suggest contact urticaria or other diagnosis</td>
</tr>
<tr>
<td><strong>Associated Symptoms</strong></td>
<td>”Is there any swelling of lips, eyes, hands, or feet?” “Any trouble breathing, swallowing, or a change in voice?”</td>
<td>Angioedema present in 40% of cases; respiratory symptoms indicate potential anaphylaxis</td>
</tr>
<tr>
<td><strong>Pruritus Severity</strong></td>
<td>”How itchy is it on a scale of 1-10?” “Does it wake your child at night?” “Does scratching make it worse?”</td>
<td>Assesses impact on quality of life; guides treatment intensity; dermatographism may worsen with scratching</td>
</tr>
</tbody>
</table>
</div>
<h2>Targeted Questions by Suspected Cause</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Suspected Cause</th>
<th>Key Features</th>
<th>Ask This Question</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Viral Infection</strong></td>
<td>Recent or concurrent upper respiratory symptoms, fever, gastrointestinal illness; gradual onset; widespread distribution</td>
<td>”Has your child had any cold symptoms, fever, sore throat, vomiting, or diarrhea in the past 1-2 weeks?”</td>
</tr>
<tr>
<td><strong>Food Allergy (IgE-mediated)</strong></td>
<td>Rapid onset (within 2 hours of eating); reproducible with same food; often with other symptoms</td>
<td>”What did your child eat in the 2 hours before the rash appeared? Has this food ever caused a reaction before?”</td>
</tr>
<tr>
<td><strong>Medication Reaction</strong></td>
<td>Temporal relationship to drug; onset within days of starting new medication; common culprits: antibiotics, NSAIDs</td>
<td>”Has your child taken any medications, including over-the-counter drugs, supplements, or herbal remedies, in the past 2 weeks?”</td>
</tr>
<tr>
<td><strong>Insect Sting or Bite</strong></td>
<td>History of sting; local reaction at site followed by generalized urticaria; outdoor activity</td>
<td>”Was your child stung by a bee, wasp, or other insect? Did you notice any bug bites before the rash spread?”</td>
</tr>
<tr>
<td><strong>Cold Urticaria</strong></td>
<td>Occurs after cold exposure; wheals on exposed skin; may occur after swimming or eating cold foods</td>
<td>”Does the rash appear after being outside in cold weather, swimming, or eating ice cream or cold drinks?”</td>
</tr>
<tr>
<td><strong>Cholinergic Urticaria</strong></td>
<td>Small punctate wheals (1-3 mm); triggered by sweating, exercise, emotional stress, hot showers</td>
<td>”Does the rash appear during or after exercise, hot baths, or when your child gets very warm or stressed?”</td>
</tr>
<tr>
<td><strong>Dermatographism</strong></td>
<td>Linear wheals at sites of scratching or pressure; often asymptomatic until noticed</td>
<td>”Do you notice that scratching or rubbing the skin causes raised red lines? Does tight clothing cause welts?”</td>
</tr>
<tr>
<td><strong>Pressure Urticaria</strong></td>
<td>Delayed swelling (4-6 hours) at pressure sites; often painful; affects palms, soles, buttocks</td>
<td>”Does your child develop swelling on their feet after walking, or on their bottom after sitting for a long time?”</td>
</tr>
<tr>
<td><strong>Contact Urticaria</strong></td>
<td>Wheals localized to contact area; immediate onset on exposure; common triggers: foods, animals, latex</td>
<td>”Does the rash appear only where something touched the skin? Does it happen when touching certain foods or animals?”</td>
</tr>
<tr>
<td><strong>Serum Sickness-Like Reaction</strong></td>
<td>Urticaria with fever, arthralgia, lymphadenopathy; 1-3 weeks after starting antibiotic (often cefaclor, amoxicillin)</td>
<td>”Has your child taken any antibiotics in the past 3 weeks? Is there any joint pain, swelling, or fever along with the rash?”</td>
</tr>
<tr>
<td><strong>Hereditary Angioedema</strong></td>
<td>Recurrent angioedema WITHOUT urticaria; family history; abdominal pain episodes; triggered by trauma, stress, infection</td>
<td>”Does anyone in the family have recurrent swelling episodes? Does your child get swelling without any hives?”</td>
</tr>
</tbody>
</table>
</div>
<h2>Pediatric-Specific History Components</h2>
<div class=”grid-2″>
<div class=”grid-item”>
<h3>Age-Related Considerations</h3>
<ul>
<li><strong>Infants (0-12 months):</strong> Cow’s milk and egg are common food triggers; consider maternal diet if breastfeeding; viral infections very common</li>
<li><strong>Toddlers (1-3 years):</strong> Expanding diet introduces new food allergens; frequent viral infections from daycare; peanut and tree nut allergies emerge</li>
<li><strong>School-age (4-12 years):</strong> Physical urticarias become more apparent; cold urticaria common; consider stress and school-related triggers</li>
<li><strong>Adolescents (13-18 years):</strong> Cholinergic urticaria peaks; consider NSAIDs for menstrual pain; chronic spontaneous urticaria more common</li>
</ul>
</div>
<div class=”grid-item”>
<h3>Feeding and Dietary History</h3>
<ul>
<li><strong>Breastfed infants:</strong> Maternal diet may be relevant (dairy, egg, peanut can pass into breast milk)</li>
<li><strong>Formula type:</strong> Cow’s milk formula vs extensively hydrolyzed vs amino acid-based</li>
<li><strong>Introduction of solids:</strong> Timing of allergen introduction; any reactions to new foods</li>
<li><strong>Recent dietary changes:</strong> New foods, restaurants, ethnic cuisines, hidden ingredients</li>
<li><strong>Food diary:</strong> May be helpful in recurrent urticaria to identify patterns</li>
</ul>
</div>
</div>
<div class=”grid-2″>
<div class=”grid-item”>
<h3>Birth and Early Medical History</h3>
<ul>
<li><strong>Neonatal history:</strong> Prolonged jaundice, neonatal infections (may predispose to atopy)</li>
<li><strong>Eczema history:</strong> Atopic dermatitis is a strong risk factor for food allergies and atopic urticaria</li>
<li><strong>Previous allergic reactions:</strong> Prior urticaria episodes, known food allergies, medication reactions</li>
<li><strong>Immunization history:</strong> Recent vaccines (urticaria can occur post-vaccination, usually benign)</li>
</ul>
</div>
<div class=”grid-item”>
<h3>Family History</h3>
<ul>
<li><strong>Atopic conditions:</strong> Eczema, asthma, allergic rhinitis, food allergies in parents or siblings</li>
<li><strong>Urticaria:</strong> Chronic urticaria, physical urticarias (may have genetic component)</li>
<li><strong>Angioedema:</strong> Recurrent swelling, unexplained abdominal pain, laryngeal edema — consider hereditary angioedema</li>
<li><strong>Autoimmune conditions:</strong> Thyroid disease, vitiligo, celiac disease (associated with chronic spontaneous urticaria)</li>
</ul>
</div>
</div>
<h2>Medication and Substance History</h2>
<div class=”columns”>
<div class=”column”>
<h3>Medications That Commonly Cause Urticaria in Children</h3>
<ul>
<li><strong>Antibiotics:</strong> Penicillins, cephalosporins (especially cefaclor), sulfonamides — most common drug cause in children</li>
<li><strong>NSAIDs:</strong> Ibuprofen, aspirin — can cause urticaria via COX-1 inhibition; may worsen existing urticaria</li>
<li><strong>Opioids:</strong> Codeine, morphine — direct mast cell activation (pseudoallergic)</li>
<li><strong>Vaccines:</strong> Generally mild, self-limiting reactions; gelatin component may cause true allergy</li>
<li><strong>Radiocontrast media:</strong> Direct mast cell activation; premedication can reduce risk</li>
<li><strong>Herbal remedies and supplements:</strong> Often overlooked; may contain allergens or undisclosed ingredients</li>
</ul>
</div>
<div class=”column”>
<h3>Environmental and Social History</h3>
<ul>
<li><strong>Daycare or school:</strong> Exposure to infections; shared foods; new allergens</li>
<li><strong>Pets:</strong> New animals; contact with animals at school or friends’ homes</li>
<li><strong>Home environment:</strong> New laundry detergent, soaps, lotions; dust exposure; mold</li>
<li><strong>Recent travel:</strong> Parasitic infections (especially with eosinophilia); new food exposures</li>
<li><strong>Stress and emotional factors:</strong> School pressures, family changes — can trigger or worsen urticaria</li>
<li><strong>Outdoor activities:</strong> Insect exposure, plant contact, cold or heat exposure</li>
</ul>
</div>
</div>
<h2>Timeline Reconstruction</h2>
<div class=”callout-box info-box”>
<div class=”callout-icon”><i class=”fa fa-info-circle”></i></div>
<div class=”callout-content”>
<h4>Detailed Timeline Questions</h4>
<p>For acute urticaria with suspected allergic trigger, carefully reconstruct the hours before onset:</p>
<ul>
<li><strong>2 hours before onset:</strong> Foods eaten, medications taken (IgE-mediated reactions typically occur within this window)</li>
<li><strong>24-48 hours before:</strong> New medications started, insect stings, unusual exposures</li>
<li><strong>1-2 weeks before:</strong> Viral illness, antibiotic courses (serum sickness-like reaction typically 7-21 days after drug initiation)</li>
<li><strong>Pattern with physical triggers:</strong> Temporal relationship to exercise, cold exposure, pressure, heat</li>
</ul>
</div>
</div>
<h2>Questions About Previous Episodes</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Question</th>
<th>Why It Matters</th>
</tr>
</thead>
<tbody>
<tr>
<td>”Has this ever happened before?”</td>
<td>Recurrent episodes suggest identifiable trigger or chronic urticaria</td>
</tr>
<tr>
<td>”What was your child doing or eating during previous episodes?”</td>
<td>Pattern recognition may identify consistent trigger</td>
</tr>
<tr>
<td>”How long did previous episodes last?”</td>
<td>Self-limiting episodes suggest acute urticaria; persistent symptoms suggest chronic</td>
</tr>
<tr>
<td>”What treatments have worked or not worked before?”</td>
<td>Guides medication selection; lack of antihistamine response may suggest alternative diagnosis</td>
</tr>
<tr>
<td>”Were there any severe reactions with breathing problems or fainting?”</td>
<td>History of anaphylaxis determines need for epinephrine auto-injector prescription</td>
</tr>
</tbody>
</table>
</div>
<h2>Collateral History from Caregivers</h2>
<div class=”callout-box tip-box”>
<div class=”callout-icon”><i class=”fa fa-lightbulb-o”></i></div>
<div class=”callout-content”>
<h4>Practical Tips for Pediatric History</h4>
<div class=”points-list”>
<div class=”point-item”>
<i class=”fa fa-check-circle” style=”color: #2e7d32;”></i>
<span class=”point-text”><strong>Ask for photos:</strong> Parents often photograph rashes — photos can show lesion morphology, distribution, and evolution over time</span>
</div>
<div class=”point-item”>
<i class=”fa fa-check-circle” style=”color: #2e7d32;”></i>
<span class=”point-text”><strong>Request food packaging:</strong> Ingredient lists can identify hidden allergens (e.g., egg in baked goods, milk in processed foods)</span>
</div>
<div class=”point-item”>
<i class=”fa fa-check-circle” style=”color: #2e7d32;”></i>
<span class=”point-text”><strong>Contact daycare or school:</strong> May provide information about meals served, sick contacts, or environmental exposures</span>
</div>
<div class=”point-item”>
<i class=”fa fa-check-circle” style=”color: #2e7d32;”></i>
<span class=”point-text”><strong>Ask about siblings:</strong> Similar symptoms in siblings may suggest infectious cause or shared environmental trigger</span>
</div>
<div class=”point-item”>
<i class=”fa fa-check-circle” style=”color: #2e7d32;”></i>
<span class=”point-text”><strong>Observe the child:</strong> Note scratching behavior, comfort level, respiratory effort during the consultation</span>
</div>
</div>
</div>
</div>
<div class=”content-footer”>
<div class=”copyright”>© Medaptly. All rights reserved.</div>
<div class=”logo”><img src=”https://medaptlytemplates.doo.ee/Medaptly_Logo-removebg-preview.png” alt=”Medaptly Logo”></div>
</div>
</div>
</div>
<!– ==================== TASK 4: PHYSICAL EXAMINATION ==================== –>
<div class=”task-content” id=”task4-content”>
<div class=”task-header”>
<h1 class=”task-title”>4. Physical Examination</h1>
<p class=”task-subtitle”>A systematic head-to-toe approach for urticaria in children</p>
</div>
<div class=”task-body”>
<div class=”highlight-box”>
<p><strong>Systematic Framework:</strong> Use the “Head to Extremities” approach for complete examination of children presenting with urticaria. The primary goals are to: (1) confirm the diagnosis of urticaria, (2) assess severity and rule out anaphylaxis, (3) identify any associated features suggesting specific etiology, and (4) exclude urticaria mimics.</p>
</div>
<div class=”callout-box warning-box”>
<div class=”callout-icon”><i class=”fa fa-exclamation-triangle”></i></div>
<div class=”callout-content”>
<h4>Immediate Assessment: Rule Out Anaphylaxis First</h4>
<p>Before proceeding with detailed examination, rapidly assess for signs of anaphylaxis:</p>
<div class=”grid-2″>
<div>
<ul>
<li><strong>Airway:</strong> Stridor, hoarseness, drooling, tongue or lip swelling</li>
<li><strong>Breathing:</strong> Wheeze, respiratory distress, hypoxia, use of accessory muscles</li>
</ul>
</div>
<div>
<ul>
<li><strong>Circulation:</strong> Pallor, hypotension, weak pulse, prolonged capillary refill, tachycardia</li>
<li><strong>Disability:</strong> Altered consciousness, confusion, lethargy</li>
</ul>
</div>
</div>
<p><strong>If any signs of anaphylaxis are present, treat immediately with intramuscular epinephrine before completing examination.</strong></p>
</div>
</div>
<h2>General Inspection</h2>
<ul>
<li><strong>Appearance:</strong> Well or unwell; comfortable or distressed; alert or lethargic; level of activity</li>
<li><strong>Respiratory effort:</strong> Respiratory rate; work of breathing; audible wheeze or stridor; nasal flaring; retractions</li>
<li><strong>Color:</strong> Normal, pale, flushed, or cyanotic; perioral pallor or cyanosis</li>
<li><strong>Behavior:</strong> Scratching, rubbing skin, irritability, or ability to be consoled</li>
<li><strong>Hydration status:</strong> Mucous membranes, tears, skin turgor (especially if vomiting or diarrhea present)</li>
<li><strong>Growth parameters:</strong> Plot weight and height on growth chart — failure to thrive may suggest chronic disease or severe food allergies with dietary restrictions</li>
</ul>
<h2>Vital Signs</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Age Group</th>
<th>Heart Rate (bpm)</th>
<th>Respiratory Rate (/min)</th>
<th>Systolic BP (mmHg)</th>
<th>Temperature</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Neonate (0-1 month)</strong></td>
<td>100-160</td>
<td>30-60</td>
<td>60-90</td>
<td>36.5-37.5°C</td>
</tr>
<tr>
<td><strong>Infant (1-12 months)</strong></td>
<td>100-150</td>
<td>25-40</td>
<td>80-100</td>
<td>36.5-37.5°C</td>
</tr>
<tr>
<td><strong>Toddler (1-3 years)</strong></td>
<td>90-140</td>
<td>20-30</td>
<td>90-105</td>
<td>36.5-37.5°C</td>
</tr>
<tr>
<td><strong>Preschool (3-5 years)</strong></td>
<td>80-120</td>
<td>20-25</td>
<td>95-110</td>
<td>36.5-37.5°C</td>
</tr>
<tr>
<td><strong>School-age (6-12 years)</strong></td>
<td>70-110</td>
<td>18-25</td>
<td>100-120</td>
<td>36.5-37.5°C</td>
</tr>
<tr>
<td><strong>Adolescent (13-18 years)</strong></td>
<td>60-100</td>
<td>12-20</td>
<td>110-130</td>
<td>36.5-37.5°C</td>
</tr>
</tbody>
</table>
</div>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Vital Sign</th>
<th>Abnormality to Look For</th>
<th>Clinical Significance</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Temperature</strong></td>
<td>Fever (greater than 38°C)</td>
<td>Suggests infection as trigger; consider serum sickness-like reaction if with arthralgia; rule out sepsis if ill-appearing</td>
</tr>
<tr>
<td><strong>Heart Rate</strong></td>
<td>Tachycardia above age-normal range</td>
<td>May indicate anaphylaxis, anxiety, fever, or pain; persistent unexplained tachycardia concerning for cardiovascular compromise</td>
</tr>
<tr>
<td><strong>Blood Pressure</strong></td>
<td>Hypotension (systolic BP less than 5th percentile for age)</td>
<td>Late sign of anaphylaxis in children — indicates cardiovascular decompensation; requires immediate intervention</td>
</tr>
<tr>
<td><strong>Respiratory Rate</strong></td>
<td>Tachypnea above age-normal range</td>
<td>May indicate respiratory involvement (bronchospasm, laryngeal edema); also seen with anxiety or fever</td>
</tr>
<tr>
<td><strong>Oxygen Saturation</strong></td>
<td>SpO2 less than 94% on room air</td>
<td>Indicates significant respiratory compromise; urgent intervention required</td>
</tr>
</tbody>
</table>
</div>
<h2>Skin Examination — The Key to Diagnosis</h2>
<p>A thorough skin examination is essential to confirm the diagnosis of urticaria and distinguish it from mimics.</p>
<h3>Inspection of Wheals</h3>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Feature</th>
<th>Typical Urticaria</th>
<th>Concerning for Alternative Diagnosis</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Shape</strong></td>
<td>Round, oval, or serpiginous; may coalesce into larger plaques</td>
<td>Fixed target lesions (erythema multiforme); annular with scale (tinea, annular erythema)</td>
</tr>
<tr>
<td><strong>Color</strong></td>
<td>Erythematous with pale center; blanches with pressure</td>
<td>Purpuric (does not blanch) — suggests vasculitis; brown/hyperpigmented — suggests urticaria pigmentosa</td>
</tr>
<tr>
<td><strong>Size</strong></td>
<td>Variable: 1-2 mm (cholinergic) to several centimeters; may coalesce</td>
<td>Fixed size lesions recurring in same location suggest other diagnosis</td>
</tr>
<tr>
<td><strong>Distribution</strong></td>
<td>Generalized, random distribution; migratory</td>
<td>Localized to sun-exposed areas (solar urticaria, lupus); dermatomal (zoster)</td>
</tr>
<tr>
<td><strong>Surface</strong></td>
<td>Smooth, raised; no vesicles, scale, or crust</td>
<td>Vesicles (viral exanthem, bullous disease); scale (eczema, psoriasis, fungal)</td>
</tr>
<tr>
<td><strong>Duration of individual lesions</strong></td>
<td>Each wheal resolves within 24 hours</td>
<td>Lesions lasting greater than 24 hours, leaving bruising or pigmentation — urticarial vasculitis</td>
</tr>
</tbody>
</table>
</div>
<h3>Special Skin Tests</h3>
<div class=”grid-2″>
<div class=”grid-item”>
<h4>Dermatographism Test</h4>
<p><strong>How to perform:</strong> Using a tongue depressor or blunt object, stroke the skin of the back or forearm with moderate pressure</p>
<p><strong>Positive result:</strong> Linear wheal and flare develops along the stroke line within 5-10 minutes</p>
<p><strong>Interpretation:</strong> Present in approximately 5% of the population; may be the cause of urticaria or incidental finding</p>
</div>
<div class=”grid-item”>
<h4>Ice Cube Test (for suspected cold urticaria)</h4>
<p><strong>How to perform:</strong> Place an ice cube in a plastic bag on the forearm for 5 minutes, then remove and observe for 10 minutes</p>
<p><strong>Positive result:</strong> Wheal develops at the site of cold exposure after rewarming</p>
<p><strong>Caution:</strong> In severe cold urticaria, systemic symptoms may occur — perform in monitored setting with resuscitation available</p>
</div>
</div>
<h2>Head, Eyes, Ears, Nose, and Throat Examination</h2>
<div class=”grid-2″>
<div class=”grid-item”>
<h3>Eyes</h3>
<ul>
<li><strong>Periorbital edema:</strong> Common site of angioedema; assess symmetry and severity</li>
<li><strong>Conjunctival injection or chemosis:</strong> May indicate allergic component</li>
<li><strong>Allergic shiners:</strong> Dark circles under eyes — suggest chronic allergic disease</li>
<li><strong>Scleral icterus:</strong> If present, consider systemic causes (hepatitis with urticaria)</li>
</ul>
</div>
<div class=”grid-item”>
<h3>Ears</h3>
<ul>
<li><strong>Otoscopy:</strong> Middle ear infection may be trigger; examine for otitis media</li>
<li><strong>Ear canal edema:</strong> Rare site of angioedema</li>
<li><strong>Auricular involvement:</strong> Note any wheals on external ear</li>
</ul>
</div>
</div>
<div class=”grid-2″>
<div class=”grid-item”>
<h3>Nose</h3>
<ul>
<li><strong>Rhinorrhea:</strong> Clear discharge suggests allergic component or viral infection</li>
<li><strong>Nasal congestion:</strong> Common with upper respiratory infection trigger</li>
<li><strong>Allergic salute and nasal crease:</strong> Signs of chronic allergic rhinitis</li>
<li><strong>Turbinate swelling:</strong> Pale, boggy turbinates suggest allergy; erythematous suggests infection</li>
</ul>
</div>
<div class=”grid-item”>
<h3>Oropharynx</h3>
<ul>
<li><strong>Lip swelling:</strong> Common angioedema site — assess degree and symmetry</li>
<li><strong>Tongue swelling:</strong> Concerning for airway compromise — assess ability to protrude, size, floor of mouth</li>
<li><strong>Uvula swelling:</strong> May indicate significant upper airway angioedema</li>
<li><strong>Pharyngitis or tonsillar exudate:</strong> Suggests infectious trigger</li>
<li><strong>Voice changes:</strong> Hoarseness, muffled voice — suggests laryngeal involvement</li>
</ul>
</div>
</div>
<h2>Neck Examination</h2>
<ul>
<li><strong>Lymphadenopathy:</strong> Cervical lymph nodes enlarged with viral infections; generalized lymphadenopathy may suggest serum sickness or systemic illness</li>
<li><strong>Thyroid:</strong> Goiter or thyroid nodules — chronic urticaria is associated with autoimmune thyroid disease</li>
<li><strong>Neck swelling:</strong> Anterior neck swelling may indicate laryngeal or pharyngeal angioedema — urgent assessment required</li>
<li><strong>Stridor:</strong> Listen without stethoscope — inspiratory stridor indicates upper airway obstruction</li>
</ul>
<h2>Respiratory Examination</h2>
<h3>Inspection</h3>
<ul>
<li><strong>Work of breathing:</strong> Nasal flaring, subcostal or intercostal retractions, head bobbing (infants), tripod positioning</li>
<li><strong>Chest wall movement:</strong> Symmetry, adequacy of expansion</li>
<li><strong>Use of accessory muscles:</strong> Sternocleidomastoid, scalene muscles visible — indicates significant respiratory distress</li>
</ul>
<h3>Auscultation</h3>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Finding</th>
<th>Description</th>
<th>Clinical Significance</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Wheeze</strong></td>
<td>High-pitched, musical expiratory sound</td>
<td>Indicates bronchospasm — may be part of allergic reaction or coexisting asthma; if new and progressive, consider anaphylaxis</td>
</tr>
<tr>
<td><strong>Stridor</strong></td>
<td>High-pitched inspiratory sound; often audible without stethoscope</td>
<td>Upper airway obstruction — laryngeal angioedema; requires immediate attention</td>
</tr>
<tr>
<td><strong>Decreased air entry</strong></td>
<td>Quiet breath sounds; may be bilateral or localized</td>
<td>Severe bronchospasm (silent chest) or pneumonia; concerning finding requiring urgent evaluation</td>
</tr>
<tr>
<td><strong>Crackles</strong></td>
<td>Discontinuous sounds, usually inspiratory</td>
<td>May indicate pneumonia as triggering infection; not typical of uncomplicated urticaria</td>
</tr>
<tr>
<td><strong>Normal breath sounds</strong></td>
<td>Clear, vesicular breathing bilaterally</td>
<td>Reassuring — no pulmonary involvement; most common finding in uncomplicated urticaria</td>
</tr>
</tbody>
</table>
</div>
<h2>Cardiovascular Examination</h2>
<ul>
<li><strong>Heart sounds:</strong> Tachycardia common; new murmurs unusual (consider rheumatic fever if with fever and arthralgia)</li>
<li><strong>Capillary refill:</strong> Greater than 2 seconds suggests poor perfusion — concerning for cardiovascular component of anaphylaxis</li>
<li><strong>Peripheral pulses:</strong> Weak or thready pulses indicate circulatory compromise</li>
<li><strong>Perfusion:</strong> Mottled, cool extremities suggest shock</li>
</ul>
<h2>Abdominal Examination</h2>
<ul>
<li><strong>Inspection:</strong> Distension may indicate intestinal angioedema (especially in hereditary angioedema)</li>
<li><strong>Palpation:</strong> Tenderness may indicate gastroenteritis (viral trigger) or intestinal angioedema; hepatosplenomegaly suggests systemic illness</li>
<li><strong>Bowel sounds:</strong> Hyperactive with gastroenteritis; may be decreased with severe intestinal angioedema</li>
<li><strong>Gastrointestinal symptoms:</strong> Nausea, vomiting, cramping, diarrhea may be part of allergic reaction or indicate infectious trigger</li>
</ul>
<h2>Extremities Examination</h2>
<ul>
<li><strong>Angioedema of hands and feet:</strong> Common sites — assess for swelling, especially dorsal surfaces</li>
<li><strong>Joint examination:</strong> Arthralgia and joint swelling suggest serum sickness-like reaction or urticarial vasculitis</li>
<li><strong>Clubbing:</strong> Not associated with urticaria; if present, suggests underlying chronic disease</li>
<li><strong>Peripheral edema:</strong> Distinguish localized angioedema from generalized edema (consider nephrotic syndrome, cardiac causes)</li>
<li><strong>Skin changes:</strong> Examine palms and soles for wheals (pressure urticaria), eczematous changes (atopic diathesis)</li>
</ul>
<h2>Examination for Physical Urticaria Triggers</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Type</th>
<th>Examination Technique</th>
<th>Positive Finding</th>
<th>Precautions</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Dermatographism</strong></td>
<td>Stroke skin with tongue depressor</td>
<td>Linear wheal along stroke within 10 minutes</td>
<td>Common incidental finding; may not be clinically significant</td>
</tr>
<tr>
<td><strong>Cold urticaria</strong></td>
<td>Ice cube in bag on forearm for 5 minutes</td>
<td>Wheal at site after rewarming</td>
<td>Perform in monitored setting; systemic reaction possible</td>
</tr>
<tr>
<td><strong>Cholinergic urticaria</strong></td>
<td>Exercise challenge or hot bath</td>
<td>Punctate 1-3 mm wheals with exercise or heat</td>
<td>Usually performed in specialized setting</td>
</tr>
<tr>
<td><strong>Pressure urticaria</strong></td>
<td>Apply weighted strap to forearm for 15 minutes</td>
<td>Swelling at site after 4-6 hours</td>
<td>Delayed response; may need follow-up assessment</td>
</tr>
<tr>
<td><strong>Solar urticaria</strong></td>
<td>Expose skin to sunlight or UV light</td>
<td>Wheals in exposed area within minutes</td>
<td>Performed in dermatology or allergy clinic</td>
</tr>
</tbody>
</table>
</div>
<h2>Expected Findings by Etiology</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Condition</th>
<th>General Appearance</th>
<th>Skin Findings</th>
<th>Other Findings</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Viral Infection-Associated</strong></td>
<td>May have low-grade fever; mildly unwell</td>
<td>Widespread urticaria; variable morphology</td>
<td>Pharyngitis, rhinorrhea, cervical lymphadenopathy, diarrhea</td>
</tr>
<tr>
<td><strong>IgE-Mediated Food Allergy</strong></td>
<td>Well to acutely unwell; anxious</td>
<td>Urticaria ± angioedema (lips, face); contact urticaria at mouth</td>
<td>May have wheeze, vomiting, throat symptoms if anaphylaxis</td>
</tr>
<tr>
<td><strong>Cold Urticaria</strong></td>
<td>Well at presentation (triggered by cold)</td>
<td>Wheals on previously cold-exposed areas</td>
<td>History of symptoms with cold exposure; ice cube test positive</td>
</tr>
<tr>
<td><strong>Dermatographism</strong></td>
<td>Well; often incidental finding</td>
<td>Linear wheals at scratch or pressure sites</td>
<td>Positive dermatographism test; often asymptomatic</td>
</tr>
<tr>
<td><strong>Chronic Spontaneous Urticaria</strong></td>
<td>Well; may be frustrated by chronic symptoms</td>
<td>Variable wheals; may have excoriations from chronic scratching</td>
<td>Usually no other findings; possible thyroid enlargement</td>
</tr>
<tr>
<td><strong>Serum Sickness-Like Reaction</strong></td>
<td>Unwell; febrile</td>
<td>Urticaria; may have purpuric elements</td>
<td>Fever, arthralgia, joint swelling, lymphadenopathy</td>
</tr>
<tr>
<td><strong>Urticarial Vasculitis</strong></td>
<td>May be unwell; systemic symptoms</td>
<td>Lesions lasting greater than 24 hours; residual purpura or pigmentation; painful rather than pruritic</td>
<td>Joint pain, fever, malaise; may have renal or pulmonary involvement</td>
</tr>
<tr>
<td><strong>Mastocytosis</strong></td>
<td>Well or episodically unwell</td>
<td>Urticaria pigmentosa: brown macules that urticate when stroked (Darier sign positive)</td>
<td>Flushing, abdominal symptoms, hepatosplenomegaly in systemic disease</td>
</tr>
</tbody>
</table>
</div>
<div class=”callout-box info-box”>
<div class=”callout-icon”><i class=”fa fa-info-circle”></i></div>
<div class=”callout-content”>
<h4>Important Teaching Point</h4>
<p><strong>Normal examination is common in urticaria.</strong> Most children with acute urticaria — particularly those with viral infection triggers, mild allergic reactions, or idiopathic urticaria — will have an entirely normal physical examination aside from the skin findings. The examination serves primarily to:</p>
<ul>
<li>Confirm the diagnosis by observing characteristic wheals</li>
<li>Exclude anaphylaxis and other emergencies</li>
<li>Identify clues to specific etiology</li>
<li>Rule out urticaria mimics</li>
</ul>
<p>A normal examination in a well-appearing child with typical urticaria is reassuring and supports conservative management.</p>
</div>
</div>
<h2>Examination Findings That Change Management</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Finding</th>
<th>Implication</th>
<th>Action Required</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Any sign of anaphylaxis</strong></td>
<td>Life-threatening allergic reaction</td>
<td>Immediate epinephrine; call for help; resuscitation as needed</td>
</tr>
<tr>
<td><strong>Stridor or significant tongue swelling</strong></td>
<td>Impending airway obstruction</td>
<td>Epinephrine; prepare for advanced airway management</td>
</tr>
<tr>
<td><strong>Lesions lasting greater than 24 hours with bruising</strong></td>
<td>Urticarial vasculitis likely</td>
<td>Different workup required; consider skin biopsy; evaluate for systemic involvement</td>
</tr>
<tr>
<td><strong>Positive Darier sign (brown lesions that urticate)</strong></td>
<td>Mastocytosis</td>
<td>Specialist referral; avoid mast cell degranulating triggers; serum tryptase level</td>
</tr>
<tr>
<td><strong>Fever with arthralgia and lymphadenopathy</strong></td>
<td>Serum sickness-like reaction</td>
<td>Stop causative medication; supportive care; consider corticosteroids</td>
</tr>
<tr>
<td><strong>Angioedema without urticaria</strong></td>
<td>Consider hereditary angioedema</td>
<td>Check C4, C1-inhibitor level and function; different treatment required</td>
</tr>
</tbody>
</table>
</div>
<div class=”callout-box tip-box”>
<div class=”callout-icon”><i class=”fa fa-lightbulb-o”></i></div>
<div class=”callout-content”>
<h4>Clinical Pearl: The Disappearing Rash</h4>
<p>By the time children reach the clinic or emergency department, the urticaria may have partially or completely resolved. This is actually a helpful diagnostic feature — the transient, migratory nature of wheals is characteristic of urticaria. Ask caregivers to take photographs when the rash is active, as these are invaluable for confirming the diagnosis. If the rash is present during examination, mark one or two wheals with a pen and recheck in 1-2 hours — true urticarial wheals will have faded or moved, while fixed lesions suggest alternative diagnoses.</p>
</div>
</div>
<div class=”content-footer”>
<div class=”copyright”>© Medaptly. All rights reserved.</div>
<div class=”logo”><img src=”https://medaptlytemplates.doo.ee/Medaptly_Logo-removebg-preview.png” alt=”Medaptly Logo”></div>
</div>
</div>
</div>
<div class=”task-content” id=”task3-content”>
<div class=”task-header”>
<h1 class=”task-title”>3. History Taking</h1>
<p class=”task-subtitle”>A comprehensive approach to eliciting the urticaria history in children</p>
</div>
<div class=”task-body”>
<!– RED FLAGS – MUST BE FIRST –>
<div class=”callout-box warning-box”>
<div class=”callout-icon”><i class=”fa fa-exclamation-triangle”></i></div>
<div class=”callout-content”>
<h4>Red Flags — Require Urgent Evaluation</h4>
<div class=”grid-2″>
<div>
<ul>
<li><strong>Respiratory distress</strong> — stridor, wheeze, dyspnea, hoarse voice (airway angioedema, anaphylaxis)</li>
<li><strong>Tongue or throat swelling</strong> — impending airway compromise</li>
<li><strong>Hypotension or tachycardia</strong> — anaphylactic shock</li>
<li><strong>Altered consciousness</strong> — severe anaphylaxis or sepsis</li>
<li><strong>Drooling or difficulty swallowing</strong> — oropharyngeal angioedema</li>
</ul>
</div>
<div>
<ul>
<li><strong>Angioedema without urticaria</strong> — consider hereditary angioedema</li>
<li><strong>Family history of laryngeal edema deaths</strong> — hereditary angioedema</li>
<li><strong>Individual lesions lasting greater than 24 hours</strong> — urticarial vasculitis</li>
<li><strong>Lesions that bruise or leave pigmentation</strong> — vasculitis, mastocytosis</li>
<li><strong>Fever with ill appearance</strong> — systemic infection, serum sickness</li>
<li><strong>Joint pain and swelling</strong> — serum sickness-like reaction, vasculitis</li>
</ul>
</div>
</div>
</div>
</div>
<!– MNEMONIC –>
<h2>Systematic History: The “WHEALS” Approach</h2>
<div class=”highlight-box”>
<p>Use the mnemonic <strong>”WHEALS”</strong> to ensure comprehensive history taking in pediatric urticaria:</p>
<ul>
<li><strong>W</strong> — <strong>What do they look like and When did they start?</strong> Describe the lesions; onset timing; duration of individual wheals; pattern of recurrence</li>
<li><strong>H</strong> — <strong>How is the child affected?</strong> Pruritus severity; sleep disturbance; school absence; associated symptoms (respiratory, gastrointestinal, systemic)</li>
<li><strong>E</strong> — <strong>Exposures and Events preceding onset:</strong> Foods eaten; medications; infections; insect stings; new products; travel; physical triggers</li>
<li><strong>A</strong> — <strong>Allergies and Atopic history:</strong> Known allergies; eczema; asthma; allergic rhinitis; previous similar episodes; family atopic history</li>
<li><strong>L</strong> — <strong>Lasting features and Lesion characteristics:</strong> Do individual lesions resolve within 24 hours? Any bruising, pain, or residual marks? Angioedema present?</li>
<li><strong>S</strong> — <strong>Systemic symptoms and Social history:</strong> Fever; joint pain; breathing difficulty; family history of angioedema; daycare; recent travel; stress</li>
</ul>
</div>
<h2>Characterizing the Urticaria</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Question Category</th>
<th>Specific Questions to Ask</th>
<th>Clinical Relevance</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Onset and Duration</strong></td>
<td>”When did the rash first appear?” “How long has this episode been going on?” “Has this happened before?”</td>
<td>Distinguishes acute (less than 6 weeks) from chronic (greater than 6 weeks); recurrent episodes suggest identifiable trigger</td>
</tr>
<tr>
<td><strong>Individual Lesion Duration</strong></td>
<td>”How long does each bump last before it fades?” “Do they leave any marks when they go away?”</td>
<td>Wheals lasting greater than 24 hours or leaving bruising suggest urticarial vasculitis — requires different workup</td>
</tr>
<tr>
<td><strong>Distribution and Migration</strong></td>
<td>”Where on the body did it start?” “Does it move around?” “Is it always in the same place?”</td>
<td>Migratory pattern typical of urticaria; fixed lesions suggest contact urticaria or other diagnosis</td>
</tr>
<tr>
<td><strong>Associated Symptoms</strong></td>
<td>”Is there any swelling of lips, eyes, hands, or feet?” “Any trouble breathing, swallowing, or a change in voice?”</td>
<td>Angioedema present in 40% of cases; respiratory symptoms indicate potential anaphylaxis</td>
</tr>
<tr>
<td><strong>Pruritus Severity</strong></td>
<td>”How itchy is it on a scale of 1-10?” “Does it wake your child at night?” “Does scratching make it worse?”</td>
<td>Assesses impact on quality of life; guides treatment intensity; dermatographism may worsen with scratching</td>
</tr>
</tbody>
</table>
</div>
<h2>Targeted Questions by Suspected Cause</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Suspected Cause</th>
<th>Key Features</th>
<th>Ask This Question</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Viral Infection</strong></td>
<td>Recent or concurrent upper respiratory symptoms, fever, gastrointestinal illness; gradual onset; widespread distribution</td>
<td>”Has your child had any cold symptoms, fever, sore throat, vomiting, or diarrhea in the past 1-2 weeks?”</td>
</tr>
<tr>
<td><strong>Food Allergy (IgE-mediated)</strong></td>
<td>Rapid onset (within 2 hours of eating); reproducible with same food; often with other symptoms</td>
<td>”What did your child eat in the 2 hours before the rash appeared? Has this food ever caused a reaction before?”</td>
</tr>
<tr>
<td><strong>Medication Reaction</strong></td>
<td>Temporal relationship to drug; onset within days of starting new medication; common culprits: antibiotics, NSAIDs</td>
<td>”Has your child taken any medications, including over-the-counter drugs, supplements, or herbal remedies, in the past 2 weeks?”</td>
</tr>
<tr>
<td><strong>Insect Sting or Bite</strong></td>
<td>History of sting; local reaction at site followed by generalized urticaria; outdoor activity</td>
<td>”Was your child stung by a bee, wasp, or other insect? Did you notice any bug bites before the rash spread?”</td>
</tr>
<tr>
<td><strong>Cold Urticaria</strong></td>
<td>Occurs after cold exposure; wheals on exposed skin; may occur after swimming or eating cold foods</td>
<td>”Does the rash appear after being outside in cold weather, swimming, or eating ice cream or cold drinks?”</td>
</tr>
<tr>
<td><strong>Cholinergic Urticaria</strong></td>
<td>Small punctate wheals (1-3 mm); triggered by sweating, exercise, emotional stress, hot showers</td>
<td>”Does the rash appear during or after exercise, hot baths, or when your child gets very warm or stressed?”</td>
</tr>
<tr>
<td><strong>Dermatographism</strong></td>
<td>Linear wheals at sites of scratching or pressure; often asymptomatic until noticed</td>
<td>”Do you notice that scratching or rubbing the skin causes raised red lines? Does tight clothing cause welts?”</td>
</tr>
<tr>
<td><strong>Pressure Urticaria</strong></td>
<td>Delayed swelling (4-6 hours) at pressure sites; often painful; affects palms, soles, buttocks</td>
<td>”Does your child develop swelling on their feet after walking, or on their bottom after sitting for a long time?”</td>
</tr>
<tr>
<td><strong>Contact Urticaria</strong></td>
<td>Wheals localized to contact area; immediate onset on exposure; common triggers: foods, animals, latex</td>
<td>”Does the rash appear only where something touched the skin? Does it happen when touching certain foods or animals?”</td>
</tr>
<tr>
<td><strong>Serum Sickness-Like Reaction</strong></td>
<td>Urticaria with fever, arthralgia, lymphadenopathy; 1-3 weeks after starting antibiotic (often cefaclor, amoxicillin)</td>
<td>”Has your child taken any antibiotics in the past 3 weeks? Is there any joint pain, swelling, or fever along with the rash?”</td>
</tr>
<tr>
<td><strong>Hereditary Angioedema</strong></td>
<td>Recurrent angioedema WITHOUT urticaria; family history; abdominal pain episodes; triggered by trauma, stress, infection</td>
<td>”Does anyone in the family have recurrent swelling episodes? Does your child get swelling without any hives?”</td>
</tr>
</tbody>
</table>
</div>
<h2>Pediatric-Specific History Components</h2>
<div class=”grid-2″>
<div class=”grid-item”>
<h3>Age-Related Considerations</h3>
<ul>
<li><strong>Infants (0-12 months):</strong> Cow’s milk and egg are common food triggers; consider maternal diet if breastfeeding; viral infections very common</li>
<li><strong>Toddlers (1-3 years):</strong> Expanding diet introduces new food allergens; frequent viral infections from daycare; peanut and tree nut allergies emerge</li>
<li><strong>School-age (4-12 years):</strong> Physical urticarias become more apparent; cold urticaria common; consider stress and school-related triggers</li>
<li><strong>Adolescents (13-18 years):</strong> Cholinergic urticaria peaks; consider NSAIDs for menstrual pain; chronic spontaneous urticaria more common</li>
</ul>
</div>
<div class=”grid-item”>
<h3>Feeding and Dietary History</h3>
<ul>
<li><strong>Breastfed infants:</strong> Maternal diet may be relevant (dairy, egg, peanut can pass into breast milk)</li>
<li><strong>Formula type:</strong> Cow’s milk formula vs extensively hydrolyzed vs amino acid-based</li>
<li><strong>Introduction of solids:</strong> Timing of allergen introduction; any reactions to new foods</li>
<li><strong>Recent dietary changes:</strong> New foods, restaurants, ethnic cuisines, hidden ingredients</li>
<li><strong>Food diary:</strong> May be helpful in recurrent urticaria to identify patterns</li>
</ul>
</div>
</div>
<div class=”grid-2″>
<div class=”grid-item”>
<h3>Birth and Early Medical History</h3>
<ul>
<li><strong>Neonatal history:</strong> Prolonged jaundice, neonatal infections (may predispose to atopy)</li>
<li><strong>Eczema history:</strong> Atopic dermatitis is a strong risk factor for food allergies and atopic urticaria</li>
<li><strong>Previous allergic reactions:</strong> Prior urticaria episodes, known food allergies, medication reactions</li>
<li><strong>Immunization history:</strong> Recent vaccines (urticaria can occur post-vaccination, usually benign)</li>
</ul>
</div>
<div class=”grid-item”>
<h3>Family History</h3>
<ul>
<li><strong>Atopic conditions:</strong> Eczema, asthma, allergic rhinitis, food allergies in parents or siblings</li>
<li><strong>Urticaria:</strong> Chronic urticaria, physical urticarias (may have genetic component)</li>
<li><strong>Angioedema:</strong> Recurrent swelling, unexplained abdominal pain, laryngeal edema — consider hereditary angioedema</li>
<li><strong>Autoimmune conditions:</strong> Thyroid disease, vitiligo, celiac disease (associated with chronic spontaneous urticaria)</li>
</ul>
</div>
</div>
<h2>Medication and Substance History</h2>
<div class=”columns”>
<div class=”column”>
<h3>Medications That Commonly Cause Urticaria in Children</h3>
<ul>
<li><strong>Antibiotics:</strong> Penicillins, cephalosporins (especially cefaclor), sulfonamides — most common drug cause in children</li>
<li><strong>NSAIDs:</strong> Ibuprofen, aspirin — can cause urticaria via COX-1 inhibition; may worsen existing urticaria</li>
<li><strong>Opioids:</strong> Codeine, morphine — direct mast cell activation (pseudoallergic)</li>
<li><strong>Vaccines:</strong> Generally mild, self-limiting reactions; gelatin component may cause true allergy</li>
<li><strong>Radiocontrast media:</strong> Direct mast cell activation; premedication can reduce risk</li>
<li><strong>Herbal remedies and supplements:</strong> Often overlooked; may contain allergens or undisclosed ingredients</li>
</ul>
</div>
<div class=”column”>
<h3>Environmental and Social History</h3>
<ul>
<li><strong>Daycare or school:</strong> Exposure to infections; shared foods; new allergens</li>
<li><strong>Pets:</strong> New animals; contact with animals at school or friends’ homes</li>
<li><strong>Home environment:</strong> New laundry detergent, soaps, lotions; dust exposure; mold</li>
<li><strong>Recent travel:</strong> Parasitic infections (especially with eosinophilia); new food exposures</li>
<li><strong>Stress and emotional factors:</strong> School pressures, family changes — can trigger or worsen urticaria</li>
<li><strong>Outdoor activities:</strong> Insect exposure, plant contact, cold or heat exposure</li>
</ul>
</div>
</div>
<h2>Timeline Reconstruction</h2>
<div class=”callout-box info-box”>
<div class=”callout-icon”><i class=”fa fa-info-circle”></i></div>
<div class=”callout-content”>
<h4>Detailed Timeline Questions</h4>
<p>For acute urticaria with suspected allergic trigger, carefully reconstruct the hours before onset:</p>
<ul>
<li><strong>2 hours before onset:</strong> Foods eaten, medications taken (IgE-mediated reactions typically occur within this window)</li>
<li><strong>24-48 hours before:</strong> New medications started, insect stings, unusual exposures</li>
<li><strong>1-2 weeks before:</strong> Viral illness, antibiotic courses (serum sickness-like reaction typically 7-21 days after drug initiation)</li>
<li><strong>Pattern with physical triggers:</strong> Temporal relationship to exercise, cold exposure, pressure, heat</li>
</ul>
</div>
</div>
<h2>Questions About Previous Episodes</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Question</th>
<th>Why It Matters</th>
</tr>
</thead>
<tbody>
<tr>
<td>”Has this ever happened before?”</td>
<td>Recurrent episodes suggest identifiable trigger or chronic urticaria</td>
</tr>
<tr>
<td>”What was your child doing or eating during previous episodes?”</td>
<td>Pattern recognition may identify consistent trigger</td>
</tr>
<tr>
<td>”How long did previous episodes last?”</td>
<td>Self-limiting episodes suggest acute urticaria; persistent symptoms suggest chronic</td>
</tr>
<tr>
<td>”What treatments have worked or not worked before?”</td>
<td>Guides medication selection; lack of antihistamine response may suggest alternative diagnosis</td>
</tr>
<tr>
<td>”Were there any severe reactions with breathing problems or fainting?”</td>
<td>History of anaphylaxis determines need for epinephrine auto-injector prescription</td>
</tr>
</tbody>
</table>
</div>
<h2>Collateral History from Caregivers</h2>
<div class=”callout-box tip-box”>
<div class=”callout-icon”><i class=”fa fa-lightbulb-o”></i></div>
<div class=”callout-content”>
<h4>Practical Tips for Pediatric History</h4>
<div class=”points-list”>
<div class=”point-item”>
<i class=”fa fa-check-circle” style=”color: #2e7d32;”></i>
<span class=”point-text”><strong>Ask for photos:</strong> Parents often photograph rashes — photos can show lesion morphology, distribution, and evolution over time</span>
</div>
<div class=”point-item”>
<i class=”fa fa-check-circle” style=”color: #2e7d32;”></i>
<span class=”point-text”><strong>Request food packaging:</strong> Ingredient lists can identify hidden allergens (e.g., egg in baked goods, milk in processed foods)</span>
</div>
<div class=”point-item”>
<i class=”fa fa-check-circle” style=”color: #2e7d32;”></i>
<span class=”point-text”><strong>Contact daycare or school:</strong> May provide information about meals served, sick contacts, or environmental exposures</span>
</div>
<div class=”point-item”>
<i class=”fa fa-check-circle” style=”color: #2e7d32;”></i>
<span class=”point-text”><strong>Ask about siblings:</strong> Similar symptoms in siblings may suggest infectious cause or shared environmental trigger</span>
</div>
<div class=”point-item”>
<i class=”fa fa-check-circle” style=”color: #2e7d32;”></i>
<span class=”point-text”><strong>Observe the child:</strong> Note scratching behavior, comfort level, respiratory effort during the consultation</span>
</div>
</div>
</div>
</div>
<div class=”content-footer”>
<div class=”copyright”>© Medaptly. All rights reserved.</div>
<div class=”logo”><img src=”https://medaptlytemplates.doo.ee/Medaptly_Logo-removebg-preview.png” alt=”Medaptly Logo”></div>
</div>
</div>
</div>
<!– ==================== TASK 4: PHYSICAL EXAMINATION ==================== –>
<div class=”task-content” id=”task4-content”>
<div class=”task-header”>
<h1 class=”task-title”>4. Physical Examination</h1>
<p class=”task-subtitle”>A systematic head-to-toe approach for urticaria in children</p>
</div>
<div class=”task-body”>
<div class=”highlight-box”>
<p><strong>Systematic Framework:</strong> Use the “Head to Extremities” approach for complete examination of children presenting with urticaria. The primary goals are to: (1) confirm the diagnosis of urticaria, (2) assess severity and rule out anaphylaxis, (3) identify any associated features suggesting specific etiology, and (4) exclude urticaria mimics.</p>
</div>
<div class=”callout-box warning-box”>
<div class=”callout-icon”><i class=”fa fa-exclamation-triangle”></i></div>
<div class=”callout-content”>
<h4>Immediate Assessment: Rule Out Anaphylaxis First</h4>
<p>Before proceeding with detailed examination, rapidly assess for signs of anaphylaxis:</p>
<div class=”grid-2″>
<div>
<ul>
<li><strong>Airway:</strong> Stridor, hoarseness, drooling, tongue or lip swelling</li>
<li><strong>Breathing:</strong> Wheeze, respiratory distress, hypoxia, use of accessory muscles</li>
</ul>
</div>
<div>
<ul>
<li><strong>Circulation:</strong> Pallor, hypotension, weak pulse, prolonged capillary refill, tachycardia</li>
<li><strong>Disability:</strong> Altered consciousness, confusion, lethargy</li>
</ul>
</div>
</div>
<p><strong>If any signs of anaphylaxis are present, treat immediately with intramuscular epinephrine before completing examination.</strong></p>
</div>
</div>
<h2>General Inspection</h2>
<ul>
<li><strong>Appearance:</strong> Well or unwell; comfortable or distressed; alert or lethargic; level of activity</li>
<li><strong>Respiratory effort:</strong> Respiratory rate; work of breathing; audible wheeze or stridor; nasal flaring; retractions</li>
<li><strong>Color:</strong> Normal, pale, flushed, or cyanotic; perioral pallor or cyanosis</li>
<li><strong>Behavior:</strong> Scratching, rubbing skin, irritability, or ability to be consoled</li>
<li><strong>Hydration status:</strong> Mucous membranes, tears, skin turgor (especially if vomiting or diarrhea present)</li>
<li><strong>Growth parameters:</strong> Plot weight and height on growth chart — failure to thrive may suggest chronic disease or severe food allergies with dietary restrictions</li>
</ul>
<h2>Vital Signs</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Age Group</th>
<th>Heart Rate (bpm)</th>
<th>Respiratory Rate (/min)</th>
<th>Systolic BP (mmHg)</th>
<th>Temperature</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Neonate (0-1 month)</strong></td>
<td>100-160</td>
<td>30-60</td>
<td>60-90</td>
<td>36.5-37.5°C</td>
</tr>
<tr>
<td><strong>Infant (1-12 months)</strong></td>
<td>100-150</td>
<td>25-40</td>
<td>80-100</td>
<td>36.5-37.5°C</td>
</tr>
<tr>
<td><strong>Toddler (1-3 years)</strong></td>
<td>90-140</td>
<td>20-30</td>
<td>90-105</td>
<td>36.5-37.5°C</td>
</tr>
<tr>
<td><strong>Preschool (3-5 years)</strong></td>
<td>80-120</td>
<td>20-25</td>
<td>95-110</td>
<td>36.5-37.5°C</td>
</tr>
<tr>
<td><strong>School-age (6-12 years)</strong></td>
<td>70-110</td>
<td>18-25</td>
<td>100-120</td>
<td>36.5-37.5°C</td>
</tr>
<tr>
<td><strong>Adolescent (13-18 years)</strong></td>
<td>60-100</td>
<td>12-20</td>
<td>110-130</td>
<td>36.5-37.5°C</td>
</tr>
</tbody>
</table>
</div>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Vital Sign</th>
<th>Abnormality to Look For</th>
<th>Clinical Significance</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Temperature</strong></td>
<td>Fever (greater than 38°C)</td>
<td>Suggests infection as trigger; consider serum sickness-like reaction if with arthralgia; rule out sepsis if ill-appearing</td>
</tr>
<tr>
<td><strong>Heart Rate</strong></td>
<td>Tachycardia above age-normal range</td>
<td>May indicate anaphylaxis, anxiety, fever, or pain; persistent unexplained tachycardia concerning for cardiovascular compromise</td>
</tr>
<tr>
<td><strong>Blood Pressure</strong></td>
<td>Hypotension (systolic BP less than 5th percentile for age)</td>
<td>Late sign of anaphylaxis in children — indicates cardiovascular decompensation; requires immediate intervention</td>
</tr>
<tr>
<td><strong>Respiratory Rate</strong></td>
<td>Tachypnea above age-normal range</td>
<td>May indicate respiratory involvement (bronchospasm, laryngeal edema); also seen with anxiety or fever</td>
</tr>
<tr>
<td><strong>Oxygen Saturation</strong></td>
<td>SpO2 less than 94% on room air</td>
<td>Indicates significant respiratory compromise; urgent intervention required</td>
</tr>
</tbody>
</table>
</div>
<h2>Skin Examination — The Key to Diagnosis</h2>
<p>A thorough skin examination is essential to confirm the diagnosis of urticaria and distinguish it from mimics.</p>
<h3>Inspection of Wheals</h3>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Feature</th>
<th>Typical Urticaria</th>
<th>Concerning for Alternative Diagnosis</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Shape</strong></td>
<td>Round, oval, or serpiginous; may coalesce into larger plaques</td>
<td>Fixed target lesions (erythema multiforme); annular with scale (tinea, annular erythema)</td>
</tr>
<tr>
<td><strong>Color</strong></td>
<td>Erythematous with pale center; blanches with pressure</td>
<td>Purpuric (does not blanch) — suggests vasculitis; brown/hyperpigmented — suggests urticaria pigmentosa</td>
</tr>
<tr>
<td><strong>Size</strong></td>
<td>Variable: 1-2 mm (cholinergic) to several centimeters; may coalesce</td>
<td>Fixed size lesions recurring in same location suggest other diagnosis</td>
</tr>
<tr>
<td><strong>Distribution</strong></td>
<td>Generalized, random distribution; migratory</td>
<td>Localized to sun-exposed areas (solar urticaria, lupus); dermatomal (zoster)</td>
</tr>
<tr>
<td><strong>Surface</strong></td>
<td>Smooth, raised; no vesicles, scale, or crust</td>
<td>Vesicles (viral exanthem, bullous disease); scale (eczema, psoriasis, fungal)</td>
</tr>
<tr>
<td><strong>Duration of individual lesions</strong></td>
<td>Each wheal resolves within 24 hours</td>
<td>Lesions lasting greater than 24 hours, leaving bruising or pigmentation — urticarial vasculitis</td>
</tr>
</tbody>
</table>
</div>
<h3>Special Skin Tests</h3>
<div class=”grid-2″>
<div class=”grid-item”>
<h4>Dermatographism Test</h4>
<p><strong>How to perform:</strong> Using a tongue depressor or blunt object, stroke the skin of the back or forearm with moderate pressure</p>
<p><strong>Positive result:</strong> Linear wheal and flare develops along the stroke line within 5-10 minutes</p>
<p><strong>Interpretation:</strong> Present in approximately 5% of the population; may be the cause of urticaria or incidental finding</p>
</div>
<div class=”grid-item”>
<h4>Ice Cube Test (for suspected cold urticaria)</h4>
<p><strong>How to perform:</strong> Place an ice cube in a plastic bag on the forearm for 5 minutes, then remove and observe for 10 minutes</p>
<p><strong>Positive result:</strong> Wheal develops at the site of cold exposure after rewarming</p>
<p><strong>Caution:</strong> In severe cold urticaria, systemic symptoms may occur — perform in monitored setting with resuscitation available</p>
</div>
</div>
<h2>Head, Eyes, Ears, Nose, and Throat Examination</h2>
<div class=”grid-2″>
<div class=”grid-item”>
<h3>Eyes</h3>
<ul>
<li><strong>Periorbital edema:</strong> Common site of angioedema; assess symmetry and severity</li>
<li><strong>Conjunctival injection or chemosis:</strong> May indicate allergic component</li>
<li><strong>Allergic shiners:</strong> Dark circles under eyes — suggest chronic allergic disease</li>
<li><strong>Scleral icterus:</strong> If present, consider systemic causes (hepatitis with urticaria)</li>
</ul>
</div>
<div class=”grid-item”>
<h3>Ears</h3>
<ul>
<li><strong>Otoscopy:</strong> Middle ear infection may be trigger; examine for otitis media</li>
<li><strong>Ear canal edema:</strong> Rare site of angioedema</li>
<li><strong>Auricular involvement:</strong> Note any wheals on external ear</li>
</ul>
</div>
</div>
<div class=”grid-2″>
<div class=”grid-item”>
<h3>Nose</h3>
<ul>
<li><strong>Rhinorrhea:</strong> Clear discharge suggests allergic component or viral infection</li>
<li><strong>Nasal congestion:</strong> Common with upper respiratory infection trigger</li>
<li><strong>Allergic salute and nasal crease:</strong> Signs of chronic allergic rhinitis</li>
<li><strong>Turbinate swelling:</strong> Pale, boggy turbinates suggest allergy; erythematous suggests infection</li>
</ul>
</div>
<div class=”grid-item”>
<h3>Oropharynx</h3>
<ul>
<li><strong>Lip swelling:</strong> Common angioedema site — assess degree and symmetry</li>
<li><strong>Tongue swelling:</strong> Concerning for airway compromise — assess ability to protrude, size, floor of mouth</li>
<li><strong>Uvula swelling:</strong> May indicate significant upper airway angioedema</li>
<li><strong>Pharyngitis or tonsillar exudate:</strong> Suggests infectious trigger</li>
<li><strong>Voice changes:</strong> Hoarseness, muffled voice — suggests laryngeal involvement</li>
</ul>
</div>
</div>
<h2>Neck Examination</h2>
<ul>
<li><strong>Lymphadenopathy:</strong> Cervical lymph nodes enlarged with viral infections; generalized lymphadenopathy may suggest serum sickness or systemic illness</li>
<li><strong>Thyroid:</strong> Goiter or thyroid nodules — chronic urticaria is associated with autoimmune thyroid disease</li>
<li><strong>Neck swelling:</strong> Anterior neck swelling may indicate laryngeal or pharyngeal angioedema — urgent assessment required</li>
<li><strong>Stridor:</strong> Listen without stethoscope — inspiratory stridor indicates upper airway obstruction</li>
</ul>
<h2>Respiratory Examination</h2>
<h3>Inspection</h3>
<ul>
<li><strong>Work of breathing:</strong> Nasal flaring, subcostal or intercostal retractions, head bobbing (infants), tripod positioning</li>
<li><strong>Chest wall movement:</strong> Symmetry, adequacy of expansion</li>
<li><strong>Use of accessory muscles:</strong> Sternocleidomastoid, scalene muscles visible — indicates significant respiratory distress</li>
</ul>
<h3>Auscultation</h3>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Finding</th>
<th>Description</th>
<th>Clinical Significance</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Wheeze</strong></td>
<td>High-pitched, musical expiratory sound</td>
<td>Indicates bronchospasm — may be part of allergic reaction or coexisting asthma; if new and progressive, consider anaphylaxis</td>
</tr>
<tr>
<td><strong>Stridor</strong></td>
<td>High-pitched inspiratory sound; often audible without stethoscope</td>
<td>Upper airway obstruction — laryngeal angioedema; requires immediate attention</td>
</tr>
<tr>
<td><strong>Decreased air entry</strong></td>
<td>Quiet breath sounds; may be bilateral or localized</td>
<td>Severe bronchospasm (silent chest) or pneumonia; concerning finding requiring urgent evaluation</td>
</tr>
<tr>
<td><strong>Crackles</strong></td>
<td>Discontinuous sounds, usually inspiratory</td>
<td>May indicate pneumonia as triggering infection; not typical of uncomplicated urticaria</td>
</tr>
<tr>
<td><strong>Normal breath sounds</strong></td>
<td>Clear, vesicular breathing bilaterally</td>
<td>Reassuring — no pulmonary involvement; most common finding in uncomplicated urticaria</td>
</tr>
</tbody>
</table>
</div>
<h2>Cardiovascular Examination</h2>
<ul>
<li><strong>Heart sounds:</strong> Tachycardia common; new murmurs unusual (consider rheumatic fever if with fever and arthralgia)</li>
<li><strong>Capillary refill:</strong> Greater than 2 seconds suggests poor perfusion — concerning for cardiovascular component of anaphylaxis</li>
<li><strong>Peripheral pulses:</strong> Weak or thready pulses indicate circulatory compromise</li>
<li><strong>Perfusion:</strong> Mottled, cool extremities suggest shock</li>
</ul>
<h2>Abdominal Examination</h2>
<ul>
<li><strong>Inspection:</strong> Distension may indicate intestinal angioedema (especially in hereditary angioedema)</li>
<li><strong>Palpation:</strong> Tenderness may indicate gastroenteritis (viral trigger) or intestinal angioedema; hepatosplenomegaly suggests systemic illness</li>
<li><strong>Bowel sounds:</strong> Hyperactive with gastroenteritis; may be decreased with severe intestinal angioedema</li>
<li><strong>Gastrointestinal symptoms:</strong> Nausea, vomiting, cramping, diarrhea may be part of allergic reaction or indicate infectious trigger</li>
</ul>
<h2>Extremities Examination</h2>
<ul>
<li><strong>Angioedema of hands and feet:</strong> Common sites — assess for swelling, especially dorsal surfaces</li>
<li><strong>Joint examination:</strong> Arthralgia and joint swelling suggest serum sickness-like reaction or urticarial vasculitis</li>
<li><strong>Clubbing:</strong> Not associated with urticaria; if present, suggests underlying chronic disease</li>
<li><strong>Peripheral edema:</strong> Distinguish localized angioedema from generalized edema (consider nephrotic syndrome, cardiac causes)</li>
<li><strong>Skin changes:</strong> Examine palms and soles for wheals (pressure urticaria), eczematous changes (atopic diathesis)</li>
</ul>
<h2>Examination for Physical Urticaria Triggers</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Type</th>
<th>Examination Technique</th>
<th>Positive Finding</th>
<th>Precautions</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Dermatographism</strong></td>
<td>Stroke skin with tongue depressor</td>
<td>Linear wheal along stroke within 10 minutes</td>
<td>Common incidental finding; may not be clinically significant</td>
</tr>
<tr>
<td><strong>Cold urticaria</strong></td>
<td>Ice cube in bag on forearm for 5 minutes</td>
<td>Wheal at site after rewarming</td>
<td>Perform in monitored setting; systemic reaction possible</td>
</tr>
<tr>
<td><strong>Cholinergic urticaria</strong></td>
<td>Exercise challenge or hot bath</td>
<td>Punctate 1-3 mm wheals with exercise or heat</td>
<td>Usually performed in specialized setting</td>
</tr>
<tr>
<td><strong>Pressure urticaria</strong></td>
<td>Apply weighted strap to forearm for 15 minutes</td>
<td>Swelling at site after 4-6 hours</td>
<td>Delayed response; may need follow-up assessment</td>
</tr>
<tr>
<td><strong>Solar urticaria</strong></td>
<td>Expose skin to sunlight or UV light</td>
<td>Wheals in exposed area within minutes</td>
<td>Performed in dermatology or allergy clinic</td>
</tr>
</tbody>
</table>
</div>
<h2>Expected Findings by Etiology</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Condition</th>
<th>General Appearance</th>
<th>Skin Findings</th>
<th>Other Findings</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Viral Infection-Associated</strong></td>
<td>May have low-grade fever; mildly unwell</td>
<td>Widespread urticaria; variable morphology</td>
<td>Pharyngitis, rhinorrhea, cervical lymphadenopathy, diarrhea</td>
</tr>
<tr>
<td><strong>IgE-Mediated Food Allergy</strong></td>
<td>Well to acutely unwell; anxious</td>
<td>Urticaria ± angioedema (lips, face); contact urticaria at mouth</td>
<td>May have wheeze, vomiting, throat symptoms if anaphylaxis</td>
</tr>
<tr>
<td><strong>Cold Urticaria</strong></td>
<td>Well at presentation (triggered by cold)</td>
<td>Wheals on previously cold-exposed areas</td>
<td>History of symptoms with cold exposure; ice cube test positive</td>
</tr>
<tr>
<td><strong>Dermatographism</strong></td>
<td>Well; often incidental finding</td>
<td>Linear wheals at scratch or pressure sites</td>
<td>Positive dermatographism test; often asymptomatic</td>
</tr>
<tr>
<td><strong>Chronic Spontaneous Urticaria</strong></td>
<td>Well; may be frustrated by chronic symptoms</td>
<td>Variable wheals; may have excoriations from chronic scratching</td>
<td>Usually no other findings; possible thyroid enlargement</td>
</tr>
<tr>
<td><strong>Serum Sickness-Like Reaction</strong></td>
<td>Unwell; febrile</td>
<td>Urticaria; may have purpuric elements</td>
<td>Fever, arthralgia, joint swelling, lymphadenopathy</td>
</tr>
<tr>
<td><strong>Urticarial Vasculitis</strong></td>
<td>May be unwell; systemic symptoms</td>
<td>Lesions lasting greater than 24 hours; residual purpura or pigmentation; painful rather than pruritic</td>
<td>Joint pain, fever, malaise; may have renal or pulmonary involvement</td>
</tr>
<tr>
<td><strong>Mastocytosis</strong></td>
<td>Well or episodically unwell</td>
<td>Urticaria pigmentosa: brown macules that urticate when stroked (Darier sign positive)</td>
<td>Flushing, abdominal symptoms, hepatosplenomegaly in systemic disease</td>
</tr>
</tbody>
</table>
</div>
<div class=”callout-box info-box”>
<div class=”callout-icon”><i class=”fa fa-info-circle”></i></div>
<div class=”callout-content”>
<h4>Important Teaching Point</h4>
<p><strong>Normal examination is common in urticaria.</strong> Most children with acute urticaria — particularly those with viral infection triggers, mild allergic reactions, or idiopathic urticaria — will have an entirely normal physical examination aside from the skin findings. The examination serves primarily to:</p>
<ul>
<li>Confirm the diagnosis by observing characteristic wheals</li>
<li>Exclude anaphylaxis and other emergencies</li>
<li>Identify clues to specific etiology</li>
<li>Rule out urticaria mimics</li>
</ul>
<p>A normal examination in a well-appearing child with typical urticaria is reassuring and supports conservative management.</p>
</div>
</div>
<h2>Examination Findings That Change Management</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Finding</th>
<th>Implication</th>
<th>Action Required</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Any sign of anaphylaxis</strong></td>
<td>Life-threatening allergic reaction</td>
<td>Immediate epinephrine; call for help; resuscitation as needed</td>
</tr>
<tr>
<td><strong>Stridor or significant tongue swelling</strong></td>
<td>Impending airway obstruction</td>
<td>Epinephrine; prepare for advanced airway management</td>
</tr>
<tr>
<td><strong>Lesions lasting greater than 24 hours with bruising</strong></td>
<td>Urticarial vasculitis likely</td>
<td>Different workup required; consider skin biopsy; evaluate for systemic involvement</td>
</tr>
<tr>
<td><strong>Positive Darier sign (brown lesions that urticate)</strong></td>
<td>Mastocytosis</td>
<td>Specialist referral; avoid mast cell degranulating triggers; serum tryptase level</td>
</tr>
<tr>
<td><strong>Fever with arthralgia and lymphadenopathy</strong></td>
<td>Serum sickness-like reaction</td>
<td>Stop causative medication; supportive care; consider corticosteroids</td>
</tr>
<tr>
<td><strong>Angioedema without urticaria</strong></td>
<td>Consider hereditary angioedema</td>
<td>Check C4, C1-inhibitor level and function; different treatment required</td>
</tr>
</tbody>
</table>
</div>
<div class=”callout-box tip-box”>
<div class=”callout-icon”><i class=”fa fa-lightbulb-o”></i></div>
<div class=”callout-content”>
<h4>Clinical Pearl: The Disappearing Rash</h4>
<p>By the time children reach the clinic or emergency department, the urticaria may have partially or completely resolved. This is actually a helpful diagnostic feature — the transient, migratory nature of wheals is characteristic of urticaria. Ask caregivers to take photographs when the rash is active, as these are invaluable for confirming the diagnosis. If the rash is present during examination, mark one or two wheals with a pen and recheck in 1-2 hours — true urticarial wheals will have faded or moved, while fixed lesions suggest alternative diagnoses.</p>
</div>
</div>
<div class=”content-footer”>
<div class=”copyright”>© Medaptly. All rights reserved.</div>
<div class=”logo”><img src=”https://medaptlytemplates.doo.ee/Medaptly_Logo-removebg-preview.png” alt=”Medaptly Logo”></div>
</div>
</div>
</div>
<!– ==================== TASK 5: DIFFERENTIAL DIAGNOSIS ==================== –>
<div class=”task-content” id=”task5-content”>
<div class=”task-header”>
<h1 class=”task-title”>5. Differential Diagnosis</h1>
<p class=”task-subtitle”>Systematic approach organized by probability and clinical features in pediatric urticaria</p>
</div>
<div class=”task-body”>
<p>The differential diagnosis of urticaria in children requires consideration of both the underlying causes of true urticaria and conditions that may mimic urticaria (“urticaria mimics”). The approach differs significantly based on whether the presentation is acute or chronic, and whether the child appears well or unwell.</p>
<h2>Acute Urticaria in Children (Duration: Less than 6 weeks)</h2>
<p>Acute urticaria is far more common than chronic urticaria in children. In most cases, a specific trigger is never identified, but when found, infections are the most common cause.</p>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Probability</th>
<th>Condition</th>
<th>Key Features</th>
<th>Red Flags</th>
</tr>
</thead>
<tbody>
<tr class=”bg-common”>
<td rowspan=”4″><strong>COMMON<br>(approximately 70-80%)</strong></td>
<td><strong>Viral Infection-Associated Urticaria</strong></td>
<td>Concurrent or recent upper respiratory infection, gastroenteritis, or nonspecific viral illness; low-grade fever; widespread distribution</td>
<td>High fever with ill appearance; petechiae (consider meningococcemia)</td>
</tr>
<tr class=”bg-common”>
<td><strong>Idiopathic Acute Urticaria</strong></td>
<td>No identifiable trigger despite thorough history; well-appearing child; self-limiting course</td>
<td>Lesions lasting greater than 24 hours; systemic symptoms</td>
</tr>
<tr class=”bg-common”>
<td><strong>IgE-Mediated Food Allergy</strong></td>
<td>Onset within 2 hours of eating; reproducible with same food; common triggers: milk, egg, peanut, tree nuts, fish, shellfish, wheat, soy</td>
<td>Respiratory symptoms; vomiting; hypotension (anaphylaxis)</td>
</tr>
<tr class=”bg-common”>
<td><strong>Medication Reaction</strong></td>
<td>Temporal relationship to drug; antibiotics (especially penicillins, cephalosporins) and NSAIDs most common in children</td>
<td>Fever, mucosal involvement (Stevens-Johnson syndrome); arthralgia (serum sickness)</td>
</tr>
<tr class=”bg-less-common”>
<td rowspan=”4″><strong>LESS COMMON<br>(approximately 15-20%)</strong></td>
<td><strong>Insect Sting Hypersensitivity</strong></td>
<td>History of sting; local reaction followed by generalized urticaria; bee, wasp, fire ant stings</td>
<td>Rapid progression; respiratory symptoms; prior severe reaction</td>
</tr>
<tr class=”bg-less-common”>
<td><strong>Contact Urticaria</strong></td>
<td>Localized wheals at contact site; immediate onset; triggers: latex, foods, animal saliva, plants</td>
<td>Progression to generalized urticaria; systemic symptoms</td>
</tr>
<tr class=”bg-less-common”>
<td><strong>Physical Urticaria (acute presentation)</strong></td>
<td>Triggered by cold, heat, pressure, or exercise; reproducible pattern; may present acutely before pattern recognized</td>
<td>Cold urticaria with swimming (risk of drowning); exercise-induced anaphylaxis</td>
</tr>
<tr class=”bg-less-common”>
<td><strong>Serum Sickness-Like Reaction</strong></td>
<td>Urticaria with fever, arthralgia, lymphadenopathy; 7-21 days after starting antibiotic (cefaclor, amoxicillin common)</td>
<td>High fever; severe joint swelling; renal involvement</td>
</tr>
<tr class=”bg-uncommon”>
<td rowspan=”3″><strong>UNCOMMON BUT SERIOUS<br>(approximately 5%)</strong></td>
<td><strong>Anaphylaxis</strong></td>
<td>Urticaria with respiratory, cardiovascular, or severe gastrointestinal symptoms; rapid onset after trigger exposure</td>
<td>Stridor, wheeze, hypotension, altered consciousness — EMERGENCY</td>
</tr>
<tr class=”bg-uncommon”>
<td><strong>Urticarial Vasculitis</strong></td>
<td>Individual lesions lasting greater than 24 hours; painful rather than pruritic; residual purpura or pigmentation</td>
<td>Systemic symptoms; renal, pulmonary, or joint involvement</td>
</tr>
<tr class=”bg-uncommon”>
<td><strong>Systemic Infection</strong></td>
<td>Bacterial infection (streptococcal, staphylococcal); parasitic infection (especially if eosinophilia); hepatitis</td>
<td>High fever; ill appearance; localizing symptoms</td>
</tr>
</tbody>
</table>
</div>
<h2>Chronic Urticaria in Children (Duration: Greater than 6 weeks)</h2>
<p>Chronic urticaria is less common in children than adults but can significantly impact quality of life. Unlike acute urticaria, a specific external trigger is rarely identified.</p>
<div class=”highlight-box”>
<p><strong>Step-by-Step Approach to Chronic Urticaria in Children:</strong></p>
<ol>
<li><strong>Step 1: Confirm the diagnosis</strong> — Are these true urticarial wheals (transient, migratory, lasting less than 24 hours each)?</li>
<li><strong>Step 2: Rule out physical urticarias</strong> — History and provocation testing for cold, heat, pressure, dermatographism, cholinergic triggers</li>
<li><strong>Step 3: Consider chronic spontaneous urticaria</strong> — Most common cause; may be autoimmune or idiopathic</li>
<li><strong>Step 4: Evaluate for underlying conditions</strong> — Thyroid disease, chronic infection, autoinflammatory conditions (if other features present)</li>
</ol>
</div>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Probability</th>
<th>Condition</th>
<th>Approximate Frequency</th>
<th>Key Distinguishing Features</th>
</tr>
</thead>
<tbody>
<tr class=”bg-common”>
<td rowspan=”2″><strong>COMMON</strong></td>
<td><strong>Chronic Spontaneous Urticaria — Idiopathic</strong></td>
<td>40-50% of chronic cases</td>
<td>No identifiable trigger; unpredictable flares; may last months to years; often remits spontaneously</td>
</tr>
<tr class=”bg-common”>
<td><strong>Chronic Spontaneous Urticaria — Autoimmune</strong></td>
<td>30-40% of chronic cases</td>
<td>Anti-IgE or anti-FcεRI autoantibodies; may have positive autologous serum skin test; associated with thyroid autoimmunity</td>
</tr>
<tr class=”bg-less-common”>
<td rowspan=”5″><strong>LESS COMMON</strong></td>
<td><strong>Chronic Inducible Urticaria — Cold</strong></td>
<td>5-10%</td>
<td>Wheals after cold exposure; positive ice cube test; risk of systemic reaction with swimming</td>
</tr>
<tr class=”bg-less-common”>
<td><strong>Chronic Inducible Urticaria — Dermatographism</strong></td>
<td>5-10%</td>
<td>Linear wheals from scratching or pressure; may be primary cause or exacerbating factor</td>
</tr>
<tr class=”bg-less-common”>
<td><strong>Chronic Inducible Urticaria — Cholinergic</strong></td>
<td>5-10%</td>
<td>Small punctate wheals (1-3 mm) with exercise, heat, or emotional stress; peaks in adolescence</td>
</tr>
<tr class=”bg-less-common”>
<td><strong>Chronic Inducible Urticaria — Delayed Pressure</strong></td>
<td>2-5%</td>
<td>Swelling 4-6 hours after sustained pressure; palms, soles, buttocks; often painful</td>
</tr>
<tr class=”bg-less-common”>
<td><strong>Recurrent Viral-Triggered Urticaria</strong></td>
<td>Variable</td>
<td>Repeated acute episodes with viral infections; symptom-free intervals; common in young children with frequent infections</td>
</tr>
<tr class=”bg-uncommon”>
<td rowspan=”4″><strong>UNCOMMON OR RARE</strong></td>
<td><strong>Urticarial Vasculitis</strong></td>
<td>Less than 5%</td>
<td>Lesions lasting greater than 24 hours; painful; residual marks; may have systemic involvement; requires biopsy for diagnosis</td>
</tr>
<tr class=”bg-uncommon”>
<td><strong>Mastocytosis</strong></td>
<td>Rare</td>
<td>Urticaria pigmentosa with brown macules; positive Darier sign; flushing; may have systemic symptoms</td>
</tr>
<tr class=”bg-uncommon”>
<td><strong>Autoinflammatory Syndromes</strong></td>
<td>Rare</td>
<td>Cryopyrin-associated periodic syndromes; urticaria with fever, arthralgia; often presents in infancy</td>
</tr>
<tr class=”bg-uncommon”>
<td><strong>Thyroid Autoimmunity-Associated</strong></td>
<td>2-5%</td>
<td>Associated with Hashimoto thyroiditis or Graves disease; elevated thyroid antibodies; urticaria may improve with thyroid treatment</td>
</tr>
</tbody>
</table>
</div>
<h2>Age-Based Differential Considerations</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Age Group</th>
<th>More Common Causes</th>
<th>Special Considerations</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Infants (0-12 months)</strong></td>
<td>Viral infections; cow’s milk and egg allergy; drug reactions (antibiotics)</td>
<td>Consider maternal diet if breastfeeding; urticarial rashes may be confused with other infantile dermatoses; mastocytosis may present at this age</td>
</tr>
<tr>
<td><strong>Toddlers (1-3 years)</strong></td>
<td>Viral infections (very common due to daycare exposure); food allergies (peanut, tree nut emergence); insect stings</td>
<td>High frequency of viral URIs can cause recurrent episodes; food allergies often apparent with diet expansion</td>
</tr>
<tr>
<td><strong>Preschool (3-5 years)</strong></td>
<td>Viral infections; food allergies; physical urticarias becoming apparent</td>
<td>Cold urticaria often first noticed at this age; can articulate symptoms better</td>
</tr>
<tr>
<td><strong>School-age (6-12 years)</strong></td>
<td>Viral infections; physical urticarias; early chronic spontaneous urticaria</td>
<td>Exercise-related urticaria may emerge; stress-related exacerbations; better history available</td>
</tr>
<tr>
<td><strong>Adolescents (13-18 years)</strong></td>
<td>Chronic spontaneous urticaria; cholinergic urticaria; NSAID-related</td>
<td>Pattern more similar to adults; autoimmune urticaria more common; consider NSAID use for menstrual pain</td>
</tr>
</tbody>
</table>
</div>
<h2>Anatomical/Mechanistic Approach to Urticaria Causes</h2>
<div class=”eisenhower-matrix”>
<div class=”quadrant q2″>
<h3>Immune-Mediated</h3>
<p><strong>IgE-mediated:</strong> Food allergy, drug allergy, insect venom, latex, aeroallergens</p>
<p><strong>Autoimmune:</strong> Anti-IgE antibodies, anti-FcεRI antibodies</p>
<p><strong>Immune complex:</strong> Serum sickness, urticarial vasculitis, infection-associated</p>
</div>
<div class=”quadrant q1″>
<h3>Physical Triggers</h3>
<p><strong>Temperature:</strong> Cold urticaria, heat urticaria, cholinergic (heat/sweat)</p>
<p><strong>Mechanical:</strong> Dermatographism, delayed pressure urticaria, vibratory</p>
<p><strong>Other:</strong> Solar urticaria, aquagenic urticaria</p>
</div>
<div class=”quadrant q4″>
<h3>Infection-Associated</h3>
<p><strong>Viral:</strong> Upper respiratory viruses, enteroviruses, EBV, hepatitis, COVID-19</p>
<p><strong>Bacterial:</strong> Streptococcal, Helicobacter pylori, urinary tract infection</p>
<p><strong>Parasitic:</strong> Giardia, helminths, Toxocara (consider with eosinophilia/travel)</p>
</div>
<div class=”quadrant q3″>
<h3>Drug and Substance-Related</h3>
<p><strong>Immunologic:</strong> Penicillins, cephalosporins, sulfonamides (true allergy)</p>
<p><strong>Pseudoallergic:</strong> NSAIDs, opioids, radiocontrast, vancomycin</p>
<p><strong>Food additives:</strong> Salicylates, benzoates, tartrazine (controversial)</p>
</div>
</div>
<h2>Urticaria Mimics — Conditions That Look Like Urticaria</h2>
<p>Several conditions can present with urticaria-like lesions but have different etiologies and require different management. Accurate differentiation is essential.</p>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Condition</th>
<th>Key Differentiating Features</th>
<th>Diagnostic Clues</th>
<th>Management Differs</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Urticarial Vasculitis</strong></td>
<td>Individual lesions last greater than 24 hours; painful more than pruritic; leaves bruising or pigmentation</td>
<td>Skin biopsy shows leukocytoclastic vasculitis; low complement (hypocomplementemic variant)</td>
<td>Yes — requires workup for systemic involvement; may need immunosuppression</td>
</tr>
<tr>
<td><strong>Erythema Multiforme</strong></td>
<td>Target or targetoid lesions; fixed location; often acral distribution; may have mucosal involvement</td>
<td>Classic three-zone target; history of herpes simplex or Mycoplasma infection; fixed lesions</td>
<td>Yes — address underlying infection; supportive care; monitor for Stevens-Johnson syndrome</td>
</tr>
<tr>
<td><strong>Viral Exanthems</strong></td>
<td>Maculopapular rather than wheals; not migratory; often symmetric; associated viral symptoms</td>
<td>Lesions persist in same location; may have fever, lymphadenopathy; usually self-limiting</td>
<td>Somewhat — supportive care; specific antivirals if indicated</td>
</tr>
<tr>
<td><strong>Insect Bite Reactions (Papular Urticaria)</strong></td>
<td>Grouped papules; persistent (days to weeks); often on exposed areas; may have central punctum</td>
<td>Clustered distribution; history of outdoor exposure; seasonal pattern; may see active bites</td>
<td>Yes — environmental control; topical treatment; different from systemic insect allergy</td>
</tr>
<tr>
<td><strong>Mastocytosis (Urticaria Pigmentosa)</strong></td>
<td>Brown/tan macules that urticate when stroked; persistent lesions; Darier sign positive</td>
<td>Lesions present at baseline; urtication with rubbing; serum tryptase may be elevated</td>
<td>Yes — avoid mast cell degranulating triggers; monitor for systemic disease</td>
</tr>
<tr>
<td><strong>Contact Dermatitis (Acute)</strong></td>
<td>Erythematous, edematous plaques; may have vesicles; geometric pattern matching contactant</td>
<td>Distribution matches exposure; pruritic; may progress to vesiculation; persists until allergen removed</td>
<td>Yes — allergen identification and avoidance; topical corticosteroids</td>
</tr>
<tr>
<td><strong>Henoch-Schönlein Purpura</strong></td>
<td>Palpable purpura (does not blanch); typically lower extremities and buttocks; may start urticaria-like</td>
<td>Purpura develops; associated arthralgia, abdominal pain, renal involvement</td>
<td>Yes — monitor for renal disease; supportive care; different prognosis</td>
</tr>
<tr>
<td><strong>Hereditary Angioedema</strong></td>
<td>Recurrent angioedema WITHOUT urticaria; family history; may have abdominal attacks</td>
<td>No wheals; angioedema painful not pruritic; no response to antihistamines; low C4</td>
<td>Yes — requires specific treatment (C1-inhibitor, icatibant); epinephrine ineffective</td>
</tr>
<tr>
<td><strong>Autoinflammatory Syndromes</strong></td>
<td>Urticarial rash with periodic fevers; onset often in infancy; family history may be present</td>
<td>CAPS: cold-triggered; NOMID: severe neurologic involvement; elevated inflammatory markers</td>
<td>Yes — IL-1 inhibitors for CAPS; different long-term management</td>
</tr>
</tbody>
</table>
</div>
<h2>Drug-Induced Urticaria in Children</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Drug or Drug Class</th>
<th>Mechanism</th>
<th>Characteristics in Children</th>
<th>Time to Resolution After Stopping</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Penicillins and Amoxicillin</strong></td>
<td>IgE-mediated (immediate) or delayed T-cell mediated; also non-allergic rash common with viral illness</td>
<td>Most common drug cause in children; often occurs during viral illness making causation unclear; amoxicillin rash with EBV is NOT allergy</td>
<td>Immediate: hours to days; Delayed: days to 2 weeks</td>
</tr>
<tr>
<td><strong>Cephalosporins</strong></td>
<td>IgE-mediated; serum sickness-like reaction (especially cefaclor)</td>
<td>Cross-reactivity with penicillins approximately 2%; cefaclor associated with serum sickness-like reaction</td>
<td>Days to weeks; serum sickness resolves in 1-3 weeks</td>
</tr>
<tr>
<td><strong>NSAIDs (Ibuprofen, Aspirin)</strong></td>
<td>COX-1 inhibition causing leukotriene shunting; can also cause IgE-mediated reactions</td>
<td>May exacerbate existing urticaria; can cause de novo urticaria; cross-reactivity between different NSAIDs common</td>
<td>Hours to 1-2 days</td>
</tr>
<tr>
<td><strong>Sulfonamide Antibiotics</strong></td>
<td>Delayed T-cell mediated; rarely IgE-mediated</td>
<td>Used for UTIs; can cause severe cutaneous reactions; rash onset typically 7-14 days after starting</td>
<td>Days to 2 weeks</td>
</tr>
<tr>
<td><strong>Opioids (Codeine, Morphine)</strong></td>
<td>Direct mast cell activation via MRGPRX2 receptor (pseudoallergic, not IgE)</td>
<td>Causes flushing, pruritus, urticaria; dose-dependent; not true allergy in most cases</td>
<td>Hours</td>
</tr>
<tr>
<td><strong>Radiocontrast Media</strong></td>
<td>Direct mast cell activation; complement activation</td>
<td>Less common with newer low-osmolar agents; premedication can reduce risk in those with prior reaction</td>
<td>Hours to 1 day</td>
</tr>
<tr>
<td><strong>Vaccines</strong></td>
<td>Usually non-IgE mediated; gelatin component can cause true allergy; egg allergy concern with some vaccines</td>
<td>Generally mild, self-limiting; serious reactions rare; egg allergy no longer contraindication to most vaccines</td>
<td>Hours to days</td>
</tr>
<tr>
<td><strong>Anticonvulsants</strong></td>
<td>Delayed hypersensitivity; drug reaction with eosinophilia and systemic symptoms (DRESS)</td>
<td>Rash onset 2-6 weeks after starting; watch for systemic involvement; may be serious</td>
<td>Weeks; DRESS may take months to resolve</td>
</tr>
</tbody>
</table>
</div>
<div class=”callout-box tip-box”>
<div class=”callout-icon”><i class=”fa fa-lightbulb-o”></i></div>
<div class=”callout-content”>
<h4>Clinical Pearl: The Amoxicillin-EBV Rash Dilemma</h4>
<p>A maculopapular (not urticarial) rash occurring during amoxicillin treatment for suspected strep throat in a child with unrecognized infectious mononucleosis (EBV) is NOT a true penicillin allergy. This rash occurs in 70-100% of children with EBV who receive amoxicillin. True penicillin allergy is characterized by urticaria, angioedema, or anaphylaxis with rapid onset. Incorrectly labeling children as “penicillin allergic” leads to use of broader-spectrum antibiotics and poorer outcomes. When history is unclear, consider referral for formal penicillin allergy testing.</p>
</div>
</div>
<h2>Quick Reference: “If You See This, Think This First”</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Clinical Clue</th>
<th>Think This First</th>
<th>Next Step</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Urticaria + concurrent cold symptoms</strong></td>
<td>Viral infection-associated urticaria</td>
<td>Symptomatic treatment; reassurance; usually self-limiting</td>
</tr>
<tr>
<td><strong>Urticaria within 2 hours of eating</strong></td>
<td>IgE-mediated food allergy</td>
<td>Identify food; avoid; allergy testing; consider epinephrine prescription</td>
</tr>
<tr>
<td><strong>Urticaria 7-21 days after starting antibiotic + fever + joint pain</strong></td>
<td>Serum sickness-like reaction</td>
<td>Stop antibiotic; supportive care; usually resolves in 1-3 weeks</td>
</tr>
<tr>
<td><strong>Urticaria after cold exposure (swimming, cold weather)</strong></td>
<td>Cold urticaria</td>
<td>Ice cube test; counsel on swimming safety; antihistamines before exposure</td>
</tr>
<tr>
<td><strong>Small punctate wheals with exercise or hot shower</strong></td>
<td>Cholinergic urticaria</td>
<td>Avoid triggers when possible; antihistamines; usually improves with age</td>
</tr>
<tr>
<td><strong>Linear wheals where skin was scratched</strong></td>
<td>Dermatographism</td>
<td>Confirm with skin stroking; antihistamines if symptomatic; reassurance</td>
</tr>
<tr>
<td><strong>Urticaria + wheeze + vomiting + hypotension</strong></td>
<td>Anaphylaxis</td>
<td>Immediate epinephrine; emergency management; identify trigger</td>
</tr>
<tr>
<td><strong>Lesions lasting greater than 24 hours with bruising</strong></td>
<td>Urticarial vasculitis</td>
<td>Skin biopsy; systemic workup; rheumatology referral</td>
</tr>
<tr>
<td><strong>Angioedema WITHOUT any urticaria</strong></td>
<td>Hereditary angioedema (especially if family history)</td>
<td>Check C4, C1-inhibitor level and function; do not rely on antihistamines</td>
</tr>
<tr>
<td><strong>Brown macules that wheal when rubbed</strong></td>
<td>Mastocytosis (urticaria pigmentosa)</td>
<td>Avoid mast cell triggers; check serum tryptase; pediatric hematology referral</td>
</tr>
<tr>
<td><strong>Chronic urticaria greater than 6 weeks, no trigger found</strong></td>
<td>Chronic spontaneous urticaria (idiopathic or autoimmune)</td>
<td>Limited baseline workup; trial of higher-dose antihistamines; consider specialist referral</td>
</tr>
<tr>
<td><strong>Recurrent urticaria episodes only with viral illnesses</strong></td>
<td>Recurrent viral-triggered urticaria</td>
<td>Reassurance; symptom-free between infections; will decrease as child ages</td>
</tr>
</tbody>
</table>
</div>
<div class=”content-footer”>
<div class=”copyright”>© Medaptly. All rights reserved.</div>
<div class=”logo”><img src=”https://medaptlytemplates.doo.ee/Medaptly_Logo-removebg-preview.png” alt=”Medaptly Logo”></div>
</div>
</div>
</div>
<!– ==================== TASK 6: DIAGNOSTIC INVESTIGATIONS ==================== –>
<div class=”task-content” id=”task6-content”>
<div class=”task-header”>
<h1 class=”task-title”>6. Diagnostic Investigations</h1>
<p class=”task-subtitle”>A stepwise, targeted approach guided by clinical suspicion in pediatric urticaria</p>
</div>
<div class=”task-body”>
<div class=”highlight-box”>
<p><strong>Key Principle:</strong> In the majority of pediatric urticaria cases — particularly acute urticaria in a well-appearing child — <strong>no laboratory investigations are required</strong>. The diagnosis is clinical, based on history and examination. Investigations should be targeted based on specific clinical suspicion, not performed routinely.</p>
</div>
<h2>When to Investigate</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Scenario</th>
<th>Investigations Indicated?</th>
<th>Rationale</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Acute urticaria, well child, self-limiting</strong></td>
<td>No</td>
<td>Diagnosis is clinical; most cases are viral or idiopathic; investigations will not change management</td>
</tr>
<tr>
<td><strong>Suspected IgE-mediated food allergy</strong></td>
<td>Yes — allergy testing</td>
<td>Specific IgE testing helps confirm trigger; guides dietary avoidance; informs need for epinephrine</td>
</tr>
<tr>
<td><strong>Anaphylaxis</strong></td>
<td>Yes — during and after event</td>
<td>Serum tryptase during event confirms mast cell activation; allergy workup identifies trigger</td>
</tr>
<tr>
<td><strong>Chronic urticaria greater than 6 weeks</strong></td>
<td>Limited baseline workup</td>
<td>Excludes underlying conditions; extensive testing rarely yields diagnosis</td>
</tr>
<tr>
<td><strong>Suspected urticarial vasculitis</strong></td>
<td>Yes — skin biopsy and systemic workup</td>
<td>Different diagnosis with different management; need to assess for systemic involvement</td>
</tr>
<tr>
<td><strong>Angioedema without urticaria</strong></td>
<td>Yes — complement studies</td>
<td>Must exclude hereditary angioedema; treatment is different</td>
</tr>
<tr>
<td><strong>Systemic symptoms (fever, arthralgia, weight loss)</strong></td>
<td>Yes — directed by symptoms</td>
<td>May indicate systemic disease, infection, or vasculitis</td>
</tr>
</tbody>
</table>
</div>
<h2>Baseline Investigations for Chronic Urticaria</h2>
<p>For children with chronic urticaria (greater than 6 weeks), a limited baseline workup is reasonable to exclude underlying conditions, although yield is low.</p>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Investigation</th>
<th>Purpose</th>
<th>What to Look For</th>
<th>Practical Points</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Complete Blood Count with Differential</strong></td>
<td>Screen for infection, eosinophilia, hematologic abnormality</td>
<td>Eosinophilia (parasites, allergic conditions); leukocytosis (infection); anemia (chronic disease)</td>
<td>Often normal in chronic urticaria; eosinophilia prompts consideration of parasitic infection if risk factors present</td>
</tr>
<tr>
<td><strong>Erythrocyte Sedimentation Rate or C-Reactive Protein</strong></td>
<td>Screen for inflammation</td>
<td>Elevated in urticarial vasculitis, infection, autoimmune conditions</td>
<td>Should be normal in uncomplicated chronic spontaneous urticaria; elevation warrants further investigation</td>
</tr>
<tr>
<td><strong>Thyroid Function Tests and Thyroid Antibodies</strong></td>
<td>Screen for autoimmune thyroid disease</td>
<td>Elevated TSH, abnormal T4; positive anti-thyroid peroxidase or anti-thyroglobulin antibodies</td>
<td>Association between chronic urticaria and autoimmune thyroiditis; more common in adolescents; treatment of thyroid disease may improve urticaria</td>
</tr>
</tbody>
</table>
</div>
<div class=”callout-box info-box”>
<div class=”callout-icon”><i class=”fa fa-info-circle”></i></div>
<div class=”callout-content”>
<h4>Evidence-Based Approach</h4>
<p>Multiple studies and guidelines confirm that extensive laboratory workup in chronic urticaria has very low diagnostic yield. The above limited panel is recommended by international guidelines (EAACI/GA²LEN/EuroGuiDerm/APAAACI). Additional investigations should only be performed if history or examination suggests a specific underlying cause.</p>
</div>
</div>
<h2>Targeted Investigations by Suspected Etiology</h2>
<h3>If Suspecting IgE-Mediated Food Allergy</h3>
<div class=”columns”>
<div class=”column”>
<h4>First-Line Tests</h4>
<ul>
<li><strong>Skin Prick Testing:</strong> Rapid results; high sensitivity; tests specific allergens; wheal ≥3 mm greater than negative control is positive</li>
<li><strong>Serum Specific IgE (sIgE):</strong> Blood test; useful when skin testing not possible; results in kU/L; higher levels correlate with increased likelihood of clinical reactivity</li>
</ul>
</div>
<div class=”column”>
<h4>Second-Line Tests</h4>
<ul>
<li><strong>Component-Resolved Diagnostics:</strong> Tests for specific allergenic proteins (e.g., Ara h 2 for peanut); helps predict severity and likelihood of reaction</li>
<li><strong>Oral Food Challenge:</strong> Gold standard for diagnosis; performed in supervised setting; confirms or excludes clinical allergy when testing is inconclusive</li>
</ul>
</div>
</div>
<div class=”callout-box warning-box”>
<div class=”callout-icon”><i class=”fa fa-exclamation-triangle”></i></div>
<div class=”callout-content”>
<h4>Pediatric Testing Considerations</h4>
<ul>
<li><strong>Only test for suspected allergens</strong> — large panels of “screening” tests have high false-positive rates and lead to unnecessary dietary restrictions</li>
<li><strong>Positive test ≠ clinical allergy</strong> — sensitization (positive IgE) without symptoms is common; clinical history is essential</li>
<li><strong>Skin prick testing is preferred</strong> in children when available — less invasive, immediate results, better sensitivity for some allergens</li>
<li><strong>Testing during acute urticaria</strong> should be deferred — may have false results; wait 4-6 weeks</li>
</ul>
</div>
</div>
<h3>If Suspecting Drug Allergy</h3>
<div class=”columns”>
<div class=”column”>
<h4>For Immediate-Type Reactions (IgE-mediated)</h4>
<ul>
<li><strong>Skin Prick Testing:</strong> Available for penicillin (major and minor determinants); limited availability for other drugs</li>
<li><strong>Intradermal Testing:</strong> More sensitive than skin prick; performed after negative skin prick</li>
<li><strong>Drug Provocation Test:</strong> Gold standard when skin testing negative or unavailable; graded dose challenge in supervised setting</li>
<li><strong>Serum Specific IgE:</strong> Available for penicillins, some other drugs; limited sensitivity</li>
</ul>
</div>
<div class=”column”>
<h4>For Delayed-Type Reactions</h4>
<ul>
<li><strong>Patch Testing:</strong> Useful for delayed contact-type reactions; limited utility for systemic reactions</li>
<li><strong>Delayed Intradermal Testing:</strong> Read at 48-72 hours; may identify delayed T-cell mediated reactions</li>
<li><strong>Drug Provocation Test:</strong> After waiting appropriate interval; confirms or excludes clinical allergy</li>
</ul>
</div>
</div>
<h3>If Suspecting Chronic Spontaneous Urticaria (Autoimmune)</h3>
<div class=”columns”>
<div class=”column”>
<h4>Supportive Tests</h4>
<ul>
<li><strong>Autologous Serum Skin Test (ASST):</strong> Intradermal injection of patient’s own serum; positive wheal suggests autoimmune etiology; not widely available</li>
<li><strong>Basophil Activation Tests:</strong> Research tool; measures CD63 expression on basophils; not routine clinical use</li>
<li><strong>Total IgE:</strong> Low total IgE may predict better response to omalizumab</li>
</ul>
</div>
<div class=”column”>
<h4>Associated Autoimmune Screen</h4>
<ul>
<li><strong>Thyroid Antibodies:</strong> Anti-TPO, anti-thyroglobulin — positive in 10-20% of chronic urticaria patients</li>
<li><strong>Thyroid Function:</strong> TSH, free T4 — autoimmune thyroiditis may be associated</li>
<li><strong>ANA (if clinical suspicion):</strong> Only if features suggest autoimmune connective tissue disease</li>
</ul>
</div>
</div>
<h3>If Suspecting Urticarial Vasculitis</h3>
<div class=”columns”>
<div class=”column”>
<h4>Essential Investigations</h4>
<ul>
<li><strong>Skin Biopsy:</strong> Diagnostic — shows leukocytoclastic vasculitis with neutrophil infiltration, fibrinoid necrosis, red cell extravasation</li>
<li><strong>Complement Levels:</strong> C3, C4, CH50 — low in hypocomplementemic urticarial vasculitis (HUV)</li>
<li><strong>ESR and CRP:</strong> Usually elevated</li>
</ul>
</div>
<div class=”column”>
<h4>Systemic Evaluation</h4>
<ul>
<li><strong>Urinalysis:</strong> Proteinuria, hematuria may indicate renal involvement</li>
<li><strong>Renal Function:</strong> Creatinine, eGFR</li>
<li><strong>ANA, Anti-dsDNA:</strong> May be positive; association with lupus-like syndrome</li>
<li><strong>Chest X-ray:</strong> If respiratory symptoms — pulmonary involvement possible</li>
</ul>
</div>
</div>
<h3>If Suspecting Hereditary Angioedema</h3>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Test</th>
<th>Type I HAE (85%)</th>
<th>Type II HAE (15%)</th>
<th>HAE with Normal C1-INH</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>C4 Level</strong></td>
<td>Low (screening test — if normal during attack, HAE unlikely)</td>
<td>Low</td>
<td>Normal</td>
</tr>
<tr>
<td><strong>C1-Inhibitor Level (quantitative)</strong></td>
<td>Low (less than 50% of normal)</td>
<td>Normal or elevated</td>
<td>Normal</td>
</tr>
<tr>
<td><strong>C1-Inhibitor Function (functional assay)</strong></td>
<td>Low</td>
<td>Low (diagnostic)</td>
<td>Normal</td>
</tr>
<tr>
<td><strong>C1q Level</strong></td>
<td>Normal (low suggests acquired angioedema)</td>
<td>Normal</td>
<td>Normal</td>
</tr>
<tr>
<td><strong>Genetic Testing</strong></td>
<td>SERPING1 mutation (confirmatory)</td>
<td>SERPING1 mutation</td>
<td>May identify F12, PLG, ANGPT1, KNG1, MYOF, HS3ST6 mutations</td>
</tr>
</tbody>
</table>
</div>
<div class=”callout-box tip-box”>
<div class=”callout-icon”><i class=”fa fa-lightbulb-o”></i></div>
<div class=”callout-content”>
<h4>Pediatric HAE Testing Considerations</h4>
<p>C1-inhibitor levels and function may be physiologically low in infants and young children (up to age 1-2 years), leading to potential false-positive results. If HAE is suspected in a young child, repeat testing after age 1 year, or perform genetic testing for confirmation. Family screening should be performed if a parent is affected — approximately 50% of children will inherit the condition.</p>
</div>
</div>
<h3>If Suspecting Physical Urticaria</h3>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Type</th>
<th>Provocation Test</th>
<th>Positive Result</th>
<th>Precautions</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Cold Urticaria</strong></td>
<td>Ice cube in plastic bag on forearm for 5 minutes; observe for 10 minutes after removal</td>
<td>Wheal and flare at test site after rewarming</td>
<td>Perform in monitored setting; severe cases may have systemic symptoms</td>
</tr>
<tr>
<td><strong>Dermatographism</strong></td>
<td>Stroke skin with tongue depressor or dermographometer</td>
<td>Linear wheal along stroke line within 10 minutes</td>
<td>Very common; may be incidental; clinical correlation needed</td>
</tr>
<tr>
<td><strong>Delayed Pressure Urticaria</strong></td>
<td>Apply 2.5 kg weight to forearm for 15-20 minutes; observe for 6 hours</td>
<td>Swelling at site after 4-6 hours</td>
<td>May need to see patient for delayed reading; often painful</td>
</tr>
<tr>
<td><strong>Cholinergic Urticaria</strong></td>
<td>Exercise challenge or hot bath challenge (increase core temperature by 1°C)</td>
<td>Punctate 1-3 mm wheals with exercise or heat</td>
<td>Usually performed in allergy clinic; monitor for systemic symptoms</td>
</tr>
<tr>
<td><strong>Solar Urticaria</strong></td>
<td>Exposure to sunlight or specific UV wavelengths</td>
<td>Wheals in exposed area within minutes</td>
<td>Performed in dermatology/allergy clinic with UV light source</td>
</tr>
<tr>
<td><strong>Aquagenic Urticaria</strong></td>
<td>Apply wet cloth to skin for 20-30 minutes</td>
<td>Wheals at contact site regardless of water temperature</td>
<td>Rare; distinguish from cold urticaria</td>
</tr>
</tbody>
</table>
</div>
<h3>If Suspecting Infection as Trigger</h3>
<div class=”columns”>
<div class=”column”>
<h4>Based on Clinical Suspicion</h4>
<ul>
<li><strong>Throat Swab / Rapid Strep:</strong> If pharyngitis present</li>
<li><strong>Urinalysis:</strong> If urinary symptoms or unexplained fever</li>
<li><strong>Stool Studies:</strong> Ova and parasites if travel history, eosinophilia, or gastrointestinal symptoms</li>
<li><strong>Viral Serology:</strong> EBV, hepatitis B/C if clinical features suggest (generally not routine)</li>
</ul>
</div>
<div class=”column”>
<h4>Not Routinely Recommended</h4>
<ul>
<li><strong>Extensive infection screening</strong> in well-appearing children with acute urticaria is not indicated</li>
<li><strong>Helicobacter pylori testing</strong> is not routinely recommended in pediatric chronic urticaria (unlike adults)</li>
<li><strong>Stool parasites</strong> only if risk factors present (travel to endemic areas, eosinophilia, gastrointestinal symptoms)</li>
</ul>
</div>
</div>
<h2>Investigations During Anaphylaxis</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Investigation</th>
<th>Timing</th>
<th>Interpretation</th>
<th>Practical Points</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Serum Tryptase</strong></td>
<td>Ideally 15 minutes to 3 hours after symptom onset; also baseline (greater than 24 hours later or at follow-up)</td>
<td>Peak greater than 1.2× baseline + 2 ng/mL indicates mast cell activation; supports anaphylaxis diagnosis</td>
<td>May be normal in food-induced anaphylaxis; baseline tryptase important for comparison; elevated baseline suggests mastocytosis</td>
</tr>
<tr>
<td><strong>Serum Histamine</strong></td>
<td>Within 15-60 minutes of onset (degrades rapidly)</td>
<td>Elevated during acute reaction</td>
<td>Difficult to obtain in time; tryptase preferred; research use mainly</td>
</tr>
</tbody>
</table>
</div>
<div class=”section-divider”>
<div class=”section-divider-icon”><i class=”fa fa-flask”></i></div>
</div>
<h2>Empiric Treatment Trials as Diagnostic Tools</h2>
<div class=”callout-box info-box”>
<div class=”callout-icon”><i class=”fa fa-info-circle”></i></div>
<div class=”callout-content”>
<h4>Therapeutic Trial Approach in Chronic Urticaria</h4>
<p>In chronic spontaneous urticaria where no trigger is identified, response to treatment can provide diagnostic information and guide management:</p>
<ol>
<li><strong>First-line trial:</strong> Second-generation H1-antihistamine at standard dose for 2-4 weeks — response suggests histamine-mediated urticaria</li>
<li><strong>Second-line trial:</strong> Increase antihistamine to 2-4× standard dose (up-dosing) for 2-4 weeks — effective in approximately 60% of patients uncontrolled on standard dose</li>
<li><strong>Consider alternative diagnosis:</strong> If no response to high-dose antihistamines, reconsider diagnosis (urticarial vasculitis? mastocytosis?) or escalate to specialist care</li>
</ol>
<p>Response to omalizumab supports autoimmune or IgE-mediated mechanism. Lack of response to antihistamines should prompt reconsideration of the diagnosis.</p>
</div>
</div>
<h2>Investigations NOT Routinely Recommended</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Test</th>
<th>Why Not Routine</th>
<th>When It May Be Appropriate</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Large allergen panels (“screening” tests)</strong></td>
<td>High false-positive rate; leads to unnecessary avoidance; does not identify cause in most cases</td>
<td>Only test specific allergens suggested by history</td>
</tr>
<tr>
<td><strong>IgG food antibody testing</strong></td>
<td>No evidence of clinical utility; measures normal immune response to foods; not validated for urticaria</td>
<td>Never — this testing is not recommended by any allergy society</td>
</tr>
<tr>
<td><strong>Extensive autoimmune panels</strong></td>
<td>Low yield in absence of other features; may create anxiety about false-positive results</td>
<td>Only if clinical features suggest autoimmune disease (joint symptoms, rash characteristics, multi-organ involvement)</td>
</tr>
<tr>
<td><strong>Skin biopsy in typical urticaria</strong></td>
<td>Diagnosis is clinical; biopsy shows nonspecific changes in ordinary urticaria</td>
<td>Indicated if lesions last greater than 24 hours, are painful, or leave marks (suspect vasculitis)</td>
</tr>
<tr>
<td><strong>Elimination diet without positive allergy testing</strong></td>
<td>May lead to nutritional deficiencies; often unnecessary; not evidence-based for chronic urticaria</td>
<td>Short-term trial if strong history suggests specific food trigger; work with dietitian</td>
</tr>
</tbody>
</table>
</div>
<h2>Age-Specific Investigation Considerations</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Age Group</th>
<th>Special Considerations</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Infants (less than 1 year)</strong></td>
<td>Skin prick testing can be performed but may have lower sensitivity; serum IgE can be used; C1-inhibitor levels may be physiologically low — interpret with caution; genetic testing may be needed for HAE</td>
</tr>
<tr>
<td><strong>Toddlers (1-3 years)</strong></td>
<td>Skin prick testing is well-tolerated and preferred; blood draws may be distressing — use sparingly; food allergy testing most relevant at this age</td>
</tr>
<tr>
<td><strong>School-age (4-12 years)</strong></td>
<td>Cooperative for most testing; spirometry possible for exercise-induced symptoms; physical urticaria provocation tests feasible</td>
</tr>
<tr>
<td><strong>Adolescents (13-18 years)</strong></td>
<td>Investigation approach similar to adults; consider thyroid testing more routinely in chronic urticaria; drug challenge for NSAID sensitivity can be performed</td>
</tr>
</tbody>
</table>
</div>
<h2>Summary: Investigation Algorithm</h2>
<div class=”highlight-box”>
<p><strong>Stepwise Approach to Investigations in Pediatric Urticaria:</strong></p>
<ol>
<li><strong>Acute urticaria, well child:</strong> No investigations needed — diagnose clinically and treat symptomatically</li>
<li><strong>Suspected food or drug allergy:</strong> Targeted specific IgE testing or skin prick testing for suspected allergens only</li>
<li><strong>Anaphylaxis:</strong> Serum tryptase (acute and baseline); allergy referral for trigger identification</li>
<li><strong>Chronic urticaria (greater than 6 weeks):</strong> Limited baseline workup (CBC, ESR/CRP, thyroid function/antibodies); provocation testing if physical urticaria suspected</li>
<li><strong>Lesions lasting greater than 24 hours or leaving marks:</strong> Skin biopsy; complement levels; systemic workup for vasculitis</li>
<li><strong>Angioedema without urticaria:</strong> C4, C1-inhibitor level and function; consider genetic testing</li>
<li><strong>Systemic symptoms (fever, arthralgia, lymphadenopathy):</strong> Investigate directed by clinical features — consider serum sickness, vasculitis, systemic infection</li>
</ol>
</div>
<div class=”content-footer”>
<div class=”copyright”>© Medaptly. All rights reserved.</div>
<div class=”logo”><img src=”https://medaptlytemplates.doo.ee/Medaptly_Logo-removebg-preview.png” alt=”Medaptly Logo”></div>
</div>
</div>
</div>
<div class=”task-content” id=”task5-content”>
<div class=”task-header”>
<h1 class=”task-title”>5. Differential Diagnosis</h1>
<p class=”task-subtitle”>Systematic approach organized by probability and clinical features in pediatric urticaria</p>
</div>
<div class=”task-body”>
<p>The differential diagnosis of urticaria in children requires consideration of both the underlying causes of true urticaria and conditions that may mimic urticaria (“urticaria mimics”). The approach differs significantly based on whether the presentation is acute or chronic, and whether the child appears well or unwell.</p>
<h2>Acute Urticaria in Children (Duration: Less than 6 weeks)</h2>
<p>Acute urticaria is far more common than chronic urticaria in children. In most cases, a specific trigger is never identified, but when found, infections are the most common cause.</p>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Probability</th>
<th>Condition</th>
<th>Key Features</th>
<th>Red Flags</th>
</tr>
</thead>
<tbody>
<tr class=”bg-common”>
<td rowspan=”4″><strong>COMMON<br>(approximately 70-80%)</strong></td>
<td><strong>Viral Infection-Associated Urticaria</strong></td>
<td>Concurrent or recent upper respiratory infection, gastroenteritis, or nonspecific viral illness; low-grade fever; widespread distribution</td>
<td>High fever with ill appearance; petechiae (consider meningococcemia)</td>
</tr>
<tr class=”bg-common”>
<td><strong>Idiopathic Acute Urticaria</strong></td>
<td>No identifiable trigger despite thorough history; well-appearing child; self-limiting course</td>
<td>Lesions lasting greater than 24 hours; systemic symptoms</td>
</tr>
<tr class=”bg-common”>
<td><strong>IgE-Mediated Food Allergy</strong></td>
<td>Onset within 2 hours of eating; reproducible with same food; common triggers: milk, egg, peanut, tree nuts, fish, shellfish, wheat, soy</td>
<td>Respiratory symptoms; vomiting; hypotension (anaphylaxis)</td>
</tr>
<tr class=”bg-common”>
<td><strong>Medication Reaction</strong></td>
<td>Temporal relationship to drug; antibiotics (especially penicillins, cephalosporins) and NSAIDs most common in children</td>
<td>Fever, mucosal involvement (Stevens-Johnson syndrome); arthralgia (serum sickness)</td>
</tr>
<tr class=”bg-less-common”>
<td rowspan=”4″><strong>LESS COMMON<br>(approximately 15-20%)</strong></td>
<td><strong>Insect Sting Hypersensitivity</strong></td>
<td>History of sting; local reaction followed by generalized urticaria; bee, wasp, fire ant stings</td>
<td>Rapid progression; respiratory symptoms; prior severe reaction</td>
</tr>
<tr class=”bg-less-common”>
<td><strong>Contact Urticaria</strong></td>
<td>Localized wheals at contact site; immediate onset; triggers: latex, foods, animal saliva, plants</td>
<td>Progression to generalized urticaria; systemic symptoms</td>
</tr>
<tr class=”bg-less-common”>
<td><strong>Physical Urticaria (acute presentation)</strong></td>
<td>Triggered by cold, heat, pressure, or exercise; reproducible pattern; may present acutely before pattern recognized</td>
<td>Cold urticaria with swimming (risk of drowning); exercise-induced anaphylaxis</td>
</tr>
<tr class=”bg-less-common”>
<td><strong>Serum Sickness-Like Reaction</strong></td>
<td>Urticaria with fever, arthralgia, lymphadenopathy; 7-21 days after starting antibiotic (cefaclor, amoxicillin common)</td>
<td>High fever; severe joint swelling; renal involvement</td>
</tr>
<tr class=”bg-uncommon”>
<td rowspan=”3″><strong>UNCOMMON BUT SERIOUS<br>(approximately 5%)</strong></td>
<td><strong>Anaphylaxis</strong></td>
<td>Urticaria with respiratory, cardiovascular, or severe gastrointestinal symptoms; rapid onset after trigger exposure</td>
<td>Stridor, wheeze, hypotension, altered consciousness — EMERGENCY</td>
</tr>
<tr class=”bg-uncommon”>
<td><strong>Urticarial Vasculitis</strong></td>
<td>Individual lesions lasting greater than 24 hours; painful rather than pruritic; residual purpura or pigmentation</td>
<td>Systemic symptoms; renal, pulmonary, or joint involvement</td>
</tr>
<tr class=”bg-uncommon”>
<td><strong>Systemic Infection</strong></td>
<td>Bacterial infection (streptococcal, staphylococcal); parasitic infection (especially if eosinophilia); hepatitis</td>
<td>High fever; ill appearance; localizing symptoms</td>
</tr>
</tbody>
</table>
</div>
<h2>Chronic Urticaria in Children (Duration: Greater than 6 weeks)</h2>
<p>Chronic urticaria is less common in children than adults but can significantly impact quality of life. Unlike acute urticaria, a specific external trigger is rarely identified.</p>
<div class=”highlight-box”>
<p><strong>Step-by-Step Approach to Chronic Urticaria in Children:</strong></p>
<ol>
<li><strong>Step 1: Confirm the diagnosis</strong> — Are these true urticarial wheals (transient, migratory, lasting less than 24 hours each)?</li>
<li><strong>Step 2: Rule out physical urticarias</strong> — History and provocation testing for cold, heat, pressure, dermatographism, cholinergic triggers</li>
<li><strong>Step 3: Consider chronic spontaneous urticaria</strong> — Most common cause; may be autoimmune or idiopathic</li>
<li><strong>Step 4: Evaluate for underlying conditions</strong> — Thyroid disease, chronic infection, autoinflammatory conditions (if other features present)</li>
</ol>
</div>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Probability</th>
<th>Condition</th>
<th>Approximate Frequency</th>
<th>Key Distinguishing Features</th>
</tr>
</thead>
<tbody>
<tr class=”bg-common”>
<td rowspan=”2″><strong>COMMON</strong></td>
<td><strong>Chronic Spontaneous Urticaria — Idiopathic</strong></td>
<td>40-50% of chronic cases</td>
<td>No identifiable trigger; unpredictable flares; may last months to years; often remits spontaneously</td>
</tr>
<tr class=”bg-common”>
<td><strong>Chronic Spontaneous Urticaria — Autoimmune</strong></td>
<td>30-40% of chronic cases</td>
<td>Anti-IgE or anti-FcεRI autoantibodies; may have positive autologous serum skin test; associated with thyroid autoimmunity</td>
</tr>
<tr class=”bg-less-common”>
<td rowspan=”5″><strong>LESS COMMON</strong></td>
<td><strong>Chronic Inducible Urticaria — Cold</strong></td>
<td>5-10%</td>
<td>Wheals after cold exposure; positive ice cube test; risk of systemic reaction with swimming</td>
</tr>
<tr class=”bg-less-common”>
<td><strong>Chronic Inducible Urticaria — Dermatographism</strong></td>
<td>5-10%</td>
<td>Linear wheals from scratching or pressure; may be primary cause or exacerbating factor</td>
</tr>
<tr class=”bg-less-common”>
<td><strong>Chronic Inducible Urticaria — Cholinergic</strong></td>
<td>5-10%</td>
<td>Small punctate wheals (1-3 mm) with exercise, heat, or emotional stress; peaks in adolescence</td>
</tr>
<tr class=”bg-less-common”>
<td><strong>Chronic Inducible Urticaria — Delayed Pressure</strong></td>
<td>2-5%</td>
<td>Swelling 4-6 hours after sustained pressure; palms, soles, buttocks; often painful</td>
</tr>
<tr class=”bg-less-common”>
<td><strong>Recurrent Viral-Triggered Urticaria</strong></td>
<td>Variable</td>
<td>Repeated acute episodes with viral infections; symptom-free intervals; common in young children with frequent infections</td>
</tr>
<tr class=”bg-uncommon”>
<td rowspan=”4″><strong>UNCOMMON OR RARE</strong></td>
<td><strong>Urticarial Vasculitis</strong></td>
<td>Less than 5%</td>
<td>Lesions lasting greater than 24 hours; painful; residual marks; may have systemic involvement; requires biopsy for diagnosis</td>
</tr>
<tr class=”bg-uncommon”>
<td><strong>Mastocytosis</strong></td>
<td>Rare</td>
<td>Urticaria pigmentosa with brown macules; positive Darier sign; flushing; may have systemic symptoms</td>
</tr>
<tr class=”bg-uncommon”>
<td><strong>Autoinflammatory Syndromes</strong></td>
<td>Rare</td>
<td>Cryopyrin-associated periodic syndromes; urticaria with fever, arthralgia; often presents in infancy</td>
</tr>
<tr class=”bg-uncommon”>
<td><strong>Thyroid Autoimmunity-Associated</strong></td>
<td>2-5%</td>
<td>Associated with Hashimoto thyroiditis or Graves disease; elevated thyroid antibodies; urticaria may improve with thyroid treatment</td>
</tr>
</tbody>
</table>
</div>
<h2>Age-Based Differential Considerations</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Age Group</th>
<th>More Common Causes</th>
<th>Special Considerations</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Infants (0-12 months)</strong></td>
<td>Viral infections; cow’s milk and egg allergy; drug reactions (antibiotics)</td>
<td>Consider maternal diet if breastfeeding; urticarial rashes may be confused with other infantile dermatoses; mastocytosis may present at this age</td>
</tr>
<tr>
<td><strong>Toddlers (1-3 years)</strong></td>
<td>Viral infections (very common due to daycare exposure); food allergies (peanut, tree nut emergence); insect stings</td>
<td>High frequency of viral URIs can cause recurrent episodes; food allergies often apparent with diet expansion</td>
</tr>
<tr>
<td><strong>Preschool (3-5 years)</strong></td>
<td>Viral infections; food allergies; physical urticarias becoming apparent</td>
<td>Cold urticaria often first noticed at this age; can articulate symptoms better</td>
</tr>
<tr>
<td><strong>School-age (6-12 years)</strong></td>
<td>Viral infections; physical urticarias; early chronic spontaneous urticaria</td>
<td>Exercise-related urticaria may emerge; stress-related exacerbations; better history available</td>
</tr>
<tr>
<td><strong>Adolescents (13-18 years)</strong></td>
<td>Chronic spontaneous urticaria; cholinergic urticaria; NSAID-related</td>
<td>Pattern more similar to adults; autoimmune urticaria more common; consider NSAID use for menstrual pain</td>
</tr>
</tbody>
</table>
</div>
<h2>Anatomical/Mechanistic Approach to Urticaria Causes</h2>
<div class=”eisenhower-matrix”>
<div class=”quadrant q2″>
<h3>Immune-Mediated</h3>
<p><strong>IgE-mediated:</strong> Food allergy, drug allergy, insect venom, latex, aeroallergens</p>
<p><strong>Autoimmune:</strong> Anti-IgE antibodies, anti-FcεRI antibodies</p>
<p><strong>Immune complex:</strong> Serum sickness, urticarial vasculitis, infection-associated</p>
</div>
<div class=”quadrant q1″>
<h3>Physical Triggers</h3>
<p><strong>Temperature:</strong> Cold urticaria, heat urticaria, cholinergic (heat/sweat)</p>
<p><strong>Mechanical:</strong> Dermatographism, delayed pressure urticaria, vibratory</p>
<p><strong>Other:</strong> Solar urticaria, aquagenic urticaria</p>
</div>
<div class=”quadrant q4″>
<h3>Infection-Associated</h3>
<p><strong>Viral:</strong> Upper respiratory viruses, enteroviruses, EBV, hepatitis, COVID-19</p>
<p><strong>Bacterial:</strong> Streptococcal, Helicobacter pylori, urinary tract infection</p>
<p><strong>Parasitic:</strong> Giardia, helminths, Toxocara (consider with eosinophilia/travel)</p>
</div>
<div class=”quadrant q3″>
<h3>Drug and Substance-Related</h3>
<p><strong>Immunologic:</strong> Penicillins, cephalosporins, sulfonamides (true allergy)</p>
<p><strong>Pseudoallergic:</strong> NSAIDs, opioids, radiocontrast, vancomycin</p>
<p><strong>Food additives:</strong> Salicylates, benzoates, tartrazine (controversial)</p>
</div>
</div>
<h2>Urticaria Mimics — Conditions That Look Like Urticaria</h2>
<p>Several conditions can present with urticaria-like lesions but have different etiologies and require different management. Accurate differentiation is essential.</p>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Condition</th>
<th>Key Differentiating Features</th>
<th>Diagnostic Clues</th>
<th>Management Differs</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Urticarial Vasculitis</strong></td>
<td>Individual lesions last greater than 24 hours; painful more than pruritic; leaves bruising or pigmentation</td>
<td>Skin biopsy shows leukocytoclastic vasculitis; low complement (hypocomplementemic variant)</td>
<td>Yes — requires workup for systemic involvement; may need immunosuppression</td>
</tr>
<tr>
<td><strong>Erythema Multiforme</strong></td>
<td>Target or targetoid lesions; fixed location; often acral distribution; may have mucosal involvement</td>
<td>Classic three-zone target; history of herpes simplex or Mycoplasma infection; fixed lesions</td>
<td>Yes — address underlying infection; supportive care; monitor for Stevens-Johnson syndrome</td>
</tr>
<tr>
<td><strong>Viral Exanthems</strong></td>
<td>Maculopapular rather than wheals; not migratory; often symmetric; associated viral symptoms</td>
<td>Lesions persist in same location; may have fever, lymphadenopathy; usually self-limiting</td>
<td>Somewhat — supportive care; specific antivirals if indicated</td>
</tr>
<tr>
<td><strong>Insect Bite Reactions (Papular Urticaria)</strong></td>
<td>Grouped papules; persistent (days to weeks); often on exposed areas; may have central punctum</td>
<td>Clustered distribution; history of outdoor exposure; seasonal pattern; may see active bites</td>
<td>Yes — environmental control; topical treatment; different from systemic insect allergy</td>
</tr>
<tr>
<td><strong>Mastocytosis (Urticaria Pigmentosa)</strong></td>
<td>Brown/tan macules that urticate when stroked; persistent lesions; Darier sign positive</td>
<td>Lesions present at baseline; urtication with rubbing; serum tryptase may be elevated</td>
<td>Yes — avoid mast cell degranulating triggers; monitor for systemic disease</td>
</tr>
<tr>
<td><strong>Contact Dermatitis (Acute)</strong></td>
<td>Erythematous, edematous plaques; may have vesicles; geometric pattern matching contactant</td>
<td>Distribution matches exposure; pruritic; may progress to vesiculation; persists until allergen removed</td>
<td>Yes — allergen identification and avoidance; topical corticosteroids</td>
</tr>
<tr>
<td><strong>Henoch-Schönlein Purpura</strong></td>
<td>Palpable purpura (does not blanch); typically lower extremities and buttocks; may start urticaria-like</td>
<td>Purpura develops; associated arthralgia, abdominal pain, renal involvement</td>
<td>Yes — monitor for renal disease; supportive care; different prognosis</td>
</tr>
<tr>
<td><strong>Hereditary Angioedema</strong></td>
<td>Recurrent angioedema WITHOUT urticaria; family history; may have abdominal attacks</td>
<td>No wheals; angioedema painful not pruritic; no response to antihistamines; low C4</td>
<td>Yes — requires specific treatment (C1-inhibitor, icatibant); epinephrine ineffective</td>
</tr>
<tr>
<td><strong>Autoinflammatory Syndromes</strong></td>
<td>Urticarial rash with periodic fevers; onset often in infancy; family history may be present</td>
<td>CAPS: cold-triggered; NOMID: severe neurologic involvement; elevated inflammatory markers</td>
<td>Yes — IL-1 inhibitors for CAPS; different long-term management</td>
</tr>
</tbody>
</table>
</div>
<h2>Drug-Induced Urticaria in Children</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Drug or Drug Class</th>
<th>Mechanism</th>
<th>Characteristics in Children</th>
<th>Time to Resolution After Stopping</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Penicillins and Amoxicillin</strong></td>
<td>IgE-mediated (immediate) or delayed T-cell mediated; also non-allergic rash common with viral illness</td>
<td>Most common drug cause in children; often occurs during viral illness making causation unclear; amoxicillin rash with EBV is NOT allergy</td>
<td>Immediate: hours to days; Delayed: days to 2 weeks</td>
</tr>
<tr>
<td><strong>Cephalosporins</strong></td>
<td>IgE-mediated; serum sickness-like reaction (especially cefaclor)</td>
<td>Cross-reactivity with penicillins approximately 2%; cefaclor associated with serum sickness-like reaction</td>
<td>Days to weeks; serum sickness resolves in 1-3 weeks</td>
</tr>
<tr>
<td><strong>NSAIDs (Ibuprofen, Aspirin)</strong></td>
<td>COX-1 inhibition causing leukotriene shunting; can also cause IgE-mediated reactions</td>
<td>May exacerbate existing urticaria; can cause de novo urticaria; cross-reactivity between different NSAIDs common</td>
<td>Hours to 1-2 days</td>
</tr>
<tr>
<td><strong>Sulfonamide Antibiotics</strong></td>
<td>Delayed T-cell mediated; rarely IgE-mediated</td>
<td>Used for UTIs; can cause severe cutaneous reactions; rash onset typically 7-14 days after starting</td>
<td>Days to 2 weeks</td>
</tr>
<tr>
<td><strong>Opioids (Codeine, Morphine)</strong></td>
<td>Direct mast cell activation via MRGPRX2 receptor (pseudoallergic, not IgE)</td>
<td>Causes flushing, pruritus, urticaria; dose-dependent; not true allergy in most cases</td>
<td>Hours</td>
</tr>
<tr>
<td><strong>Radiocontrast Media</strong></td>
<td>Direct mast cell activation; complement activation</td>
<td>Less common with newer low-osmolar agents; premedication can reduce risk in those with prior reaction</td>
<td>Hours to 1 day</td>
</tr>
<tr>
<td><strong>Vaccines</strong></td>
<td>Usually non-IgE mediated; gelatin component can cause true allergy; egg allergy concern with some vaccines</td>
<td>Generally mild, self-limiting; serious reactions rare; egg allergy no longer contraindication to most vaccines</td>
<td>Hours to days</td>
</tr>
<tr>
<td><strong>Anticonvulsants</strong></td>
<td>Delayed hypersensitivity; drug reaction with eosinophilia and systemic symptoms (DRESS)</td>
<td>Rash onset 2-6 weeks after starting; watch for systemic involvement; may be serious</td>
<td>Weeks; DRESS may take months to resolve</td>
</tr>
</tbody>
</table>
</div>
<div class=”callout-box tip-box”>
<div class=”callout-icon”><i class=”fa fa-lightbulb-o”></i></div>
<div class=”callout-content”>
<h4>Clinical Pearl: The Amoxicillin-EBV Rash Dilemma</h4>
<p>A maculopapular (not urticarial) rash occurring during amoxicillin treatment for suspected strep throat in a child with unrecognized infectious mononucleosis (EBV) is NOT a true penicillin allergy. This rash occurs in 70-100% of children with EBV who receive amoxicillin. True penicillin allergy is characterized by urticaria, angioedema, or anaphylaxis with rapid onset. Incorrectly labeling children as “penicillin allergic” leads to use of broader-spectrum antibiotics and poorer outcomes. When history is unclear, consider referral for formal penicillin allergy testing.</p>
</div>
</div>
<h2>Quick Reference: “If You See This, Think This First”</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Clinical Clue</th>
<th>Think This First</th>
<th>Next Step</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Urticaria + concurrent cold symptoms</strong></td>
<td>Viral infection-associated urticaria</td>
<td>Symptomatic treatment; reassurance; usually self-limiting</td>
</tr>
<tr>
<td><strong>Urticaria within 2 hours of eating</strong></td>
<td>IgE-mediated food allergy</td>
<td>Identify food; avoid; allergy testing; consider epinephrine prescription</td>
</tr>
<tr>
<td><strong>Urticaria 7-21 days after starting antibiotic + fever + joint pain</strong></td>
<td>Serum sickness-like reaction</td>
<td>Stop antibiotic; supportive care; usually resolves in 1-3 weeks</td>
</tr>
<tr>
<td><strong>Urticaria after cold exposure (swimming, cold weather)</strong></td>
<td>Cold urticaria</td>
<td>Ice cube test; counsel on swimming safety; antihistamines before exposure</td>
</tr>
<tr>
<td><strong>Small punctate wheals with exercise or hot shower</strong></td>
<td>Cholinergic urticaria</td>
<td>Avoid triggers when possible; antihistamines; usually improves with age</td>
</tr>
<tr>
<td><strong>Linear wheals where skin was scratched</strong></td>
<td>Dermatographism</td>
<td>Confirm with skin stroking; antihistamines if symptomatic; reassurance</td>
</tr>
<tr>
<td><strong>Urticaria + wheeze + vomiting + hypotension</strong></td>
<td>Anaphylaxis</td>
<td>Immediate epinephrine; emergency management; identify trigger</td>
</tr>
<tr>
<td><strong>Lesions lasting greater than 24 hours with bruising</strong></td>
<td>Urticarial vasculitis</td>
<td>Skin biopsy; systemic workup; rheumatology referral</td>
</tr>
<tr>
<td><strong>Angioedema WITHOUT any urticaria</strong></td>
<td>Hereditary angioedema (especially if family history)</td>
<td>Check C4, C1-inhibitor level and function; do not rely on antihistamines</td>
</tr>
<tr>
<td><strong>Brown macules that wheal when rubbed</strong></td>
<td>Mastocytosis (urticaria pigmentosa)</td>
<td>Avoid mast cell triggers; check serum tryptase; pediatric hematology referral</td>
</tr>
<tr>
<td><strong>Chronic urticaria greater than 6 weeks, no trigger found</strong></td>
<td>Chronic spontaneous urticaria (idiopathic or autoimmune)</td>
<td>Limited baseline workup; trial of higher-dose antihistamines; consider specialist referral</td>
</tr>
<tr>
<td><strong>Recurrent urticaria episodes only with viral illnesses</strong></td>
<td>Recurrent viral-triggered urticaria</td>
<td>Reassurance; symptom-free between infections; will decrease as child ages</td>
</tr>
</tbody>
</table>
</div>
<div class=”content-footer”>
<div class=”copyright”>© Medaptly. All rights reserved.</div>
<div class=”logo”><img src=”https://medaptlytemplates.doo.ee/Medaptly_Logo-removebg-preview.png” alt=”Medaptly Logo”></div>
</div>
</div>
</div>
<!– ==================== TASK 6: DIAGNOSTIC INVESTIGATIONS ==================== –>
<div class=”task-content” id=”task6-content”>
<div class=”task-header”>
<h1 class=”task-title”>6. Diagnostic Investigations</h1>
<p class=”task-subtitle”>A stepwise, targeted approach guided by clinical suspicion in pediatric urticaria</p>
</div>
<div class=”task-body”>
<div class=”highlight-box”>
<p><strong>Key Principle:</strong> In the majority of pediatric urticaria cases — particularly acute urticaria in a well-appearing child — <strong>no laboratory investigations are required</strong>. The diagnosis is clinical, based on history and examination. Investigations should be targeted based on specific clinical suspicion, not performed routinely.</p>
</div>
<h2>When to Investigate</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Scenario</th>
<th>Investigations Indicated?</th>
<th>Rationale</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Acute urticaria, well child, self-limiting</strong></td>
<td>No</td>
<td>Diagnosis is clinical; most cases are viral or idiopathic; investigations will not change management</td>
</tr>
<tr>
<td><strong>Suspected IgE-mediated food allergy</strong></td>
<td>Yes — allergy testing</td>
<td>Specific IgE testing helps confirm trigger; guides dietary avoidance; informs need for epinephrine</td>
</tr>
<tr>
<td><strong>Anaphylaxis</strong></td>
<td>Yes — during and after event</td>
<td>Serum tryptase during event confirms mast cell activation; allergy workup identifies trigger</td>
</tr>
<tr>
<td><strong>Chronic urticaria greater than 6 weeks</strong></td>
<td>Limited baseline workup</td>
<td>Excludes underlying conditions; extensive testing rarely yields diagnosis</td>
</tr>
<tr>
<td><strong>Suspected urticarial vasculitis</strong></td>
<td>Yes — skin biopsy and systemic workup</td>
<td>Different diagnosis with different management; need to assess for systemic involvement</td>
</tr>
<tr>
<td><strong>Angioedema without urticaria</strong></td>
<td>Yes — complement studies</td>
<td>Must exclude hereditary angioedema; treatment is different</td>
</tr>
<tr>
<td><strong>Systemic symptoms (fever, arthralgia, weight loss)</strong></td>
<td>Yes — directed by symptoms</td>
<td>May indicate systemic disease, infection, or vasculitis</td>
</tr>
</tbody>
</table>
</div>
<h2>Baseline Investigations for Chronic Urticaria</h2>
<p>For children with chronic urticaria (greater than 6 weeks), a limited baseline workup is reasonable to exclude underlying conditions, although yield is low.</p>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Investigation</th>
<th>Purpose</th>
<th>What to Look For</th>
<th>Practical Points</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Complete Blood Count with Differential</strong></td>
<td>Screen for infection, eosinophilia, hematologic abnormality</td>
<td>Eosinophilia (parasites, allergic conditions); leukocytosis (infection); anemia (chronic disease)</td>
<td>Often normal in chronic urticaria; eosinophilia prompts consideration of parasitic infection if risk factors present</td>
</tr>
<tr>
<td><strong>Erythrocyte Sedimentation Rate or C-Reactive Protein</strong></td>
<td>Screen for inflammation</td>
<td>Elevated in urticarial vasculitis, infection, autoimmune conditions</td>
<td>Should be normal in uncomplicated chronic spontaneous urticaria; elevation warrants further investigation</td>
</tr>
<tr>
<td><strong>Thyroid Function Tests and Thyroid Antibodies</strong></td>
<td>Screen for autoimmune thyroid disease</td>
<td>Elevated TSH, abnormal T4; positive anti-thyroid peroxidase or anti-thyroglobulin antibodies</td>
<td>Association between chronic urticaria and autoimmune thyroiditis; more common in adolescents; treatment of thyroid disease may improve urticaria</td>
</tr>
</tbody>
</table>
</div>
<div class=”callout-box info-box”>
<div class=”callout-icon”><i class=”fa fa-info-circle”></i></div>
<div class=”callout-content”>
<h4>Evidence-Based Approach</h4>
<p>Multiple studies and guidelines confirm that extensive laboratory workup in chronic urticaria has very low diagnostic yield. The above limited panel is recommended by international guidelines (EAACI/GA²LEN/EuroGuiDerm/APAAACI). Additional investigations should only be performed if history or examination suggests a specific underlying cause.</p>
</div>
</div>
<h2>Targeted Investigations by Suspected Etiology</h2>
<h3>If Suspecting IgE-Mediated Food Allergy</h3>
<div class=”columns”>
<div class=”column”>
<h4>First-Line Tests</h4>
<ul>
<li><strong>Skin Prick Testing:</strong> Rapid results; high sensitivity; tests specific allergens; wheal ≥3 mm greater than negative control is positive</li>
<li><strong>Serum Specific IgE (sIgE):</strong> Blood test; useful when skin testing not possible; results in kU/L; higher levels correlate with increased likelihood of clinical reactivity</li>
</ul>
</div>
<div class=”column”>
<h4>Second-Line Tests</h4>
<ul>
<li><strong>Component-Resolved Diagnostics:</strong> Tests for specific allergenic proteins (e.g., Ara h 2 for peanut); helps predict severity and likelihood of reaction</li>
<li><strong>Oral Food Challenge:</strong> Gold standard for diagnosis; performed in supervised setting; confirms or excludes clinical allergy when testing is inconclusive</li>
</ul>
</div>
</div>
<div class=”callout-box warning-box”>
<div class=”callout-icon”><i class=”fa fa-exclamation-triangle”></i></div>
<div class=”callout-content”>
<h4>Pediatric Testing Considerations</h4>
<ul>
<li><strong>Only test for suspected allergens</strong> — large panels of “screening” tests have high false-positive rates and lead to unnecessary dietary restrictions</li>
<li><strong>Positive test ≠ clinical allergy</strong> — sensitization (positive IgE) without symptoms is common; clinical history is essential</li>
<li><strong>Skin prick testing is preferred</strong> in children when available — less invasive, immediate results, better sensitivity for some allergens</li>
<li><strong>Testing during acute urticaria</strong> should be deferred — may have false results; wait 4-6 weeks</li>
</ul>
</div>
</div>
<h3>If Suspecting Drug Allergy</h3>
<div class=”columns”>
<div class=”column”>
<h4>For Immediate-Type Reactions (IgE-mediated)</h4>
<ul>
<li><strong>Skin Prick Testing:</strong> Available for penicillin (major and minor determinants); limited availability for other drugs</li>
<li><strong>Intradermal Testing:</strong> More sensitive than skin prick; performed after negative skin prick</li>
<li><strong>Drug Provocation Test:</strong> Gold standard when skin testing negative or unavailable; graded dose challenge in supervised setting</li>
<li><strong>Serum Specific IgE:</strong> Available for penicillins, some other drugs; limited sensitivity</li>
</ul>
</div>
<div class=”column”>
<h4>For Delayed-Type Reactions</h4>
<ul>
<li><strong>Patch Testing:</strong> Useful for delayed contact-type reactions; limited utility for systemic reactions</li>
<li><strong>Delayed Intradermal Testing:</strong> Read at 48-72 hours; may identify delayed T-cell mediated reactions</li>
<li><strong>Drug Provocation Test:</strong> After waiting appropriate interval; confirms or excludes clinical allergy</li>
</ul>
</div>
</div>
<h3>If Suspecting Chronic Spontaneous Urticaria (Autoimmune)</h3>
<div class=”columns”>
<div class=”column”>
<h4>Supportive Tests</h4>
<ul>
<li><strong>Autologous Serum Skin Test (ASST):</strong> Intradermal injection of patient’s own serum; positive wheal suggests autoimmune etiology; not widely available</li>
<li><strong>Basophil Activation Tests:</strong> Research tool; measures CD63 expression on basophils; not routine clinical use</li>
<li><strong>Total IgE:</strong> Low total IgE may predict better response to omalizumab</li>
</ul>
</div>
<div class=”column”>
<h4>Associated Autoimmune Screen</h4>
<ul>
<li><strong>Thyroid Antibodies:</strong> Anti-TPO, anti-thyroglobulin — positive in 10-20% of chronic urticaria patients</li>
<li><strong>Thyroid Function:</strong> TSH, free T4 — autoimmune thyroiditis may be associated</li>
<li><strong>ANA (if clinical suspicion):</strong> Only if features suggest autoimmune connective tissue disease</li>
</ul>
</div>
</div>
<h3>If Suspecting Urticarial Vasculitis</h3>
<div class=”columns”>
<div class=”column”>
<h4>Essential Investigations</h4>
<ul>
<li><strong>Skin Biopsy:</strong> Diagnostic — shows leukocytoclastic vasculitis with neutrophil infiltration, fibrinoid necrosis, red cell extravasation</li>
<li><strong>Complement Levels:</strong> C3, C4, CH50 — low in hypocomplementemic urticarial vasculitis (HUV)</li>
<li><strong>ESR and CRP:</strong> Usually elevated</li>
</ul>
</div>
<div class=”column”>
<h4>Systemic Evaluation</h4>
<ul>
<li><strong>Urinalysis:</strong> Proteinuria, hematuria may indicate renal involvement</li>
<li><strong>Renal Function:</strong> Creatinine, eGFR</li>
<li><strong>ANA, Anti-dsDNA:</strong> May be positive; association with lupus-like syndrome</li>
<li><strong>Chest X-ray:</strong> If respiratory symptoms — pulmonary involvement possible</li>
</ul>
</div>
</div>
<h3>If Suspecting Hereditary Angioedema</h3>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Test</th>
<th>Type I HAE (85%)</th>
<th>Type II HAE (15%)</th>
<th>HAE with Normal C1-INH</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>C4 Level</strong></td>
<td>Low (screening test — if normal during attack, HAE unlikely)</td>
<td>Low</td>
<td>Normal</td>
</tr>
<tr>
<td><strong>C1-Inhibitor Level (quantitative)</strong></td>
<td>Low (less than 50% of normal)</td>
<td>Normal or elevated</td>
<td>Normal</td>
</tr>
<tr>
<td><strong>C1-Inhibitor Function (functional assay)</strong></td>
<td>Low</td>
<td>Low (diagnostic)</td>
<td>Normal</td>
</tr>
<tr>
<td><strong>C1q Level</strong></td>
<td>Normal (low suggests acquired angioedema)</td>
<td>Normal</td>
<td>Normal</td>
</tr>
<tr>
<td><strong>Genetic Testing</strong></td>
<td>SERPING1 mutation (confirmatory)</td>
<td>SERPING1 mutation</td>
<td>May identify F12, PLG, ANGPT1, KNG1, MYOF, HS3ST6 mutations</td>
</tr>
</tbody>
</table>
</div>
<div class=”callout-box tip-box”>
<div class=”callout-icon”><i class=”fa fa-lightbulb-o”></i></div>
<div class=”callout-content”>
<h4>Pediatric HAE Testing Considerations</h4>
<p>C1-inhibitor levels and function may be physiologically low in infants and young children (up to age 1-2 years), leading to potential false-positive results. If HAE is suspected in a young child, repeat testing after age 1 year, or perform genetic testing for confirmation. Family screening should be performed if a parent is affected — approximately 50% of children will inherit the condition.</p>
</div>
</div>
<h3>If Suspecting Physical Urticaria</h3>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Type</th>
<th>Provocation Test</th>
<th>Positive Result</th>
<th>Precautions</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Cold Urticaria</strong></td>
<td>Ice cube in plastic bag on forearm for 5 minutes; observe for 10 minutes after removal</td>
<td>Wheal and flare at test site after rewarming</td>
<td>Perform in monitored setting; severe cases may have systemic symptoms</td>
</tr>
<tr>
<td><strong>Dermatographism</strong></td>
<td>Stroke skin with tongue depressor or dermographometer</td>
<td>Linear wheal along stroke line within 10 minutes</td>
<td>Very common; may be incidental; clinical correlation needed</td>
</tr>
<tr>
<td><strong>Delayed Pressure Urticaria</strong></td>
<td>Apply 2.5 kg weight to forearm for 15-20 minutes; observe for 6 hours</td>
<td>Swelling at site after 4-6 hours</td>
<td>May need to see patient for delayed reading; often painful</td>
</tr>
<tr>
<td><strong>Cholinergic Urticaria</strong></td>
<td>Exercise challenge or hot bath challenge (increase core temperature by 1°C)</td>
<td>Punctate 1-3 mm wheals with exercise or heat</td>
<td>Usually performed in allergy clinic; monitor for systemic symptoms</td>
</tr>
<tr>
<td><strong>Solar Urticaria</strong></td>
<td>Exposure to sunlight or specific UV wavelengths</td>
<td>Wheals in exposed area within minutes</td>
<td>Performed in dermatology/allergy clinic with UV light source</td>
</tr>
<tr>
<td><strong>Aquagenic Urticaria</strong></td>
<td>Apply wet cloth to skin for 20-30 minutes</td>
<td>Wheals at contact site regardless of water temperature</td>
<td>Rare; distinguish from cold urticaria</td>
</tr>
</tbody>
</table>
</div>
<h3>If Suspecting Infection as Trigger</h3>
<div class=”columns”>
<div class=”column”>
<h4>Based on Clinical Suspicion</h4>
<ul>
<li><strong>Throat Swab / Rapid Strep:</strong> If pharyngitis present</li>
<li><strong>Urinalysis:</strong> If urinary symptoms or unexplained fever</li>
<li><strong>Stool Studies:</strong> Ova and parasites if travel history, eosinophilia, or gastrointestinal symptoms</li>
<li><strong>Viral Serology:</strong> EBV, hepatitis B/C if clinical features suggest (generally not routine)</li>
</ul>
</div>
<div class=”column”>
<h4>Not Routinely Recommended</h4>
<ul>
<li><strong>Extensive infection screening</strong> in well-appearing children with acute urticaria is not indicated</li>
<li><strong>Helicobacter pylori testing</strong> is not routinely recommended in pediatric chronic urticaria (unlike adults)</li>
<li><strong>Stool parasites</strong> only if risk factors present (travel to endemic areas, eosinophilia, gastrointestinal symptoms)</li>
</ul>
</div>
</div>
<h2>Investigations During Anaphylaxis</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Investigation</th>
<th>Timing</th>
<th>Interpretation</th>
<th>Practical Points</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Serum Tryptase</strong></td>
<td>Ideally 15 minutes to 3 hours after symptom onset; also baseline (greater than 24 hours later or at follow-up)</td>
<td>Peak greater than 1.2× baseline + 2 ng/mL indicates mast cell activation; supports anaphylaxis diagnosis</td>
<td>May be normal in food-induced anaphylaxis; baseline tryptase important for comparison; elevated baseline suggests mastocytosis</td>
</tr>
<tr>
<td><strong>Serum Histamine</strong></td>
<td>Within 15-60 minutes of onset (degrades rapidly)</td>
<td>Elevated during acute reaction</td>
<td>Difficult to obtain in time; tryptase preferred; research use mainly</td>
</tr>
</tbody>
</table>
</div>
<div class=”section-divider”>
<div class=”section-divider-icon”><i class=”fa fa-flask”></i></div>
</div>
<h2>Empiric Treatment Trials as Diagnostic Tools</h2>
<div class=”callout-box info-box”>
<div class=”callout-icon”><i class=”fa fa-info-circle”></i></div>
<div class=”callout-content”>
<h4>Therapeutic Trial Approach in Chronic Urticaria</h4>
<p>In chronic spontaneous urticaria where no trigger is identified, response to treatment can provide diagnostic information and guide management:</p>
<ol>
<li><strong>First-line trial:</strong> Second-generation H1-antihistamine at standard dose for 2-4 weeks — response suggests histamine-mediated urticaria</li>
<li><strong>Second-line trial:</strong> Increase antihistamine to 2-4× standard dose (up-dosing) for 2-4 weeks — effective in approximately 60% of patients uncontrolled on standard dose</li>
<li><strong>Consider alternative diagnosis:</strong> If no response to high-dose antihistamines, reconsider diagnosis (urticarial vasculitis? mastocytosis?) or escalate to specialist care</li>
</ol>
<p>Response to omalizumab supports autoimmune or IgE-mediated mechanism. Lack of response to antihistamines should prompt reconsideration of the diagnosis.</p>
</div>
</div>
<h2>Investigations NOT Routinely Recommended</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Test</th>
<th>Why Not Routine</th>
<th>When It May Be Appropriate</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Large allergen panels (“screening” tests)</strong></td>
<td>High false-positive rate; leads to unnecessary avoidance; does not identify cause in most cases</td>
<td>Only test specific allergens suggested by history</td>
</tr>
<tr>
<td><strong>IgG food antibody testing</strong></td>
<td>No evidence of clinical utility; measures normal immune response to foods; not validated for urticaria</td>
<td>Never — this testing is not recommended by any allergy society</td>
</tr>
<tr>
<td><strong>Extensive autoimmune panels</strong></td>
<td>Low yield in absence of other features; may create anxiety about false-positive results</td>
<td>Only if clinical features suggest autoimmune disease (joint symptoms, rash characteristics, multi-organ involvement)</td>
</tr>
<tr>
<td><strong>Skin biopsy in typical urticaria</strong></td>
<td>Diagnosis is clinical; biopsy shows nonspecific changes in ordinary urticaria</td>
<td>Indicated if lesions last greater than 24 hours, are painful, or leave marks (suspect vasculitis)</td>
</tr>
<tr>
<td><strong>Elimination diet without positive allergy testing</strong></td>
<td>May lead to nutritional deficiencies; often unnecessary; not evidence-based for chronic urticaria</td>
<td>Short-term trial if strong history suggests specific food trigger; work with dietitian</td>
</tr>
</tbody>
</table>
</div>
<h2>Age-Specific Investigation Considerations</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Age Group</th>
<th>Special Considerations</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Infants (less than 1 year)</strong></td>
<td>Skin prick testing can be performed but may have lower sensitivity; serum IgE can be used; C1-inhibitor levels may be physiologically low — interpret with caution; genetic testing may be needed for HAE</td>
</tr>
<tr>
<td><strong>Toddlers (1-3 years)</strong></td>
<td>Skin prick testing is well-tolerated and preferred; blood draws may be distressing — use sparingly; food allergy testing most relevant at this age</td>
</tr>
<tr>
<td><strong>School-age (4-12 years)</strong></td>
<td>Cooperative for most testing; spirometry possible for exercise-induced symptoms; physical urticaria provocation tests feasible</td>
</tr>
<tr>
<td><strong>Adolescents (13-18 years)</strong></td>
<td>Investigation approach similar to adults; consider thyroid testing more routinely in chronic urticaria; drug challenge for NSAID sensitivity can be performed</td>
</tr>
</tbody>
</table>
</div>
<h2>Summary: Investigation Algorithm</h2>
<div class=”highlight-box”>
<p><strong>Stepwise Approach to Investigations in Pediatric Urticaria:</strong></p>
<ol>
<li><strong>Acute urticaria, well child:</strong> No investigations needed — diagnose clinically and treat symptomatically</li>
<li><strong>Suspected food or drug allergy:</strong> Targeted specific IgE testing or skin prick testing for suspected allergens only</li>
<li><strong>Anaphylaxis:</strong> Serum tryptase (acute and baseline); allergy referral for trigger identification</li>
<li><strong>Chronic urticaria (greater than 6 weeks):</strong> Limited baseline workup (CBC, ESR/CRP, thyroid function/antibodies); provocation testing if physical urticaria suspected</li>
<li><strong>Lesions lasting greater than 24 hours or leaving marks:</strong> Skin biopsy; complement levels; systemic workup for vasculitis</li>
<li><strong>Angioedema without urticaria:</strong> C4, C1-inhibitor level and function; consider genetic testing</li>
<li><strong>Systemic symptoms (fever, arthralgia, lymphadenopathy):</strong> Investigate directed by clinical features — consider serum sickness, vasculitis, systemic infection</li>
</ol>
</div>
<div class=”content-footer”>
<div class=”copyright”>© Medaptly. All rights reserved.</div>
<div class=”logo”><img src=”https://medaptlytemplates.doo.ee/Medaptly_Logo-removebg-preview.png” alt=”Medaptly Logo”></div>
</div>
</div>
</div>
<!– ==================== TASK 7: CLINICAL DECISION-MAKING ==================== –>
<div class=”task-content” id=”task7-content”>
<div class=”task-header”>
<h1 class=”task-title”>7. Pattern Recognition and Clinical Decision-Making</h1>
<p class=”task-subtitle”>Practical algorithms and decision pathways for pediatric urticaria</p>
</div>
<div class=”task-body”>
<h2>Step 1: Is This Urgent? — Triage Assessment</h2>
<p>The first priority in any child presenting with urticaria is to assess for anaphylaxis and other urgent conditions requiring immediate intervention.</p>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Clinical Scenario</th>
<th>Urgency Level</th>
<th>Immediate Action</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Urticaria with stridor, wheeze, respiratory distress, or hypotension</strong></td>
<td style=”color: #d32f2f;”><strong>EMERGENT</strong></td>
<td>Administer intramuscular epinephrine immediately; call for emergency assistance; prepare for airway management; position child appropriately</td>
</tr>
<tr>
<td><strong>Urticaria with tongue or significant lip swelling</strong></td>
<td style=”color: #d32f2f;”><strong>EMERGENT</strong></td>
<td>Administer epinephrine; close monitoring for airway compromise; do not leave child unattended; prepare for escalation</td>
</tr>
<tr>
<td><strong>Urticaria with altered consciousness or severe lethargy</strong></td>
<td style=”color: #d32f2f;”><strong>EMERGENT</strong></td>
<td>Epinephrine; IV access; fluid resuscitation; emergency team activation; consider anaphylactic shock</td>
</tr>
<tr>
<td><strong>Urticaria with persistent vomiting or severe abdominal pain</strong></td>
<td style=”color: #ff9800;”><strong>URGENT</strong></td>
<td>Assess for anaphylaxis; give epinephrine if anaphylaxis criteria met; antihistamines; close observation; IV access if needed</td>
</tr>
<tr>
<td><strong>Urticaria with fever, joint pain, and recent antibiotic use</strong></td>
<td style=”color: #ff9800;”><strong>URGENT</strong></td>
<td>Consider serum sickness-like reaction; stop offending medication; antihistamines ± corticosteroids; arrange follow-up</td>
</tr>
<tr>
<td><strong>Angioedema without urticaria (especially with family history)</strong></td>
<td style=”color: #ff9800;”><strong>URGENT</strong></td>
<td>Consider hereditary angioedema; standard treatment may be ineffective; obtain complement studies; specialist consultation</td>
</tr>
<tr>
<td><strong>Urticaria with lesions lasting greater than 24 hours or bruising</strong></td>
<td style=”color: #ff9800;”><strong>URGENT</strong></td>
<td>Consider urticarial vasculitis; arrange skin biopsy; systemic workup; dermatology or rheumatology referral</td>
</tr>
<tr>
<td><strong>Widespread urticaria, well child, no angioedema, no respiratory symptoms</strong></td>
<td style=”color: #2e7d32;”><strong>ROUTINE</strong></td>
<td>Oral antihistamine; reassurance; safety netting advice; follow-up if persistent or worsening</td>
</tr>
<tr>
<td><strong>Localized urticaria, well child, known trigger (e.g., insect bite)</strong></td>
<td style=”color: #2e7d32;”><strong>ROUTINE</strong></td>
<td>Remove trigger if possible; oral antihistamine; cool compresses; monitor for spread or systemic symptoms</td>
</tr>
<tr>
<td><strong>Chronic urticaria, stable, already on treatment</strong></td>
<td style=”color: #2e7d32;”><strong>ROUTINE</strong></td>
<td>Review treatment adherence; consider dose adjustment; arrange routine specialist follow-up if uncontrolled</td>
</tr>
</tbody>
</table>
</div>
<div class=”callout-box warning-box”>
<div class=”callout-icon”><i class=”fa fa-exclamation-triangle”></i></div>
<div class=”callout-content”>
<h4>Anaphylaxis Recognition in Children</h4>
<p>Anaphylaxis is likely when ONE of the following criteria is met:</p>
<ul>
<li><strong>Criterion 1:</strong> Acute onset (minutes to hours) with skin/mucosal involvement (urticaria, angioedema, flushing, pruritus) AND respiratory compromise OR hypotension/end-organ dysfunction</li>
<li><strong>Criterion 2:</strong> TWO OR MORE of the following rapidly after exposure to likely allergen: skin/mucosal symptoms, respiratory symptoms, hypotension, persistent gastrointestinal symptoms</li>
<li><strong>Criterion 3:</strong> Hypotension after exposure to known allergen (age-specific: systolic BP less than 70 + [2 × age in years] mmHg for children 1-10 years; less than 90 mmHg for children greater than 10 years)</li>
</ul>
<p><strong>When in doubt, treat as anaphylaxis — epinephrine is safe and potentially life-saving.</strong></p>
</div>
</div>
<h2>Step 2: Classify by Duration and Presentation</h2>
<div class=”grid-3″>
<div class=”grid-item”>
<h3>Acute Urticaria</h3>
<p><strong>Duration:</strong> Less than 6 weeks</p>
<p><strong>Action:</strong> Proceed to Algorithm A</p>
<p>Focus on: Trigger identification, symptomatic treatment, safety netting</p>
</div>
<div class=”grid-item”>
<h3>Acute Recurrent Urticaria</h3>
<p><strong>Pattern:</strong> Repeated episodes with symptom-free intervals</p>
<p><strong>Action:</strong> Proceed to Algorithm B</p>
<p>Focus on: Pattern recognition, trigger avoidance, consider allergy testing</p>
</div>
<div class=”grid-item”>
<h3>Chronic Urticaria</h3>
<p><strong>Duration:</strong> Greater than 6 weeks</p>
<p><strong>Action:</strong> Proceed to Algorithm C</p>
<p>Focus on: Limited workup, stepwise treatment, specialist referral if uncontrolled</p>
</div>
</div>
<h2>Step 3: Follow the Appropriate Algorithm</h2>
<h3>Algorithm A: Acute Urticaria in Children</h3>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Clinical Scenario</th>
<th>Most Likely Diagnosis</th>
<th>Action</th>
</tr>
</thead>
<tbody>
<tr>
<td>Well child with urticaria and concurrent or recent viral symptoms (cough, runny nose, fever, diarrhea)</td>
<td>Viral infection-associated urticaria</td>
<td>Antihistamines; reassurance that this is common and self-limiting; no allergy testing needed; follow-up if persists beyond 2 weeks</td>
</tr>
<tr>
<td>Urticaria within 2 hours of eating a specific food; reproducible pattern</td>
<td>IgE-mediated food allergy</td>
<td>Avoid suspected food; prescribe epinephrine auto-injector if moderate-severe reaction; refer for allergy testing and dietary guidance</td>
</tr>
<tr>
<td>Urticaria during or after antibiotic course; no systemic symptoms</td>
<td>Drug reaction (allergic vs. non-allergic)</td>
<td>Stop antibiotic if possible; antihistamines; document reaction; consider allergy referral for drug testing to clarify if true allergy</td>
</tr>
<tr>
<td>Urticaria 1-3 weeks after starting antibiotic; fever, joint pain, lymphadenopathy</td>
<td>Serum sickness-like reaction</td>
<td>Stop antibiotic; antihistamines and consider short course corticosteroids; supportive care; avoid same drug class in future</td>
</tr>
<tr>
<td>Urticaria after bee or wasp sting; local reaction followed by generalized hives</td>
<td>Insect venom hypersensitivity</td>
<td>Antihistamines; if systemic symptoms beyond skin — epinephrine; refer for venom immunotherapy evaluation</td>
</tr>
<tr>
<td>Well child, widespread urticaria, no identifiable trigger despite thorough history</td>
<td>Idiopathic acute urticaria</td>
<td>Antihistamines; reassurance; no investigation needed; safety netting for anaphylaxis; most resolve within days to weeks</td>
</tr>
</tbody>
</table>
</div>
<h3>Algorithm B: Acute Recurrent Urticaria in Children</h3>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Pattern Identified</th>
<th>Likely Cause</th>
<th>Action</th>
</tr>
</thead>
<tbody>
<tr>
<td>Urticaria episodes consistently associated with viral illnesses; symptom-free between infections</td>
<td>Recurrent viral-triggered urticaria</td>
<td>Reassurance that this is common in young children; will improve with age; antihistamines during episodes; no allergy workup needed</td>
</tr>
<tr>
<td>Urticaria after exposure to specific food on multiple occasions</td>
<td>Food allergy</td>
<td>Confirm with allergy testing (skin prick or specific IgE); strict avoidance; epinephrine prescription; dietitian referral</td>
</tr>
<tr>
<td>Urticaria after cold exposure (swimming, cold weather, cold foods)</td>
<td>Cold urticaria</td>
<td>Confirm with ice cube test; counsel on cold avoidance and swimming safety; prophylactic antihistamines before exposure</td>
</tr>
<tr>
<td>Small punctate wheals with exercise, hot showers, or emotional stress</td>
<td>Cholinergic urticaria</td>
<td>Pre-treatment with antihistamines; gradual warm-up before exercise; usually improves with age</td>
</tr>
<tr>
<td>Linear wheals whenever skin is scratched or rubbed</td>
<td>Symptomatic dermatographism</td>
<td>Antihistamines if symptomatic; avoid triggers (tight clothing, scratching); reassurance about benign nature</td>
</tr>
</tbody>
</table>
</div>
<h3>Algorithm C: Chronic Urticaria in Children (Greater than 6 weeks)</h3>
<div class=”highlight-box”>
<p><strong>Stepwise Management Approach:</strong></p>
<ol>
<li><strong>Step 1 — Confirm diagnosis:</strong> Ensure lesions are true urticarial wheals (transient, migratory, each lasting less than 24 hours). If not, consider urticarial vasculitis or other mimics.</li>
<li><strong>Step 2 — Rule out physical triggers:</strong> History and provocation testing for cold, heat, pressure, dermatographism. If positive, manage as chronic inducible urticaria.</li>
<li><strong>Step 3 — Limited baseline workup:</strong> CBC with differential, ESR or CRP, thyroid function and antibodies. Further testing only if clinically indicated.</li>
<li><strong>Step 4 — First-line treatment:</strong> Second-generation H1-antihistamine at standard dose (e.g., cetirizine, loratadine, fexofenadine) — daily for 2-4 weeks.</li>
<li><strong>Step 5 — If uncontrolled:</strong> Increase antihistamine to 2-4× standard dose (up-dosing) — effective in approximately 60% of patients.</li>
<li><strong>Step 6 — If still uncontrolled:</strong> Consider adding second antihistamine, H2-antihistamine, or leukotriene receptor antagonist. Refer to specialist (pediatric allergist or dermatologist).</li>
<li><strong>Step 7 — Specialist therapies:</strong> Omalizumab (anti-IgE); cyclosporine (third-line); other immunomodulators in refractory cases.</li>
</ol>
</div>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Scenario</th>
<th>Assessment</th>
<th>Action</th>
</tr>
</thead>
<tbody>
<tr>
<td>Chronic urticaria controlled on standard-dose antihistamine</td>
<td>Good response to first-line therapy</td>
<td>Continue treatment; attempt gradual reduction after 3-6 months of control; reassess periodically</td>
</tr>
<tr>
<td>Chronic urticaria not controlled on standard-dose antihistamine</td>
<td>Inadequate response to first-line therapy</td>
<td>Up-dose antihistamine to 2-4× standard dose; if still uncontrolled after 2-4 weeks, refer to specialist</td>
</tr>
<tr>
<td>Chronic urticaria with positive thyroid antibodies</td>
<td>Associated autoimmune thyroiditis</td>
<td>Monitor thyroid function; treatment of thyroid disease may improve urticaria in some cases</td>
</tr>
<tr>
<td>Chronic urticaria significantly impacting quality of life (sleep, school attendance)</td>
<td>Severe disease burden</td>
<td>Expedite specialist referral; consider short course of oral corticosteroids for acute flares while arranging specialist care</td>
</tr>
<tr>
<td>Chronic urticaria not responding to high-dose antihistamines</td>
<td>Antihistamine-refractory chronic urticaria</td>
<td>Specialist referral essential; consider omalizumab; reassess diagnosis (vasculitis, mastocytosis?)</td>
</tr>
</tbody>
</table>
</div>
<h2>”What Do I Do If…” — Decision Reference</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Clinical Situation</th>
<th>Immediate Action</th>
<th>Next Step</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>The child has urticaria with any respiratory symptom</strong></td>
<td>Treat as anaphylaxis — give intramuscular epinephrine (0.01 mg/kg, max 0.5 mg)</td>
<td>Observe for minimum 4-6 hours; prescribe epinephrine auto-injector; arrange allergy referral</td>
</tr>
<tr>
<td><strong>The child has urticaria and ate peanut 1 hour ago</strong></td>
<td>Assess for anaphylaxis; give epinephrine if any systemic symptoms; antihistamine if skin-only</td>
<td>Strict peanut avoidance; prescribe epinephrine; refer to allergist for testing and possible oral immunotherapy</td>
</tr>
<tr>
<td><strong>The urticaria appeared during an amoxicillin course for ear infection</strong></td>
<td>Stop amoxicillin; give antihistamine; assess severity</td>
<td>Document reaction clearly; consider if true allergy or viral-associated; refer for penicillin allergy testing to clarify</td>
</tr>
<tr>
<td><strong>The parent is anxious and wants extensive allergy testing</strong></td>
<td>Acknowledge concerns; explain that testing is only useful if directed by history</td>
<td>Targeted testing only if history suggests specific trigger; explain false-positive risks of panel testing</td>
</tr>
<tr>
<td><strong>The child has urticaria every time they swim</strong></td>
<td>Differentiate cold urticaria (cold water) from aquagenic urticaria (water itself) from exercise-induced</td>
<td>Ice cube test; counsel on swimming safety (cold urticaria can cause drowning); prophylactic antihistamines</td>
</tr>
<tr>
<td><strong>The urticaria has persisted for 8 weeks with no identified trigger</strong></td>
<td>Diagnose chronic spontaneous urticaria; perform limited baseline workup</td>
<td>Stepwise antihistamine therapy; specialist referral if uncontrolled on high-dose antihistamines</td>
</tr>
<tr>
<td><strong>The individual wheals are lasting more than 24 hours and leaving bruises</strong></td>
<td>Suspect urticarial vasculitis; this is not ordinary urticaria</td>
<td>Arrange skin biopsy; check complement and inflammatory markers; refer to dermatology or rheumatology</td>
</tr>
<tr>
<td><strong>The child has angioedema but no urticaria, and grandparent had similar episodes</strong></td>
<td>Suspect hereditary angioedema; standard urticaria treatment may not work</td>
<td>Check C4, C1-inhibitor level and function; specialist referral urgently; specific HAE treatments may be needed</td>
</tr>
<tr>
<td><strong>The child is already on maximum antihistamine dose and still having daily hives</strong></td>
<td>Confirm adherence and correct diagnosis; review for missed physical triggers</td>
<td>Add leukotriene antagonist or H2-blocker as bridge; urgent specialist referral for omalizumab consideration</td>
</tr>
<tr>
<td><strong>The family asks if the child needs to carry epinephrine</strong></td>
<td>Assess based on history: prior anaphylaxis? confirmed food allergy? insect venom allergy?</td>
<td>Prescribe if: any prior anaphylaxis, confirmed IgE-mediated food allergy, systemic reaction to insect sting; train family on use</td>
</tr>
</tbody>
</table>
</div>
<h2>Treatment Reference</h2>
<h3>Antihistamine Dosing in Children</h3>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Medication</th>
<th>Age/Weight</th>
<th>Standard Dose</th>
<th>Up-Dosing (for chronic urticaria)</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Cetirizine</strong></td>
<td>6 months to 2 years<br>2-5 years<br>6 years and older</td>
<td>2.5 mg once daily<br>2.5-5 mg once daily<br>5-10 mg once daily</td>
<td>Specialist guidance for up-dosing in young children<br>Up to 10 mg daily<br>Up to 20-40 mg daily (specialist)</td>
</tr>
<tr>
<td><strong>Loratadine</strong></td>
<td>2-5 years<br>6 years and older</td>
<td>5 mg once daily<br>10 mg once daily</td>
<td>Up to 10 mg daily<br>Up to 20-40 mg daily (specialist)</td>
</tr>
<tr>
<td><strong>Fexofenadine</strong></td>
<td>2-11 years<br>12 years and older</td>
<td>30 mg twice daily<br>180 mg once daily</td>
<td>Up to 60 mg twice daily<br>Up to 360 mg daily (specialist)</td>
</tr>
<tr>
<td><strong>Desloratadine</strong></td>
<td>1-5 years<br>6-11 years<br>12 years and older</td>
<td>1.25 mg once daily<br>2.5 mg once daily<br>5 mg once daily</td>
<td>Specialist guidance<br>Up to 5 mg daily<br>Up to 20 mg daily (specialist)</td>
</tr>
</tbody>
</table>
</div>
<div class=”callout-box tip-box”>
<div class=”callout-icon”><i class=”fa fa-lightbulb-o”></i></div>
<div class=”callout-content”>
<h4>Practical Prescribing Tips</h4>
<ul>
<li><strong>Second-generation (non-sedating) antihistamines</strong> are first-line — avoid first-generation antihistamines (diphenhydramine, chlorpheniramine) for routine use due to sedation and cognitive effects</li>
<li><strong>Continuous daily dosing</strong> is more effective than as-needed dosing for chronic urticaria</li>
<li><strong>Up-dosing</strong> (2-4× standard dose) is safe and effective for chronic urticaria — this is now standard practice before escalating to other therapies</li>
<li><strong>Response may take 2-4 weeks</strong> — counsel families to allow adequate trial period before concluding treatment failure</li>
<li><strong>Liquid formulations</strong> available for young children who cannot swallow tablets</li>
</ul>
</div>
</div>
<h3>Epinephrine Auto-Injector Dosing</h3>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Weight</th>
<th>Device</th>
<th>Dose</th>
</tr>
</thead>
<tbody>
<tr>
<td>7.5 to 25 kg</td>
<td>EpiPen Jr / Auvi-Q 0.1 mg</td>
<td>0.15 mg intramuscular (anterolateral thigh)</td>
</tr>
<tr>
<td>Greater than 25 kg</td>
<td>EpiPen / Auvi-Q 0.3 mg</td>
<td>0.3 mg intramuscular (anterolateral thigh)</td>
</tr>
</tbody>
</table>
</div>
<h2>Troubleshooting Refractory Urticaria</h2>
<div class=”callout-box takeaway-box”>
<div class=”callout-icon”><i class=”fa fa-check-square-o”></i></div>
<div class=”callout-content”>
<h4>When Urticaria Is Not Responding — Ask These Questions</h4>
<ul>
<li><strong>Is the diagnosis correct?</strong> Reconsider if lesions last greater than 24 hours, are painful, or leave marks — may be vasculitis or other mimic</li>
<li><strong>Is the patient taking the medication correctly?</strong> Assess adherence; ensure daily dosing not as-needed; check technique if liquid formulation</li>
<li><strong>Has adequate time been allowed?</strong> Antihistamines may take 2-4 weeks for full effect; families may expect immediate results</li>
<li><strong>Is the dose adequate?</strong> Standard dose may be insufficient — up-dosing to 2-4× is evidence-based and safe</li>
<li><strong>Are there ongoing triggers?</strong> Unidentified food allergen, medication, physical trigger, or chronic infection</li>
<li><strong>Is there a physical urticaria component?</strong> Dermatographism, cold, or pressure urticaria may be contributing — provocation testing helpful</li>
<li><strong>Are there exacerbating factors?</strong> NSAIDs can worsen urticaria; stress, infections, and heat may trigger flares</li>
<li><strong>Is specialist input needed?</strong> If high-dose antihistamines fail, refer for consideration of omalizumab or other advanced therapies</li>
</ul>
</div>
</div>
<h2>When to Refer to a Specialist</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Referral Indication</th>
<th>Specialist</th>
<th>Urgency</th>
</tr>
</thead>
<tbody>
<tr>
<td>Anaphylaxis — for trigger identification and management plan</td>
<td>Pediatric allergist/immunologist</td>
<td>Within 4-6 weeks of event</td>
</tr>
<tr>
<td>Confirmed or suspected food allergy requiring testing and dietary guidance</td>
<td>Pediatric allergist/immunologist</td>
<td>Routine (weeks to months)</td>
</tr>
<tr>
<td>Drug allergy requiring clarification (especially penicillin allergy)</td>
<td>Pediatric allergist/immunologist</td>
<td>Routine</td>
</tr>
<tr>
<td>Chronic urticaria uncontrolled on high-dose antihistamines</td>
<td>Pediatric allergist or dermatologist</td>
<td>Within 2-4 weeks</td>
</tr>
<tr>
<td>Suspected urticarial vasculitis (lesions greater than 24 hours, bruising)</td>
<td>Pediatric dermatologist or rheumatologist</td>
<td>Urgent (within 1-2 weeks)</td>
</tr>
<tr>
<td>Suspected hereditary angioedema</td>
<td>Pediatric allergist/immunologist</td>
<td>Urgent (within 1-2 weeks)</td>
</tr>
<tr>
<td>Suspected mastocytosis (urticaria pigmentosa, systemic symptoms)</td>
<td>Pediatric allergist or hematologist</td>
<td>Within 2-4 weeks</td>
</tr>
<tr>
<td>Cold urticaria requiring counseling on swimming safety and prophylaxis</td>
<td>Pediatric allergist</td>
<td>Routine</td>
</tr>
</tbody>
</table>
</div>
<div class=”content-footer”>
<div class=”copyright”>© Medaptly. All rights reserved.</div>
<div class=”logo”><img src=”https://medaptlytemplates.doo.ee/Medaptly_Logo-removebg-preview.png” alt=”Medaptly Logo”></div>
</div>
</div>
</div>
<!– ==================== TASK 8: PEARLS AND PITFALLS ==================== –>
<div class=”task-content” id=”task8-content”>
<div class=”task-header”>
<h1 class=”task-title”>8. Clinical Pearls and Pitfalls</h1>
<p class=”task-subtitle”>Practical wisdom — learn from successes and avoid common mistakes in pediatric urticaria</p>
</div>
<div class=”task-body”>
<!– Pearls –>
<div class=”callout-box tip-box”>
<div class=”callout-icon”><i class=”fa fa-lightbulb-o”></i></div>
<div class=”callout-content”>
<h4>Must-Know Clinical Pearls</h4>
<div class=”points-list”>
<div class=”point-item”>
<i class=”fa fa-check-circle” style=”color: #2e7d32;”></i>
<span class=”point-text”><strong>Viral infections are the most common trigger:</strong> In children with acute urticaria, viral infections account for 40-80% of cases. A child with hives and a runny nose likely has infection-associated urticaria, not a new allergy.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-check-circle” style=”color: #2e7d32;”></i>
<span class=”point-text”><strong>The transient wheal is diagnostic:</strong> True urticarial wheals resolve within 24 hours and leave no marks. If lesions persist longer, bruise, or leave pigmentation, reconsider the diagnosis — urticarial vasculitis requires different management.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-check-circle” style=”color: #2e7d32;”></i>
<span class=”point-text”><strong>Up-dosing antihistamines is safe and effective:</strong> Increasing second-generation antihistamines to 2-4 times the standard dose is evidence-based and controls an additional 60% of patients unresponsive to standard dosing.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-check-circle” style=”color: #2e7d32;”></i>
<span class=”point-text”><strong>Most acute urticaria needs no investigation:</strong> In a well-appearing child with typical urticaria, the diagnosis is clinical. Extensive testing rarely identifies a cause and may create unnecessary anxiety and dietary restrictions.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-check-circle” style=”color: #2e7d32;”></i>
<span class=”point-text”><strong>Angioedema without urticaria is a red flag:</strong> Always consider hereditary angioedema, especially with family history. This condition does not respond to antihistamines or epinephrine and requires specific treatment.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-check-circle” style=”color: #2e7d32;”></i>
<span class=”point-text”><strong>Cold urticaria requires swimming safety counseling:</strong> Swimming in cold water can trigger massive histamine release and potentially fatal cardiovascular collapse. Children with cold urticaria should never swim alone and should premedicate with antihistamines.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-check-circle” style=”color: #2e7d32;”></i>
<span class=”point-text”><strong>Photos are invaluable:</strong> The rash may have resolved by the time you see the child. Ask parents to photograph the rash when active — this aids diagnosis and reassures families that their concerns are taken seriously.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-check-circle” style=”color: #2e7d32;”></i>
<span class=”point-text”><strong>IgE-mediated food allergy causes rapid-onset urticaria:</strong> Urticaria from food allergy typically appears within minutes to 2 hours of eating. Delayed reactions (more than 4 hours) are unlikely to be IgE-mediated food allergy.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-check-circle” style=”color: #2e7d32;”></i>
<span class=”point-text”><strong>Chronic urticaria often remits spontaneously:</strong> Although frustrating, approximately 50% of children with chronic spontaneous urticaria will achieve remission within 1-3 years. Provide realistic expectations while optimizing symptom control.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-check-circle” style=”color: #2e7d32;”></i>
<span class=”point-text”><strong>When in doubt about anaphylaxis, give epinephrine:</strong> Epinephrine is safe, and the risk of undertreating anaphylaxis far exceeds the risk of giving epinephrine to someone who didn’t need it. Do not hesitate.</span>
</div>
</div>
</div>
</div>
<!– Pitfalls –>
<div class=”callout-box warning-box”>
<div class=”callout-icon”><i class=”fa fa-exclamation-triangle”></i></div>
<div class=”callout-content”>
<h4>Critical Pitfalls to Avoid</h4>
<div class=”points-list”>
<div class=”point-item”>
<i class=”fa fa-times-circle” style=”color: #d32f2f;”></i>
<span class=”point-text”><strong>Labeling every rash during antibiotics as “drug allergy”:</strong> Many children develop viral exanthems (non-urticarial, maculopapular rashes) during viral illnesses for which antibiotics were coincidentally prescribed. The classic amoxicillin-EBV rash is not a true allergy. Incorrect allergy labels lead to suboptimal antibiotic choices for life.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-times-circle” style=”color: #d32f2f;”></i>
<span class=”point-text”><strong>Ordering large allergen panels without clinical indication:</strong> “Screening” panels have high false-positive rates. A child may test positive to foods they tolerate without problems. This leads to unnecessary avoidance, nutritional deficiencies, anxiety, and reduced quality of life.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-times-circle” style=”color: #d32f2f;”></i>
<span class=”point-text”><strong>Confusing sensitization with clinical allergy:</strong> A positive skin test or specific IgE indicates sensitization, not necessarily clinical allergy. Many children have positive tests to foods they eat without symptoms. Clinical history is essential for interpretation.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-times-circle” style=”color: #d32f2f;”></i>
<span class=”point-text”><strong>Using first-generation antihistamines routinely:</strong> Diphenhydramine causes sedation, impairs learning, and has anticholinergic side effects. Second-generation antihistamines (cetirizine, loratadine, fexofenadine) are equally effective and much safer for regular use.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-times-circle” style=”color: #d32f2f;”></i>
<span class=”point-text”><strong>Missing anaphylaxis because urticaria looks “mild”:</strong> Anaphylaxis can progress rapidly. Any respiratory symptom (wheeze, stridor, throat tightness) or cardiovascular symptom (pallor, weak pulse, dizziness) with urticaria requires immediate epinephrine, regardless of how the skin looks.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-times-circle” style=”color: #d32f2f;”></i>
<span class=”point-text”><strong>Dismissing hereditary angioedema because the child is young:</strong> HAE can present in childhood. Angioedema without urticaria, especially with family history of similar episodes or unexplained swelling deaths, should prompt complement studies even in young children.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-times-circle” style=”color: #d32f2f;”></i>
<span class=”point-text”><strong>Prescribing oral corticosteroids as first-line for chronic urticaria:</strong> Steroids provide temporary relief but do not alter the course of chronic urticaria. Long-term use causes significant side effects in children. Reserve for severe acute flares only while optimizing antihistamine therapy.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-times-circle” style=”color: #d32f2f;”></i>
<span class=”point-text”><strong>Failing to counsel about swimming in cold urticaria:</strong> Cold urticaria can cause systemic anaphylaxis when the body is immersed in cold water. Children have died from swimming-related reactions. Always counsel on swimming safety and recommend prophylactic antihistamines.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-times-circle” style=”color: #d32f2f;”></i>
<span class=”point-text”><strong>Assuming chronic urticaria must have an allergic trigger:</strong> Unlike acute urticaria, chronic spontaneous urticaria is rarely caused by allergens. Extensive food elimination diets and repeated allergy testing are usually unproductive and may harm the child.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-times-circle” style=”color: #d32f2f;”></i>
<span class=”point-text”><strong>Not providing a clear action plan for families:</strong> Families need written instructions on when to give antihistamines, when to use epinephrine (if prescribed), and when to seek emergency care. Verbal advice alone is often forgotten in a crisis.</span>
</div>
</div>
</div>
</div>
<!– Key Takeaways –>
<div class=”callout-box takeaway-box”>
<div class=”callout-icon”><i class=”fa fa-check-square-o”></i></div>
<div class=”callout-content”>
<h4>Key Takeaways</h4>
<ul>
<li><strong>Always assess for anaphylaxis first</strong> — urticaria with respiratory, cardiovascular, or severe gastrointestinal symptoms requires immediate epinephrine</li>
<li><strong>Viral infections cause most acute urticaria in children</strong> — extensive workup is not needed in well-appearing children with typical urticaria</li>
<li><strong>Duration matters</strong> — acute urticaria (less than 6 weeks) is usually self-limiting; chronic urticaria (greater than 6 weeks) requires stepwise management</li>
<li><strong>True urticarial wheals are transient</strong> — individual lesions resolve within 24 hours without marks; longer-lasting or bruising lesions suggest vasculitis</li>
<li><strong>Second-generation antihistamines are first-line</strong> — safe, effective, and can be increased to 2-4 times standard dose for chronic urticaria</li>
<li><strong>Test only suspected allergens</strong> — large panels create false positives and unnecessary dietary restrictions; clinical history guides testing</li>
<li><strong>Angioedema without urticaria requires different workup</strong> — consider hereditary angioedema, which needs specific treatment</li>
<li><strong>Cold urticaria requires safety counseling</strong> — swimming in cold water can be fatal; premedicate and supervise closely</li>
<li><strong>Not every antibiotic rash is allergy</strong> — viral exanthems are common during antibiotic courses; clarify with allergy testing before permanent labeling</li>
<li><strong>Chronic urticaria often remits</strong> — provide realistic expectations while optimizing quality of life with effective treatment</li>
<li><strong>Refer to specialists when needed</strong> — anaphylaxis, confirmed food allergy, antihistamine-refractory chronic urticaria, and suspected vasculitis or HAE warrant expert management</li>
<li><strong>Empower families</strong> — provide written action plans, prescribe epinephrine when indicated, and ensure they know when to seek emergency care</li>
</ul>
</div>
</div>
<!– Quick Reference Algorithm –>
<h2>Quick Reference Algorithm</h2>
<div class=”highlight-box”>
<p><strong>Systematic Approach to Pediatric Urticaria:</strong></p>
<ol>
<li><strong>Assess for anaphylaxis:</strong> Check airway, breathing, circulation — if any concern, give epinephrine immediately</li>
<li><strong>Confirm urticaria:</strong> Raised, erythematous wheals that are pruritic, migratory, and resolve within 24 hours without residual marks</li>
<li><strong>Take focused history:</strong> Use the “WHEALS” mnemonic — When/What, How affected, Exposures, Allergies/Atopy, Lasting features, Systemic symptoms</li>
<li><strong>Examine thoroughly:</strong> Full skin examination, vital signs, assess for angioedema, look for signs of underlying cause</li>
<li><strong>Classify by duration:</strong> Acute (less than 6 weeks) vs. chronic (greater than 6 weeks) determines approach</li>
<li><strong>Identify red flags:</strong> Anaphylaxis features, lesions greater than 24 hours, angioedema without urticaria, systemic symptoms</li>
<li><strong>Investigate selectively:</strong> Most acute urticaria needs no testing; target investigations to clinical suspicion</li>
<li><strong>Treat appropriately:</strong> Second-generation antihistamines first-line; up-dose for chronic urticaria; epinephrine for anaphylaxis</li>
<li><strong>Educate and safety net:</strong> Explain diagnosis, provide written action plan, specify when to return or seek emergency care</li>
<li><strong>Refer when indicated:</strong> Anaphylaxis, suspected food allergy, antihistamine-refractory disease, vasculitis, hereditary angioedema</li>
</ol>
</div>
<h2>Quick Dosing Reference Card</h2>
<div class=”grid-2″>
<div class=”grid-item”>
<h3>Antihistamines (First-Line)</h3>
<ul>
<li><strong>Cetirizine:</strong> 2.5-10 mg daily based on age</li>
<li><strong>Loratadine:</strong> 5-10 mg daily based on age</li>
<li><strong>Fexofenadine:</strong> 30 mg twice daily (2-11 years) or 180 mg daily (12+ years)</li>
<li><strong>Up-dosing:</strong> 2-4× standard dose for chronic urticaria</li>
</ul>
</div>
<div class=”grid-item”>
<h3>Epinephrine (Anaphylaxis)</h3>
<ul>
<li><strong>7.5-25 kg:</strong> 0.15 mg intramuscular (EpiPen Jr)</li>
<li><strong>Greater than 25 kg:</strong> 0.3 mg intramuscular (EpiPen)</li>
<li><strong>Site:</strong> Anterolateral thigh</li>
<li><strong>Repeat:</strong> Every 5-15 minutes if needed</li>
</ul>
</div>
</div>
<div class=”content-footer”>
<div class=”copyright”>© Medaptly. All rights reserved.</div>
<div class=”logo”><img src=”https://medaptlytemplates.doo.ee/Medaptly_Logo-removebg-preview.png” alt=”Medaptly Logo”></div>
</div>
</div>
</div>
</div>
</div>
</div>
</body>
</html>
<div class=”task-content” id=”task7-content”>
<div class=”task-header”>
<h1 class=”task-title”>7. Pattern Recognition and Clinical Decision-Making</h1>
<p class=”task-subtitle”>Practical algorithms and decision pathways for pediatric urticaria</p>
</div>
<div class=”task-body”>
<h2>Step 1: Is This Urgent? — Triage Assessment</h2>
<p>The first priority in any child presenting with urticaria is to assess for anaphylaxis and other urgent conditions requiring immediate intervention.</p>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Clinical Scenario</th>
<th>Urgency Level</th>
<th>Immediate Action</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Urticaria with stridor, wheeze, respiratory distress, or hypotension</strong></td>
<td style=”color: #d32f2f;”><strong>EMERGENT</strong></td>
<td>Administer intramuscular epinephrine immediately; call for emergency assistance; prepare for airway management; position child appropriately</td>
</tr>
<tr>
<td><strong>Urticaria with tongue or significant lip swelling</strong></td>
<td style=”color: #d32f2f;”><strong>EMERGENT</strong></td>
<td>Administer epinephrine; close monitoring for airway compromise; do not leave child unattended; prepare for escalation</td>
</tr>
<tr>
<td><strong>Urticaria with altered consciousness or severe lethargy</strong></td>
<td style=”color: #d32f2f;”><strong>EMERGENT</strong></td>
<td>Epinephrine; IV access; fluid resuscitation; emergency team activation; consider anaphylactic shock</td>
</tr>
<tr>
<td><strong>Urticaria with persistent vomiting or severe abdominal pain</strong></td>
<td style=”color: #ff9800;”><strong>URGENT</strong></td>
<td>Assess for anaphylaxis; give epinephrine if anaphylaxis criteria met; antihistamines; close observation; IV access if needed</td>
</tr>
<tr>
<td><strong>Urticaria with fever, joint pain, and recent antibiotic use</strong></td>
<td style=”color: #ff9800;”><strong>URGENT</strong></td>
<td>Consider serum sickness-like reaction; stop offending medication; antihistamines ± corticosteroids; arrange follow-up</td>
</tr>
<tr>
<td><strong>Angioedema without urticaria (especially with family history)</strong></td>
<td style=”color: #ff9800;”><strong>URGENT</strong></td>
<td>Consider hereditary angioedema; standard treatment may be ineffective; obtain complement studies; specialist consultation</td>
</tr>
<tr>
<td><strong>Urticaria with lesions lasting greater than 24 hours or bruising</strong></td>
<td style=”color: #ff9800;”><strong>URGENT</strong></td>
<td>Consider urticarial vasculitis; arrange skin biopsy; systemic workup; dermatology or rheumatology referral</td>
</tr>
<tr>
<td><strong>Widespread urticaria, well child, no angioedema, no respiratory symptoms</strong></td>
<td style=”color: #2e7d32;”><strong>ROUTINE</strong></td>
<td>Oral antihistamine; reassurance; safety netting advice; follow-up if persistent or worsening</td>
</tr>
<tr>
<td><strong>Localized urticaria, well child, known trigger (e.g., insect bite)</strong></td>
<td style=”color: #2e7d32;”><strong>ROUTINE</strong></td>
<td>Remove trigger if possible; oral antihistamine; cool compresses; monitor for spread or systemic symptoms</td>
</tr>
<tr>
<td><strong>Chronic urticaria, stable, already on treatment</strong></td>
<td style=”color: #2e7d32;”><strong>ROUTINE</strong></td>
<td>Review treatment adherence; consider dose adjustment; arrange routine specialist follow-up if uncontrolled</td>
</tr>
</tbody>
</table>
</div>
<div class=”callout-box warning-box”>
<div class=”callout-icon”><i class=”fa fa-exclamation-triangle”></i></div>
<div class=”callout-content”>
<h4>Anaphylaxis Recognition in Children</h4>
<p>Anaphylaxis is likely when ONE of the following criteria is met:</p>
<ul>
<li><strong>Criterion 1:</strong> Acute onset (minutes to hours) with skin/mucosal involvement (urticaria, angioedema, flushing, pruritus) AND respiratory compromise OR hypotension/end-organ dysfunction</li>
<li><strong>Criterion 2:</strong> TWO OR MORE of the following rapidly after exposure to likely allergen: skin/mucosal symptoms, respiratory symptoms, hypotension, persistent gastrointestinal symptoms</li>
<li><strong>Criterion 3:</strong> Hypotension after exposure to known allergen (age-specific: systolic BP less than 70 + [2 × age in years] mmHg for children 1-10 years; less than 90 mmHg for children greater than 10 years)</li>
</ul>
<p><strong>When in doubt, treat as anaphylaxis — epinephrine is safe and potentially life-saving.</strong></p>
</div>
</div>
<h2>Step 2: Classify by Duration and Presentation</h2>
<div class=”grid-3″>
<div class=”grid-item”>
<h3>Acute Urticaria</h3>
<p><strong>Duration:</strong> Less than 6 weeks</p>
<p><strong>Action:</strong> Proceed to Algorithm A</p>
<p>Focus on: Trigger identification, symptomatic treatment, safety netting</p>
</div>
<div class=”grid-item”>
<h3>Acute Recurrent Urticaria</h3>
<p><strong>Pattern:</strong> Repeated episodes with symptom-free intervals</p>
<p><strong>Action:</strong> Proceed to Algorithm B</p>
<p>Focus on: Pattern recognition, trigger avoidance, consider allergy testing</p>
</div>
<div class=”grid-item”>
<h3>Chronic Urticaria</h3>
<p><strong>Duration:</strong> Greater than 6 weeks</p>
<p><strong>Action:</strong> Proceed to Algorithm C</p>
<p>Focus on: Limited workup, stepwise treatment, specialist referral if uncontrolled</p>
</div>
</div>
<h2>Step 3: Follow the Appropriate Algorithm</h2>
<h3>Algorithm A: Acute Urticaria in Children</h3>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Clinical Scenario</th>
<th>Most Likely Diagnosis</th>
<th>Action</th>
</tr>
</thead>
<tbody>
<tr>
<td>Well child with urticaria and concurrent or recent viral symptoms (cough, runny nose, fever, diarrhea)</td>
<td>Viral infection-associated urticaria</td>
<td>Antihistamines; reassurance that this is common and self-limiting; no allergy testing needed; follow-up if persists beyond 2 weeks</td>
</tr>
<tr>
<td>Urticaria within 2 hours of eating a specific food; reproducible pattern</td>
<td>IgE-mediated food allergy</td>
<td>Avoid suspected food; prescribe epinephrine auto-injector if moderate-severe reaction; refer for allergy testing and dietary guidance</td>
</tr>
<tr>
<td>Urticaria during or after antibiotic course; no systemic symptoms</td>
<td>Drug reaction (allergic vs. non-allergic)</td>
<td>Stop antibiotic if possible; antihistamines; document reaction; consider allergy referral for drug testing to clarify if true allergy</td>
</tr>
<tr>
<td>Urticaria 1-3 weeks after starting antibiotic; fever, joint pain, lymphadenopathy</td>
<td>Serum sickness-like reaction</td>
<td>Stop antibiotic; antihistamines and consider short course corticosteroids; supportive care; avoid same drug class in future</td>
</tr>
<tr>
<td>Urticaria after bee or wasp sting; local reaction followed by generalized hives</td>
<td>Insect venom hypersensitivity</td>
<td>Antihistamines; if systemic symptoms beyond skin — epinephrine; refer for venom immunotherapy evaluation</td>
</tr>
<tr>
<td>Well child, widespread urticaria, no identifiable trigger despite thorough history</td>
<td>Idiopathic acute urticaria</td>
<td>Antihistamines; reassurance; no investigation needed; safety netting for anaphylaxis; most resolve within days to weeks</td>
</tr>
</tbody>
</table>
</div>
<h3>Algorithm B: Acute Recurrent Urticaria in Children</h3>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Pattern Identified</th>
<th>Likely Cause</th>
<th>Action</th>
</tr>
</thead>
<tbody>
<tr>
<td>Urticaria episodes consistently associated with viral illnesses; symptom-free between infections</td>
<td>Recurrent viral-triggered urticaria</td>
<td>Reassurance that this is common in young children; will improve with age; antihistamines during episodes; no allergy workup needed</td>
</tr>
<tr>
<td>Urticaria after exposure to specific food on multiple occasions</td>
<td>Food allergy</td>
<td>Confirm with allergy testing (skin prick or specific IgE); strict avoidance; epinephrine prescription; dietitian referral</td>
</tr>
<tr>
<td>Urticaria after cold exposure (swimming, cold weather, cold foods)</td>
<td>Cold urticaria</td>
<td>Confirm with ice cube test; counsel on cold avoidance and swimming safety; prophylactic antihistamines before exposure</td>
</tr>
<tr>
<td>Small punctate wheals with exercise, hot showers, or emotional stress</td>
<td>Cholinergic urticaria</td>
<td>Pre-treatment with antihistamines; gradual warm-up before exercise; usually improves with age</td>
</tr>
<tr>
<td>Linear wheals whenever skin is scratched or rubbed</td>
<td>Symptomatic dermatographism</td>
<td>Antihistamines if symptomatic; avoid triggers (tight clothing, scratching); reassurance about benign nature</td>
</tr>
</tbody>
</table>
</div>
<h3>Algorithm C: Chronic Urticaria in Children (Greater than 6 weeks)</h3>
<div class=”highlight-box”>
<p><strong>Stepwise Management Approach:</strong></p>
<ol>
<li><strong>Step 1 — Confirm diagnosis:</strong> Ensure lesions are true urticarial wheals (transient, migratory, each lasting less than 24 hours). If not, consider urticarial vasculitis or other mimics.</li>
<li><strong>Step 2 — Rule out physical triggers:</strong> History and provocation testing for cold, heat, pressure, dermatographism. If positive, manage as chronic inducible urticaria.</li>
<li><strong>Step 3 — Limited baseline workup:</strong> CBC with differential, ESR or CRP, thyroid function and antibodies. Further testing only if clinically indicated.</li>
<li><strong>Step 4 — First-line treatment:</strong> Second-generation H1-antihistamine at standard dose (e.g., cetirizine, loratadine, fexofenadine) — daily for 2-4 weeks.</li>
<li><strong>Step 5 — If uncontrolled:</strong> Increase antihistamine to 2-4× standard dose (up-dosing) — effective in approximately 60% of patients.</li>
<li><strong>Step 6 — If still uncontrolled:</strong> Consider adding second antihistamine, H2-antihistamine, or leukotriene receptor antagonist. Refer to specialist (pediatric allergist or dermatologist).</li>
<li><strong>Step 7 — Specialist therapies:</strong> Omalizumab (anti-IgE); cyclosporine (third-line); other immunomodulators in refractory cases.</li>
</ol>
</div>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Scenario</th>
<th>Assessment</th>
<th>Action</th>
</tr>
</thead>
<tbody>
<tr>
<td>Chronic urticaria controlled on standard-dose antihistamine</td>
<td>Good response to first-line therapy</td>
<td>Continue treatment; attempt gradual reduction after 3-6 months of control; reassess periodically</td>
</tr>
<tr>
<td>Chronic urticaria not controlled on standard-dose antihistamine</td>
<td>Inadequate response to first-line therapy</td>
<td>Up-dose antihistamine to 2-4× standard dose; if still uncontrolled after 2-4 weeks, refer to specialist</td>
</tr>
<tr>
<td>Chronic urticaria with positive thyroid antibodies</td>
<td>Associated autoimmune thyroiditis</td>
<td>Monitor thyroid function; treatment of thyroid disease may improve urticaria in some cases</td>
</tr>
<tr>
<td>Chronic urticaria significantly impacting quality of life (sleep, school attendance)</td>
<td>Severe disease burden</td>
<td>Expedite specialist referral; consider short course of oral corticosteroids for acute flares while arranging specialist care</td>
</tr>
<tr>
<td>Chronic urticaria not responding to high-dose antihistamines</td>
<td>Antihistamine-refractory chronic urticaria</td>
<td>Specialist referral essential; consider omalizumab; reassess diagnosis (vasculitis, mastocytosis?)</td>
</tr>
</tbody>
</table>
</div>
<h2>”What Do I Do If…” — Decision Reference</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Clinical Situation</th>
<th>Immediate Action</th>
<th>Next Step</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>The child has urticaria with any respiratory symptom</strong></td>
<td>Treat as anaphylaxis — give intramuscular epinephrine (0.01 mg/kg, max 0.5 mg)</td>
<td>Observe for minimum 4-6 hours; prescribe epinephrine auto-injector; arrange allergy referral</td>
</tr>
<tr>
<td><strong>The child has urticaria and ate peanut 1 hour ago</strong></td>
<td>Assess for anaphylaxis; give epinephrine if any systemic symptoms; antihistamine if skin-only</td>
<td>Strict peanut avoidance; prescribe epinephrine; refer to allergist for testing and possible oral immunotherapy</td>
</tr>
<tr>
<td><strong>The urticaria appeared during an amoxicillin course for ear infection</strong></td>
<td>Stop amoxicillin; give antihistamine; assess severity</td>
<td>Document reaction clearly; consider if true allergy or viral-associated; refer for penicillin allergy testing to clarify</td>
</tr>
<tr>
<td><strong>The parent is anxious and wants extensive allergy testing</strong></td>
<td>Acknowledge concerns; explain that testing is only useful if directed by history</td>
<td>Targeted testing only if history suggests specific trigger; explain false-positive risks of panel testing</td>
</tr>
<tr>
<td><strong>The child has urticaria every time they swim</strong></td>
<td>Differentiate cold urticaria (cold water) from aquagenic urticaria (water itself) from exercise-induced</td>
<td>Ice cube test; counsel on swimming safety (cold urticaria can cause drowning); prophylactic antihistamines</td>
</tr>
<tr>
<td><strong>The urticaria has persisted for 8 weeks with no identified trigger</strong></td>
<td>Diagnose chronic spontaneous urticaria; perform limited baseline workup</td>
<td>Stepwise antihistamine therapy; specialist referral if uncontrolled on high-dose antihistamines</td>
</tr>
<tr>
<td><strong>The individual wheals are lasting more than 24 hours and leaving bruises</strong></td>
<td>Suspect urticarial vasculitis; this is not ordinary urticaria</td>
<td>Arrange skin biopsy; check complement and inflammatory markers; refer to dermatology or rheumatology</td>
</tr>
<tr>
<td><strong>The child has angioedema but no urticaria, and grandparent had similar episodes</strong></td>
<td>Suspect hereditary angioedema; standard urticaria treatment may not work</td>
<td>Check C4, C1-inhibitor level and function; specialist referral urgently; specific HAE treatments may be needed</td>
</tr>
<tr>
<td><strong>The child is already on maximum antihistamine dose and still having daily hives</strong></td>
<td>Confirm adherence and correct diagnosis; review for missed physical triggers</td>
<td>Add leukotriene antagonist or H2-blocker as bridge; urgent specialist referral for omalizumab consideration</td>
</tr>
<tr>
<td><strong>The family asks if the child needs to carry epinephrine</strong></td>
<td>Assess based on history: prior anaphylaxis? confirmed food allergy? insect venom allergy?</td>
<td>Prescribe if: any prior anaphylaxis, confirmed IgE-mediated food allergy, systemic reaction to insect sting; train family on use</td>
</tr>
</tbody>
</table>
</div>
<h2>Treatment Reference</h2>
<h3>Antihistamine Dosing in Children</h3>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Medication</th>
<th>Age/Weight</th>
<th>Standard Dose</th>
<th>Up-Dosing (for chronic urticaria)</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Cetirizine</strong></td>
<td>6 months to 2 years<br>2-5 years<br>6 years and older</td>
<td>2.5 mg once daily<br>2.5-5 mg once daily<br>5-10 mg once daily</td>
<td>Specialist guidance for up-dosing in young children<br>Up to 10 mg daily<br>Up to 20-40 mg daily (specialist)</td>
</tr>
<tr>
<td><strong>Loratadine</strong></td>
<td>2-5 years<br>6 years and older</td>
<td>5 mg once daily<br>10 mg once daily</td>
<td>Up to 10 mg daily<br>Up to 20-40 mg daily (specialist)</td>
</tr>
<tr>
<td><strong>Fexofenadine</strong></td>
<td>2-11 years<br>12 years and older</td>
<td>30 mg twice daily<br>180 mg once daily</td>
<td>Up to 60 mg twice daily<br>Up to 360 mg daily (specialist)</td>
</tr>
<tr>
<td><strong>Desloratadine</strong></td>
<td>1-5 years<br>6-11 years<br>12 years and older</td>
<td>1.25 mg once daily<br>2.5 mg once daily<br>5 mg once daily</td>
<td>Specialist guidance<br>Up to 5 mg daily<br>Up to 20 mg daily (specialist)</td>
</tr>
</tbody>
</table>
</div>
<div class=”callout-box tip-box”>
<div class=”callout-icon”><i class=”fa fa-lightbulb-o”></i></div>
<div class=”callout-content”>
<h4>Practical Prescribing Tips</h4>
<ul>
<li><strong>Second-generation (non-sedating) antihistamines</strong> are first-line — avoid first-generation antihistamines (diphenhydramine, chlorpheniramine) for routine use due to sedation and cognitive effects</li>
<li><strong>Continuous daily dosing</strong> is more effective than as-needed dosing for chronic urticaria</li>
<li><strong>Up-dosing</strong> (2-4× standard dose) is safe and effective for chronic urticaria — this is now standard practice before escalating to other therapies</li>
<li><strong>Response may take 2-4 weeks</strong> — counsel families to allow adequate trial period before concluding treatment failure</li>
<li><strong>Liquid formulations</strong> available for young children who cannot swallow tablets</li>
</ul>
</div>
</div>
<h3>Epinephrine Auto-Injector Dosing</h3>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Weight</th>
<th>Device</th>
<th>Dose</th>
</tr>
</thead>
<tbody>
<tr>
<td>7.5 to 25 kg</td>
<td>EpiPen Jr / Auvi-Q 0.1 mg</td>
<td>0.15 mg intramuscular (anterolateral thigh)</td>
</tr>
<tr>
<td>Greater than 25 kg</td>
<td>EpiPen / Auvi-Q 0.3 mg</td>
<td>0.3 mg intramuscular (anterolateral thigh)</td>
</tr>
</tbody>
</table>
</div>
<h2>Troubleshooting Refractory Urticaria</h2>
<div class=”callout-box takeaway-box”>
<div class=”callout-icon”><i class=”fa fa-check-square-o”></i></div>
<div class=”callout-content”>
<h4>When Urticaria Is Not Responding — Ask These Questions</h4>
<ul>
<li><strong>Is the diagnosis correct?</strong> Reconsider if lesions last greater than 24 hours, are painful, or leave marks — may be vasculitis or other mimic</li>
<li><strong>Is the patient taking the medication correctly?</strong> Assess adherence; ensure daily dosing not as-needed; check technique if liquid formulation</li>
<li><strong>Has adequate time been allowed?</strong> Antihistamines may take 2-4 weeks for full effect; families may expect immediate results</li>
<li><strong>Is the dose adequate?</strong> Standard dose may be insufficient — up-dosing to 2-4× is evidence-based and safe</li>
<li><strong>Are there ongoing triggers?</strong> Unidentified food allergen, medication, physical trigger, or chronic infection</li>
<li><strong>Is there a physical urticaria component?</strong> Dermatographism, cold, or pressure urticaria may be contributing — provocation testing helpful</li>
<li><strong>Are there exacerbating factors?</strong> NSAIDs can worsen urticaria; stress, infections, and heat may trigger flares</li>
<li><strong>Is specialist input needed?</strong> If high-dose antihistamines fail, refer for consideration of omalizumab or other advanced therapies</li>
</ul>
</div>
</div>
<h2>When to Refer to a Specialist</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Referral Indication</th>
<th>Specialist</th>
<th>Urgency</th>
</tr>
</thead>
<tbody>
<tr>
<td>Anaphylaxis — for trigger identification and management plan</td>
<td>Pediatric allergist/immunologist</td>
<td>Within 4-6 weeks of event</td>
</tr>
<tr>
<td>Confirmed or suspected food allergy requiring testing and dietary guidance</td>
<td>Pediatric allergist/immunologist</td>
<td>Routine (weeks to months)</td>
</tr>
<tr>
<td>Drug allergy requiring clarification (especially penicillin allergy)</td>
<td>Pediatric allergist/immunologist</td>
<td>Routine</td>
</tr>
<tr>
<td>Chronic urticaria uncontrolled on high-dose antihistamines</td>
<td>Pediatric allergist or dermatologist</td>
<td>Within 2-4 weeks</td>
</tr>
<tr>
<td>Suspected urticarial vasculitis (lesions greater than 24 hours, bruising)</td>
<td>Pediatric dermatologist or rheumatologist</td>
<td>Urgent (within 1-2 weeks)</td>
</tr>
<tr>
<td>Suspected hereditary angioedema</td>
<td>Pediatric allergist/immunologist</td>
<td>Urgent (within 1-2 weeks)</td>
</tr>
<tr>
<td>Suspected mastocytosis (urticaria pigmentosa, systemic symptoms)</td>
<td>Pediatric allergist or hematologist</td>
<td>Within 2-4 weeks</td>
</tr>
<tr>
<td>Cold urticaria requiring counseling on swimming safety and prophylaxis</td>
<td>Pediatric allergist</td>
<td>Routine</td>
</tr>
</tbody>
</table>
</div>
<div class=”content-footer”>
<div class=”copyright”>© Medaptly. All rights reserved.</div>
<div class=”logo”><img src=”https://medaptlytemplates.doo.ee/Medaptly_Logo-removebg-preview.png” alt=”Medaptly Logo”></div>
</div>
</div>
</div>
<!– ==================== TASK 8: PEARLS AND PITFALLS ==================== –>
<div class=”task-content” id=”task8-content”>
<div class=”task-header”>
<h1 class=”task-title”>8. Clinical Pearls and Pitfalls</h1>
<p class=”task-subtitle”>Practical wisdom — learn from successes and avoid common mistakes in pediatric urticaria</p>
</div>
<div class=”task-body”>
<!– Pearls –>
<div class=”callout-box tip-box”>
<div class=”callout-icon”><i class=”fa fa-lightbulb-o”></i></div>
<div class=”callout-content”>
<h4>Must-Know Clinical Pearls</h4>
<div class=”points-list”>
<div class=”point-item”>
<i class=”fa fa-check-circle” style=”color: #2e7d32;”></i>
<span class=”point-text”><strong>Viral infections are the most common trigger:</strong> In children with acute urticaria, viral infections account for 40-80% of cases. A child with hives and a runny nose likely has infection-associated urticaria, not a new allergy.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-check-circle” style=”color: #2e7d32;”></i>
<span class=”point-text”><strong>The transient wheal is diagnostic:</strong> True urticarial wheals resolve within 24 hours and leave no marks. If lesions persist longer, bruise, or leave pigmentation, reconsider the diagnosis — urticarial vasculitis requires different management.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-check-circle” style=”color: #2e7d32;”></i>
<span class=”point-text”><strong>Up-dosing antihistamines is safe and effective:</strong> Increasing second-generation antihistamines to 2-4 times the standard dose is evidence-based and controls an additional 60% of patients unresponsive to standard dosing.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-check-circle” style=”color: #2e7d32;”></i>
<span class=”point-text”><strong>Most acute urticaria needs no investigation:</strong> In a well-appearing child with typical urticaria, the diagnosis is clinical. Extensive testing rarely identifies a cause and may create unnecessary anxiety and dietary restrictions.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-check-circle” style=”color: #2e7d32;”></i>
<span class=”point-text”><strong>Angioedema without urticaria is a red flag:</strong> Always consider hereditary angioedema, especially with family history. This condition does not respond to antihistamines or epinephrine and requires specific treatment.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-check-circle” style=”color: #2e7d32;”></i>
<span class=”point-text”><strong>Cold urticaria requires swimming safety counseling:</strong> Swimming in cold water can trigger massive histamine release and potentially fatal cardiovascular collapse. Children with cold urticaria should never swim alone and should premedicate with antihistamines.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-check-circle” style=”color: #2e7d32;”></i>
<span class=”point-text”><strong>Photos are invaluable:</strong> The rash may have resolved by the time you see the child. Ask parents to photograph the rash when active — this aids diagnosis and reassures families that their concerns are taken seriously.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-check-circle” style=”color: #2e7d32;”></i>
<span class=”point-text”><strong>IgE-mediated food allergy causes rapid-onset urticaria:</strong> Urticaria from food allergy typically appears within minutes to 2 hours of eating. Delayed reactions (more than 4 hours) are unlikely to be IgE-mediated food allergy.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-check-circle” style=”color: #2e7d32;”></i>
<span class=”point-text”><strong>Chronic urticaria often remits spontaneously:</strong> Although frustrating, approximately 50% of children with chronic spontaneous urticaria will achieve remission within 1-3 years. Provide realistic expectations while optimizing symptom control.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-check-circle” style=”color: #2e7d32;”></i>
<span class=”point-text”><strong>When in doubt about anaphylaxis, give epinephrine:</strong> Epinephrine is safe, and the risk of undertreating anaphylaxis far exceeds the risk of giving epinephrine to someone who didn’t need it. Do not hesitate.</span>
</div>
</div>
</div>
</div>
<!– Pitfalls –>
<div class=”callout-box warning-box”>
<div class=”callout-icon”><i class=”fa fa-exclamation-triangle”></i></div>
<div class=”callout-content”>
<h4>Critical Pitfalls to Avoid</h4>
<div class=”points-list”>
<div class=”point-item”>
<i class=”fa fa-times-circle” style=”color: #d32f2f;”></i>
<span class=”point-text”><strong>Labeling every rash during antibiotics as “drug allergy”:</strong> Many children develop viral exanthems (non-urticarial, maculopapular rashes) during viral illnesses for which antibiotics were coincidentally prescribed. The classic amoxicillin-EBV rash is not a true allergy. Incorrect allergy labels lead to suboptimal antibiotic choices for life.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-times-circle” style=”color: #d32f2f;”></i>
<span class=”point-text”><strong>Ordering large allergen panels without clinical indication:</strong> “Screening” panels have high false-positive rates. A child may test positive to foods they tolerate without problems. This leads to unnecessary avoidance, nutritional deficiencies, anxiety, and reduced quality of life.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-times-circle” style=”color: #d32f2f;”></i>
<span class=”point-text”><strong>Confusing sensitization with clinical allergy:</strong> A positive skin test or specific IgE indicates sensitization, not necessarily clinical allergy. Many children have positive tests to foods they eat without symptoms. Clinical history is essential for interpretation.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-times-circle” style=”color: #d32f2f;”></i>
<span class=”point-text”><strong>Using first-generation antihistamines routinely:</strong> Diphenhydramine causes sedation, impairs learning, and has anticholinergic side effects. Second-generation antihistamines (cetirizine, loratadine, fexofenadine) are equally effective and much safer for regular use.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-times-circle” style=”color: #d32f2f;”></i>
<span class=”point-text”><strong>Missing anaphylaxis because urticaria looks “mild”:</strong> Anaphylaxis can progress rapidly. Any respiratory symptom (wheeze, stridor, throat tightness) or cardiovascular symptom (pallor, weak pulse, dizziness) with urticaria requires immediate epinephrine, regardless of how the skin looks.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-times-circle” style=”color: #d32f2f;”></i>
<span class=”point-text”><strong>Dismissing hereditary angioedema because the child is young:</strong> HAE can present in childhood. Angioedema without urticaria, especially with family history of similar episodes or unexplained swelling deaths, should prompt complement studies even in young children.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-times-circle” style=”color: #d32f2f;”></i>
<span class=”point-text”><strong>Prescribing oral corticosteroids as first-line for chronic urticaria:</strong> Steroids provide temporary relief but do not alter the course of chronic urticaria. Long-term use causes significant side effects in children. Reserve for severe acute flares only while optimizing antihistamine therapy.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-times-circle” style=”color: #d32f2f;”></i>
<span class=”point-text”><strong>Failing to counsel about swimming in cold urticaria:</strong> Cold urticaria can cause systemic anaphylaxis when the body is immersed in cold water. Children have died from swimming-related reactions. Always counsel on swimming safety and recommend prophylactic antihistamines.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-times-circle” style=”color: #d32f2f;”></i>
<span class=”point-text”><strong>Assuming chronic urticaria must have an allergic trigger:</strong> Unlike acute urticaria, chronic spontaneous urticaria is rarely caused by allergens. Extensive food elimination diets and repeated allergy testing are usually unproductive and may harm the child.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-times-circle” style=”color: #d32f2f;”></i>
<span class=”point-text”><strong>Not providing a clear action plan for families:</strong> Families need written instructions on when to give antihistamines, when to use epinephrine (if prescribed), and when to seek emergency care. Verbal advice alone is often forgotten in a crisis.</span>
</div>
</div>
</div>
</div>
<!– Key Takeaways –>
<div class=”callout-box takeaway-box”>
<div class=”callout-icon”><i class=”fa fa-check-square-o”></i></div>
<div class=”callout-content”>
<h4>Key Takeaways</h4>
<ul>
<li><strong>Always assess for anaphylaxis first</strong> — urticaria with respiratory, cardiovascular, or severe gastrointestinal symptoms requires immediate epinephrine</li>
<li><strong>Viral infections cause most acute urticaria in children</strong> — extensive workup is not needed in well-appearing children with typical urticaria</li>
<li><strong>Duration matters</strong> — acute urticaria (less than 6 weeks) is usually self-limiting; chronic urticaria (greater than 6 weeks) requires stepwise management</li>
<li><strong>True urticarial wheals are transient</strong> — individual lesions resolve within 24 hours without marks; longer-lasting or bruising lesions suggest vasculitis</li>
<li><strong>Second-generation antihistamines are first-line</strong> — safe, effective, and can be increased to 2-4 times standard dose for chronic urticaria</li>
<li><strong>Test only suspected allergens</strong> — large panels create false positives and unnecessary dietary restrictions; clinical history guides testing</li>
<li><strong>Angioedema without urticaria requires different workup</strong> — consider hereditary angioedema, which needs specific treatment</li>
<li><strong>Cold urticaria requires safety counseling</strong> — swimming in cold water can be fatal; premedicate and supervise closely</li>
<li><strong>Not every antibiotic rash is allergy</strong> — viral exanthems are common during antibiotic courses; clarify with allergy testing before permanent labeling</li>
<li><strong>Chronic urticaria often remits</strong> — provide realistic expectations while optimizing quality of life with effective treatment</li>
<li><strong>Refer to specialists when needed</strong> — anaphylaxis, confirmed food allergy, antihistamine-refractory chronic urticaria, and suspected vasculitis or HAE warrant expert management</li>
<li><strong>Empower families</strong> — provide written action plans, prescribe epinephrine when indicated, and ensure they know when to seek emergency care</li>
</ul>
</div>
</div>
<!– Quick Reference Algorithm –>
<h2>Quick Reference Algorithm</h2>
<div class=”highlight-box”>
<p><strong>Systematic Approach to Pediatric Urticaria:</strong></p>
<ol>
<li><strong>Assess for anaphylaxis:</strong> Check airway, breathing, circulation — if any concern, give epinephrine immediately</li>
<li><strong>Confirm urticaria:</strong> Raised, erythematous wheals that are pruritic, migratory, and resolve within 24 hours without residual marks</li>
<li><strong>Take focused history:</strong> Use the “WHEALS” mnemonic — When/What, How affected, Exposures, Allergies/Atopy, Lasting features, Systemic symptoms</li>
<li><strong>Examine thoroughly:</strong> Full skin examination, vital signs, assess for angioedema, look for signs of underlying cause</li>
<li><strong>Classify by duration:</strong> Acute (less than 6 weeks) vs. chronic (greater than 6 weeks) determines approach</li>
<li><strong>Identify red flags:</strong> Anaphylaxis features, lesions greater than 24 hours, angioedema without urticaria, systemic symptoms</li>
<li><strong>Investigate selectively:</strong> Most acute urticaria needs no testing; target investigations to clinical suspicion</li>
<li><strong>Treat appropriately:</strong> Second-generation antihistamines first-line; up-dose for chronic urticaria; epinephrine for anaphylaxis</li>
<li><strong>Educate and safety net:</strong> Explain diagnosis, provide written action plan, specify when to return or seek emergency care</li>
<li><strong>Refer when indicated:</strong> Anaphylaxis, suspected food allergy, antihistamine-refractory disease, vasculitis, hereditary angioedema</li>
</ol>
</div>
<h2>Quick Dosing Reference Card</h2>
<div class=”grid-2″>
<div class=”grid-item”>
<h3>Antihistamines (First-Line)</h3>
<ul>
<li><strong>Cetirizine:</strong> 2.5-10 mg daily based on age</li>
<li><strong>Loratadine:</strong> 5-10 mg daily based on age</li>
<li><strong>Fexofenadine:</strong> 30 mg twice daily (2-11 years) or 180 mg daily (12+ years)</li>
<li><strong>Up-dosing:</strong> 2-4× standard dose for chronic urticaria</li>
</ul>
</div>
<div class=”grid-item”>
<h3>Epinephrine (Anaphylaxis)</h3>
<ul>
<li><strong>7.5-25 kg:</strong> 0.15 mg intramuscular (EpiPen Jr)</li>
<li><strong>Greater than 25 kg:</strong> 0.3 mg intramuscular (EpiPen)</li>
<li><strong>Site:</strong> Anterolateral thigh</li>
<li><strong>Repeat:</strong> Every 5-15 minutes if needed</li>
</ul>
</div>
</div>
<div class=”content-footer”>
<div class=”copyright”>© Medaptly. All rights reserved.</div>
<div class=”logo”><img src=”https://medaptlytemplates.doo.ee/Medaptly_Logo-removebg-preview.png” alt=”Medaptly Logo”></div>
</div>
</div>
</div>
</div>
</div>
</div>
</body>
</html>